<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">Rev Saude Publica</journal-id>
			<journal-id journal-id-type="publisher-id">rsp</journal-id>
			<journal-title-group>
				<journal-title>Revista de Saúde Pública</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Rev. Saúde Pública</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0034-8910</issn>
			<issn pub-type="epub">1518-8787</issn>
			<publisher>
				<publisher-name>Faculdade de Saúde Pública da Universidade de São Paulo</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="other">00213</article-id>
			<article-id pub-id-type="doi">10.11606/s1518-8787.2022056003651</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Original Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Tobacco-related neoplasms: survival analysis and risk of death of population data from Florianópolis, SC</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-6339-7832</contrib-id>
					<name>
						<surname>Schneider</surname>
						<given-names>Ione Jayce Ceola</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>I</sup></xref>
					<xref ref-type="aff" rid="aff2"><sup>II</sup></xref>
					<xref ref-type="aff" rid="aff3"><sup>III</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-9055-0588</contrib-id>
					<name>
						<surname>Schmidt</surname>
						<given-names>Tauana Prestes</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>II</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-8972-2231</contrib-id>
					<name>
						<surname>Correa</surname>
						<given-names>Vanessa Pereira</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>II</sup></xref>
					<xref ref-type="aff" rid="aff3"><sup>III</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-8321-2700</contrib-id>
					<name>
						<surname>Santos</surname>
						<given-names>Ana Maria Martins dos</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>II</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-2787-6136</contrib-id>
					<name>
						<surname>Rocha</surname>
						<given-names>Bruna Vanti da</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>II</sup></xref>
					<xref ref-type="aff" rid="aff3"><sup>III</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-8601-7166</contrib-id>
					<name>
						<surname>Garcia</surname>
						<given-names>Leandro Pereira</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>IV</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-0846-1376</contrib-id>
					<name>
						<surname>Ceccon</surname>
						<given-names>Roger Flores</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>I</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>I</label>
				<institution content-type="orgname">Universidade Federal de Santa Catarina</institution>
				<institution content-type="orgdiv1">Departamento de Ciências da Saúde</institution>
				<addr-line>
					<named-content content-type="city">Araranguá</named-content>
					<named-content content-type="state">SC</named-content>
				</addr-line>
				<country country="BR">Brasil</country>
				<institution content-type="original">Universidade Federal de Santa Catarina. Departamento de Ciências da Saúde. Araranguá, SC, Brasil</institution>
			</aff>
			<aff id="aff2">
				<label>II</label>
				<institution content-type="orgname">Universidade Federal de Santa Catarina</institution>
				<institution content-type="orgdiv1">Programa de Pós-Graduação em Ciências da Reabilitação</institution>
				<addr-line>
					<named-content content-type="city">Araranguá</named-content>
					<named-content content-type="state">SC</named-content>
				</addr-line>
				<country country="BR">Brasil</country>
				<institution content-type="original">Universidade Federal de Santa Catarina. Programa de Pós-Graduação em Ciências da Reabilitação. Araranguá, SC, Brasil</institution>
			</aff>
			<aff id="aff3">
				<label>III</label>
				<institution content-type="orgname">Universidade Federal de Santa Catarina</institution>
				<institution content-type="orgdiv1">Programa de Pós-Graduação em Saúde Coletiva</institution>
				<addr-line>
					<named-content content-type="city">Florianópolis</named-content>
					<named-content content-type="state">SC</named-content>
				</addr-line>
				<country country="BR">Brasil</country>
				<institution content-type="original">Universidade Federal de Santa Catarina. Programa de Pós-Graduação em Saúde Coletiva. Florianópolis, SC, Brasil</institution>
			</aff>
			<aff id="aff4">
				<label>IV</label>
				<institution content-type="orgname">Secretaria Municipal de Saúde de Florianópolis</institution>
				<addr-line>
					<named-content content-type="city">Florianópolis</named-content>
					<named-content content-type="state">SC</named-content>
				</addr-line>
				<country country="BR">Brasil</country>
				<institution content-type="original">Secretaria Municipal de Saúde de Florianópolis. Florianópolis, SC, Brasil</institution>
			</aff>
			<author-notes>
				<corresp id="c01"> Correspondence: Ione Jayce Ceola Schneider Rodovia Governador Jorge Lacerda, 3.201 88906-072 Araranguá, SC, Brasil E-mail: <email>ione.schneider@ufsc.br</email>
				</corresp>
				<fn fn-type="con">
					<p><bold>Authors’ Contribution:</bold> Study design and planning: IJCS, TPS. Data collection, analysis and interpretation: IJCS, TPS, VPC, AMMS, LPG. Drafting or reviewing the manuscript: IJCS, TPS, VPC, AMMS, BVR, LPG, RFC. Final version approval: IJCS, TPS, VPC, AMMS, BVR, LPG, RFC. Public responsibility for the content of the article: IJCS, RFC.</p>
				</fn>
				<fn fn-type="conflict">
					<p><bold>Conflict of Interest:</bold> The authors declare no conflict of interest.</p>
				</fn>
			</author-notes>
			<pub-date date-type="pub" publication-format="electronic">
				<day>08</day>
				<month>04</month>
				<year>2022</year>
			</pub-date>
			<pub-date date-type="collection" publication-format="electronic">
				<year>2022</year>
			</pub-date>
			<volume>56</volume>
			<elocation-id>16</elocation-id>
			<history>
				<date date-type="received">
					<day>9</day>
					<month>03</month>
					<year>2021</year>
				</date>
				<date date-type="accepted">
					<day>31</day>
					<month>05</month>
					<year>2021</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
					<license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p>
				</license>
			</permissions>
			<abstract>
				<title>ABSTRACT</title>
				<sec>
					<title>OBJECTIVE</title>
					<p> To estimate the probability of survival and prognostic factors for tobacco-related neoplasms in a population-based cohort.</p>
				</sec>
				<sec>
					<title>METHODS</title>
					<p> This is a cohort with data from the Population-Based Cancer Registry of Florianópolis, southern Brazil, from 2008 to 2012. The Stata 16.0 software was used to estimate the probabilities of survival in five years after diagnosis, by the Kaplan Meier method, and the risk of death, by the Cox regression.</p>
				</sec>
				<sec>
					<title>RESULTS</title>
					<p> A total of 2,829 cancer records related to smoking were included, more prevalent among males, over 70 years of age, nine years or more of schooling, white, with a partner and metastatic diagnosis. The most frequent groupings were colon and rectum (28.7%), trachea, bronchi and lungs (18.6%) and stomach (11.8%). At follow-up, 1,450 died. Pancreatic cancer had the worst probability of survival (14.3%), followed by liver cancer (19.4%).</p>
				</sec>
				<sec>
					<title>CONCLUSION</title>
					<p> Risk factors for death and survival rates differ across the 13 types of tobacco-related cancers. Early diagnosis and primary prevention are strategies that must be improved to improve survival and decrease the burden related to these types of cancer.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="en">
				<kwd>Tobacco Use Disorder</kwd>
				<kwd>Neoplasms, epidemiology</kwd>
				<kwd>Survival Analysis</kwd>
				<kwd>Risk Factors</kwd>
				<kwd>Mortality</kwd>
				<kwd>Proportional Hazards Models</kwd>
			</kwd-group>
			<funding-group>
				<award-group>
					<funding-source>PPSUS</funding-source>
					<award-id>2016RT2206</award-id>
				</award-group>
				<funding-statement>Funding: Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina, Programa de Pesquisa para o SUS: Gestão Compartilhada em Saúde (PPSUS – Research Program for the SUS: Shared Management in Health - Grant No. 2016RT2206).</funding-statement>
			</funding-group>
			<counts>
				<fig-count count="2"/>
				<table-count count="8"/>
				<equation-count count="0"/>
				<ref-count count="33"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>INTRODUCTION</title>
			<p>Smoking is characterized as an important public health problem and is considered the second most prevalent modifiable risk factor for chronic non-communicable diseases (NCDs) and for global mortality. In Brazil, currently, there are more than 7 million active smokers and 1.2 million passive smokers. Furthermore, 428 people die daily as a result of nicotine dependence, 56.9 billion reais are spent annually on medical expenses and lost productivity, and 156,216 annual deaths could be avoided by reducing tobacco use<sup><xref ref-type="bibr" rid="B1">1</xref></sup>.</p>
			<p>The incidence of tobacco-related cancer has increased significantly in recent years, mainly tumors in the oral cavity, pharynx, esophagus, stomach, colon, rectum, liver, pancreas, larynx, lung, bronchi, trachea, kidneys, urinary bladder, and uterine colon, in addition to acute myeloid leukemia (AML)<sup><xref ref-type="bibr" rid="B2">2</xref></sup>. In 2015, cancer was one of the main causes of years of life lost due to disability attributable to smoking and was the cause of 20% of all deaths from the disease<sup><xref ref-type="bibr" rid="B3">3</xref></sup>.</p>
			<p>Worldwide, it is estimated that 18 million people were diagnosed with cancer and 9.6 million died in 2018, most of them male and in low- and middle-income countries<sup><xref ref-type="bibr" rid="B4">4</xref></sup>. In Brazil, the incidence is over 500,000 new cases, mortality exceeded 100,000 deaths in the same period and the expected survival rate for all cancers is approximately 50% in five years<sup><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref></sup>.</p>
			<p>Survival is defined as the period for which a patient remains alive after diagnosis of the disease or treatment initiation. Although it is an important indicator to measure the magnitude of smoking and cancer in the population, survival after the diagnosis of tumors caused by tobacco is still unknown in Brazil. Furthermore, the analysis of survival makes it possible to evaluate the actions in the oncology area implemented in the country in recent years, as well as their prognostic factors. Furthermore, the study of survival allows to know the behavior of the disease, enabling an approach that provides better quality of life to affected individuals<sup><xref ref-type="bibr" rid="B6">6</xref></sup>.</p>
			<p>There are few reports in the scientific literature about the survival of people with tobacco-related cancer, although it is clear that greater cigarette consumption is associated with worse disease progression<sup><xref ref-type="bibr" rid="B2">2</xref></sup>.</p>
			<p>Thus, the aim of this study was to estimate the probability of survival and prognostic factors for smoking-related neoplasms in a population-based cohort.</p>
		</sec>
		<sec sec-type="methods">
			<title>METHODS</title>
			<p>This is a population-based cohort with data from the Municipal Cancer Registry of Florianópolis, a municipality located in the southern region of the country. It is the capital of the state of Santa Catarina, has approximately 500 thousand residents, and is characterized by its very high Human Development Index (HDI): 0.815, mainly ascribed to longevity and income<sup><xref ref-type="bibr" rid="B7">7</xref></sup>. The municipality has high coverage and consolidated experience in primary care, reflecting good results in tracking and early detection of the health conditions of its population. In addition, care for oncology patients, in medium and high complexity, is covered by more than six hospital centers, in addition to associations dedicated to raising awareness and seeking the rights of people with cancer.</p>
			<p>The participants is composed of individuals registered in the Population-Based Cancer Registry (RCBP) of Florianópolis, from January 1, 2008 to December 31, 2012, with a diagnosis of smoking-related cancer. The cancers included were those with the International Classification of Diseases for Oncology (ICD-O)<sup><xref ref-type="bibr" rid="B8">8</xref></sup>code considered smoking-related<sup><xref ref-type="bibr" rid="B9">9</xref></sup>. These include cancers of the lips and oral cavity (C00-C08); nasopharynx (C11); other pharynxes (C09-C10, C12-C14); esophagus (C15); stomach (C16); colon and rectum (C18-C21); liver (C22); pancreas (C25); larynx (C32); trachea, bronchi and lungs (C33-C34); kidney (C64-C66); bladder (C67) and acute myeloid leukemia (C92.0). Cases that had the means of diagnosis registered as not available or in which the diagnosis was exclusively performed by the death verification service were excluded. The cases of cervical and ovarian cancer, despite being tobacco-related, were not included in the analyses, even with tobacco as a causal factor. Cervical mucus from smokers is more mutagenic and suggests an association with DNA damage in women with cervical cancer. In ovarian cancer, the data suggest that it is associated only with the mucinous type, in which smoking may contribute to a faster progression from the benign to the malignant form. These last two were not added to the analyses because they refer exclusively to females and Brazil has specific public policies for women’s health, especially with a strategic action to track cervical cancer.</p>
			<p>To make it possible to follow up on cases registered in the RCBP and estimate survival, information regarding deaths, such as date and underlying cause, is needed. For this, the Brazilian Mortality Information System (SIM) of the Ministry of Health was used, with information referring to the municipality of Florianópolis in the period from January 1, 2008 to December 31, 2017. The creation of the database was based on the technique of probabilistic relationship of records, which allows the integration of databases of different nature, contributing to the improvement of the quality of recorded data<sup><xref ref-type="bibr" rid="B12">12</xref></sup>. For this, the OpenRecLink 3.1 software was used. For data pairing, the following SIM variables were used: death certificate number, name, date of birth, mother’s name, date of death, underlying cause of death; and from the RCBP bank: registration number, name, date of birth, mother’s name. The relationship parameters followed the software instructions. After linking the databases, a single database was created containing all the information relevant to the study, allowing data analysis.</p>
			<p>Survival time was calculated as the time, in months, between the date of diagnosis and the date of death or end of follow-up. The maximum follow-up time was 60 months. All cases not found in the SIM were considered alive at the end of follow-up and censored.</p>
			<p>The independent variables were gender (female, male), age group (with cutoff points for each type of cancer), race/color (white, black/brown/indigenous/yellow, no information), schooling (9 years or more, 8 years or less, no information), marital status (with partner, no partner, no information), extension of cancer (localized, metastasis, no information) and year of diagnosis (2008, 2009, 2010, 2011, 2012).</p>
			<p>Initially, a descriptive analysis was performed with absolute and relative frequency of independent variables. Afterwards, a bivariate analysis was performed between the independent variables and the status variable (censorship/death) to estimate the incidence of deaths in each category and Pearson’s chi-square test was used to test the association between the variables. These analyses were performed for all cases and for each type of cancer.</p>
			<p>For each type of cancer, the probability of survival was estimated using the Kaplan-Meier method. We used the log-rank test to compare survival curves stratified by independent variables. The effect of the independent variables was estimated by the semiparametric model of proportional hazards of crude and adjusted Cox. The adjusted analysis included variables with p-value &lt; 0.20. For data analysis and construction of survival graphs, we used the Stata statistical program (Stata Corp, v.16.0. Stata Statistical Software. College Station: StataCorp LP, 2021).</p>
			<p>This research was based on ethical principles, based on Resolution No. 466, of December 12, 2012, of the National Health Council, and approved under CAAE: 53518116.1.0000.0121.</p>
			<p>This work is the result of the project financed by <italic>Fundação de Amparo à Pesquisa e Inovação</italic> of the State of Santa Catarina, in the <italic>Programa de Pesquisa para o SUS: Gestão Compartilhada em Saúde</italic> (PPSUS – Research Program for the SUS: Shared Management in Health) (Grant No. 2016RT2206).</p>
		</sec>
		<sec sec-type="results">
			<title>RESULTS</title>
			<sec>
				<title>General description</title>
				<p>In the period from January 1, 2008 to December 31, 2012, 3,012 cases of tobacco-related cancer were registered by the RCBP in the municipality of Florianópolis. Of these, 189 were excluded because they were diagnosed by death verification service or because the diagnostic method was not available. Thus, the population of this study is composed of 2,829 records (<xref ref-type="table" rid="t1">Table 1</xref>).</p>
				<p>
					<table-wrap id="t1">
						<label>Table 1</label>
						<caption>
							<title>Description and survival of registered cases of tobacco-related cancer, Florianópolis, 2008–2017.</title>
						</caption>
						<table frame="hsides" rules="groups">
							<colgroup>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left" rowspan="3">Variables</th>
									<th rowspan="3">n (%)</th>
									<th>Deaths</th>
									<th rowspan="3">p<sup>a</sup></th>
									<th rowspan="3">S(t) (95%CI)</th>
									<th rowspan="3">p<sup>b</sup></th>
								</tr>
								<tr>
									<th>
										<hr/>
									</th>
								</tr>
								<tr>
									<th>n (%)</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.009</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">1,104 (39.0)</td>
									<td align="center">532 (48.2)</td>
									<td>
									</td>
									<td align="center">51.8 (48.8–54.7)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">1,725 (61.0)</td>
									<td align="center">918 (53.2)</td>
									<td>
									</td>
									<td align="center">46.8 (44.4–49.1)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">414 (14.6)</td>
									<td align="center">144 (34.8)</td>
									<td>
									</td>
									<td align="center">65.2 (60.4–69.6)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">684 (24.2)</td>
									<td align="center">311 (45.4)</td>
									<td>
									</td>
									<td align="center">54.6 (50.8–58.2)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">766 (27.1)</td>
									<td align="center">395 (51.6)</td>
									<td>
									</td>
									<td align="center">48.4 (44.9–51.9)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">962 (34.0)</td>
									<td align="center">600 (62.4)</td>
									<td>
									</td>
									<td align="center">37.6 (34.6–40.7)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0 .001</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">1,311 (46.3)</td>
									<td align="center">640 (48.8)</td>
									<td>
									</td>
									<td align="center">51.2 (48.4–53.9)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">1,146 (40.5)</td>
									<td align="center">665 (58.0)</td>
									<td>
									</td>
									<td align="center">42.0 (39.1–44.8)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">372 (13.2)</td>
									<td align="center">145 (39.0)</td>
									<td>
									</td>
									<td align="center">61.0 (55.9–65.8)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">2,472 (87.4)</td>
									<td align="center">1,282 (51.9)</td>
									<td>
									</td>
									<td align="center">48.1 (46.2–50.1)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">172 (6.1)</td>
									<td align="center">108 (62.8)</td>
									<td>
									</td>
									<td align="center">37.2 (30.0–44.4)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">185 (6.5)</td>
									<td align="center">60 (32.4)</td>
									<td>
									</td>
									<td align="center">67.6 (60.3–73.8)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">1,598 (56.5)</td>
									<td align="center">824 (51.6)</td>
									<td>
									</td>
									<td align="center">48.4 (46.0–50.9)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">884 (31.3)</td>
									<td align="center">499 (56.5)</td>
									<td>
									</td>
									<td align="center">43.6 (40.3–46.8)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">347 (12.3)</td>
									<td align="center">127 (36.6)</td>
									<td>
									</td>
									<td align="center">63.4 (58.1–68.2)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
								</tr>
								<tr>
									<td>In situ</td>
									<td align="center">48 (1.7)</td>
									<td align="center">10 (20.8)</td>
									<td>
									</td>
									<td align="center">79.2 (64.7–88.2)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">541 (19.1)</td>
									<td align="center">173 (32.0)</td>
									<td>
									</td>
									<td align="center">68.0 (63.9–71.8)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">1,104 (39.0)</td>
									<td align="center">761 (68.9)</td>
									<td>
									</td>
									<td align="center">31.1 (28.4–33.8)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Not applicable</td>
									<td align="center">28 (1.0)</td>
									<td align="center">17 (60.7)</td>
									<td>
									</td>
									<td align="center">39.3 (21.7–56.5)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">1,108 (39.2)</td>
									<td align="center">489 (44.1)</td>
									<td>
									</td>
									<td align="center">55.9 (52.9–58.7)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Grouping</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
								</tr>
								<tr>
									<td>Lip and oral cavity (C00-C08)</td>
									<td align="center">165 (5.8)</td>
									<td align="center">65 (39.4)</td>
									<td>
									</td>
									<td align="center">60.6 (52.7–67.6)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Other pharynxes (C09-10; C12-14)</td>
									<td align="center">72 (2.6)</td>
									<td align="center">43 (59.7)</td>
									<td>
									</td>
									<td align="center">40.3 (29.0–51.3)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Nasopharynx (C11)</td>
									<td align="center">24 (0.9)</td>
									<td align="center">12 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (29.1–67.8)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Esophagus (C15)</td>
									<td align="center">104 (3.7)</td>
									<td align="center">71 (67.6)</td>
									<td>
									</td>
									<td align="center">32.4 (23.7–41.4)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Stomach (C16)</td>
									<td align="center">333 (11.8)</td>
									<td align="center">200 (60.1)</td>
									<td>
									</td>
									<td align="center">39.9 (34.7–45.2)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Colon and rectum (C18-21)</td>
									<td align="center">813 (28.7)</td>
									<td align="center">291 (35.8)</td>
									<td>
									</td>
									<td align="center">64.2 (60.8–67.4)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Liver (C22)</td>
									<td align="center">103 (3.6)</td>
									<td align="center">83 (80.6)</td>
									<td>
									</td>
									<td align="center">19.4 (12.5–27.6)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Pancreas (C25)</td>
									<td align="center">112 (4.0)</td>
									<td align="center">96 (85.7)</td>
									<td>
									</td>
									<td align="center">14.3 (8.6–21.4)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Larynx (C32)</td>
									<td align="center">88 (3.1)</td>
									<td align="center">36 (40.9)</td>
									<td>
									</td>
									<td align="center">59.1 (48.1–68.5)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Trachea. Bronchi and Lungs (C33-C34)</td>
									<td align="center">527 (18.6)</td>
									<td align="center">407 (77.2)</td>
									<td>
									</td>
									<td align="center">22.8 (19.3–26.4)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Kidney (C64-C66)</td>
									<td align="center">177 (6.3)</td>
									<td align="center">43 (24.3)</td>
									<td>
									</td>
									<td align="center">75.7 (68.7–81.4)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Bladder (C67)</td>
									<td align="center">282 (10.0)</td>
									<td align="center">86 (30.5)</td>
									<td>
									</td>
									<td align="center">69.5 (63.8–74.5)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Acute myeloid leukemia (C92.0)</td>
									<td align="center">28 (1.0)</td>
									<td align="center">17 (60.7)</td>
									<td>
									</td>
									<td align="center">39.3 (21.7–56.5)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.623</td>
									<td>
									</td>
									<td align="center">0.690</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">514 (18.2)</td>
									<td align="center">257 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (45.6–54.2)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">575 (20.3)</td>
									<td align="center">298 (51.8)</td>
									<td>
									</td>
									<td align="center">48.2 (44.0–52.2)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">597 (21.1)</td>
									<td align="center">316 (52.9)</td>
									<td>
									</td>
									<td align="center">47.1 (43.0–51.0)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">542 (19.2)</td>
									<td align="center">285 (52.5)</td>
									<td>
									</td>
									<td align="center">47.5 (43.3–51.6)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">600 (21.2)</td>
									<td align="center">294 (49.0)</td>
									<td>
									</td>
									<td align="center">51.0 (46.9–54.9)</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Status</td>
									<td>
									</td>
									<td>
									</td>
									<td>
									</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Censorship</td>
									<td align="center">1,379 (48.8)</td>
									<td>
									</td>
									<td>
									</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Death</td>
									<td align="center">1,450 (51.3)</td>
									<td>
									</td>
									<td>
									</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN1">
								<p><sup>a</sup> p-value of the chi-square.</p>
							</fn>
							<fn id="TFN2">
								<p><sup>b</sup> p-value of the Log-rank test.</p>
							</fn>
							<fn id="TFN3">
								<p>S(t): probability of survival as a function of time; 95%CI: 95% confidence interval.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>The cases included were mostly male (61.0%), over 70 years of age (34.0%), with 9 years of schooling or more (46.3%), of white race/color (87, 4%), with a partner (56.5%) and with a metastatic diagnosis (39.0%). During follow-up, 51.3% of cases died within five years. Except for the variable year of diagnosis, the others (gender, age group, schooling, race, marital status, extension of disease) were associated with death (<xref ref-type="table" rid="t1">Table 1</xref>). The most frequent type was colon and rectum (28.7%), followed by trachea, bronchi and lung (18.6%) and stomach (11.8%) (<xref ref-type="table" rid="t1">Table 1</xref>).</p>
			</sec>
			<sec>
				<title>Lip and oral cavity (C00-C08)</title>
				<p>One hundred sixty-five (165) people with lip and oral cavity cancer were registered, or 5.8% of the total cases included. At the end of follow-up, 39.4% of them died and the probability of survival at the end was 60.6% (95%CI: 52.7–67.6) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). It was more frequent in males, in people aged 50 to 59 years, with eight years of schooling or less, of the white race. Age range, race and disease extension were associated with survival. The adjusted analysis included the variables age, education, race, marital status and disease extension. Only other colors/races remained as a prognostic factor, with an increase of 2.6 in the risk of death (<xref ref-type="table" rid="t2">Table 2</xref>).</p>
				<p>
					<fig id="f01">
						<label>Figure 1</label>
						<caption>
							<title>Survival of registered cases of tobacco-related cancer, Florianópolis, 2008–2017.</title>
						</caption>
						<graphic xlink:href="1518-8787-rsp-56-16-gf01.tif"/>
					</fig>
				</p>
				<p>
					<table-wrap id="t2">
						<label>Table 2</label>
						<caption>
							<title>Description, survival and proportional risks of death of registered cases of cancers of the lip and oral cavity (C00-C08), other pharynxes (C09-10; C12-14), nasopharynx (C11), larynx (C32), and trachea, bronchi and lung (C33-C34). Florianópolis, 2008–2017.</title>
						</caption>
						<table frame="hsides" rules="groups">
							<colgroup>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left" rowspan="3">Variables</th>
									<th rowspan="3">n (%)</th>
									<th>Deaths</th>
									<th rowspan="3">p<sup>a</sup></th>
									<th rowspan="3">S(t) (95%CI)</th>
									<th rowspan="3">p<sup>b</sup></th>
									<th rowspan="3">HR (95%CI)</th>
									<th rowspan="3">Adjusted HR (95%CI)</th>
								</tr>
								<tr>
									<th>
										<hr/>
									</th>
								</tr>
								<tr>
									<th>n (%)</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td colspan="8"><bold>Lip and oral cavity (C00-C08)</bold><sup><bold>c</bold></sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.342</td>
									<td>
									</td>
									<td align="center">0.258</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">58 (35.2)</td>
									<td align="center">20 (34.5)</td>
									<td>
									</td>
									<td align="center">65.5 (51.8–76.2)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">107 (64.9)</td>
									<td align="center">45 (42.1)</td>
									<td>
									</td>
									<td align="center">57.9 (48.0–66.6)</td>
									<td>
									</td>
									<td align="center">1.35 (0.80–2.29)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.016</td>
									<td>
									</td>
									<td align="center">0.022</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">35 (21.2)</td>
									<td align="center">10 (28.6)</td>
									<td>
									</td>
									<td align="center">71.4 (53.4–83.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">48 (29.1)</td>
									<td align="center">22 (45.8)</td>
									<td>
									</td>
									<td align="center">54.2 (39.2–67.0)</td>
									<td>
									</td>
									<td align="center">1.77 (0.84–3.75)</td>
									<td align="center">1.40 (0.64–3.03)</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">35 (21.2)</td>
									<td align="center">8 (22.9)</td>
									<td>
									</td>
									<td align="center">77.1 (59.5–87.9)</td>
									<td>
									</td>
									<td align="center">0.75 (0.30–1.91)</td>
									<td align="center">0.63 (0.24–1.62)</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">47 (28.5)</td>
									<td align="center">25 (53.2)</td>
									<td>
									</td>
									<td align="center">46.8 (32.2–32.2)</td>
									<td>
									</td>
									<td align="center">2.14 (1.03–4.45)</td>
									<td align="center">1.94 (0.92–4.10)</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.228</td>
									<td>
									</td>
									<td align="center">0.131</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">69 (41.8)</td>
									<td align="center">22 (31.9)</td>
									<td>
									</td>
									<td align="center">68.1 (55.7–77.7)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">84 (50.9)</td>
									<td align="center">37 (44.1)</td>
									<td>
									</td>
									<td align="center">56.0 (44.7–65.8)</td>
									<td>
									</td>
									<td align="center">1.50 (0.88–2.54)</td>
									<td align="center">1.13 (0.66–1.95)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">12 (7.3)</td>
									<td align="center">6 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (20.9–73.6)</td>
									<td>
									</td>
									<td align="center">2.25 (0.91–5.56)</td>
									<td align="center">2.12 (0.48–9.27)</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.040</td>
									<td>
									</td>
									<td align="center">0.015</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">148 (89.7)</td>
									<td align="center">54 (36.5)</td>
									<td>
									</td>
									<td align="center">63.5 (55.2–70.7)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">9 (5.5)</td>
									<td align="center">7 (77.8)</td>
									<td>
									</td>
									<td align="center">22.2 (3.4–51.3)</td>
									<td>
									</td>
									<td align="center">2.80 (1.27–6.17)</td>
									<td align="center">2.61 (1.16–5.86)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">8 (4.9)</td>
									<td align="center">4 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (15.2–77.5)</td>
									<td>
									</td>
									<td align="center">2.00 (0.72–5.52)</td>
									<td align="center">1.14 (0.20–6.45)</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.929</td>
									<td>
									</td>
									<td align="center">0.948</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">94 (57.0)</td>
									<td align="center">36 (38.3)</td>
									<td>
									</td>
									<td align="center">61.7 (51.1–70.7)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">58 (35.2)</td>
									<td align="center">24 (41.4)</td>
									<td>
									</td>
									<td align="center">58.6 (44.9–70.0)</td>
									<td>
									</td>
									<td align="center">1.05 (0.63–1.76)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">13 (7.9)</td>
									<td align="center">5 (38.5)</td>
									<td>
									</td>
									<td align="center">61.5 (30.8–81.8)</td>
									<td>
									</td>
									<td align="center">1.15 (0.45–2.94)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.014</td>
									<td>
									</td>
									<td align="center">0.014</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">34 (20.6)</td>
									<td align="center">12 (35.3)</td>
									<td>
									</td>
									<td align="center">64.7 (46.3–78.2)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">57 (34.6)</td>
									<td align="center">31 (54.4)</td>
									<td>
									</td>
									<td align="center">45.6 (32.4–57.9)</td>
									<td>
									</td>
									<td align="center">1.75 (0.90–3.41)</td>
									<td align="center">1.76 (0.90–3.46)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">74 (44.9)</td>
									<td align="center">22 (29.7)</td>
									<td>
									</td>
									<td align="center">70.3 (58.5–79.3)</td>
									<td>
									</td>
									<td align="center">0.81 (0.40–1.64)</td>
									<td align="center">0.81 (0.39–1.66)</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.842</td>
									<td>
									</td>
									<td align="center">0.851</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">28 (17.0)</td>
									<td align="center">13 (46.4)</td>
									<td>
									</td>
									<td align="center">53.6 (33.8–69.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">36 (21.8)</td>
									<td align="center">14 (38.9)</td>
									<td>
									</td>
									<td align="center">61.1 (43.4–74.8)</td>
									<td>
									</td>
									<td align="center">0.78 (0.36–1.65)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">32 (19.4)</td>
									<td align="center">12 (37.5)</td>
									<td>
									</td>
									<td align="center">62.5 (43.5–76.7)</td>
									<td>
									</td>
									<td align="center">0.75 (0.34–1.63)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">31 (18.8)</td>
									<td align="center">10 (32.3)</td>
									<td>
									</td>
									<td align="center">67.7 (48.4–81.2)</td>
									<td>
									</td>
									<td align="center">0.62 (0.27–0.42)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">38 (23.0)</td>
									<td align="center">16 (42.1)</td>
									<td>
									</td>
									<td align="center">57.9 (40.8–71.7)</td>
									<td>
									</td>
									<td align="center">0.79 (0.38–1.65)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Cancer in other pharynxes (C09-C10; C12-C14)</bold></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.717</td>
									<td>
									</td>
									<td align="center">0.936</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">6 (8.3)</td>
									<td align="center">4 (66.7)</td>
									<td>
									</td>
									<td align="center">33.3 (4.6–67.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">66 (91.7)</td>
									<td align="center">39 (59.1)</td>
									<td>
									</td>
									<td align="center">40.9 (29.0–52.4)</td>
									<td>
									</td>
									<td align="center">0.96 (0.34–2.68)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.524</td>
									<td>
									</td>
									<td align="center">0.658</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">9 (12.5)</td>
									<td align="center">5 (55.6)</td>
									<td>
									</td>
									<td align="center">44.4 (13.6–71.9)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">24 (33.3)</td>
									<td align="center">12 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (29.1–67.8)</td>
									<td>
									</td>
									<td align="center">0.79 (0.28–2.24)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">24 (33.3)</td>
									<td align="center">15 (62.5)</td>
									<td>
									</td>
									<td align="center">37.5 (19.0–56.0)</td>
									<td>
									</td>
									<td align="center">1.03 (0.38–2.85)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">15 (20.8)</td>
									<td align="center">11 (73.3)</td>
									<td>
									</td>
									<td align="center">26.7 (8.3–49.6)</td>
									<td>
									</td>
									<td align="center">1.34 (0.46–3.85)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.733</td>
									<td>
									</td>
									<td align="center">0.816</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">26 (36.1)</td>
									<td align="center">17 (65.4)</td>
									<td>
									</td>
									<td align="center">34.6 (17.5–52.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">42 (58.3)</td>
									<td align="center">24 (57.1)</td>
									<td>
									</td>
									<td align="center">42.9 (27.8–57.1)</td>
									<td>
									</td>
									<td align="center">0.82 (0.44–1.52)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">4 (5.6)</td>
									<td align="center">2 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (5.8–84.5)</td>
									<td>
									</td>
									<td align="center">0.85 (0.20–3.68)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.629</td>
									<td>
									</td>
									<td align="center">0.355</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">62 (86.1)</td>
									<td align="center">36 (58.1)</td>
									<td>
									</td>
									<td align="center">41.9 (29.6–53.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">8 (11.1)</td>
									<td align="center">6 (75.0)</td>
									<td>
									</td>
									<td align="center">25.0 (3.7–55.8)</td>
									<td>
									</td>
									<td align="center">1.87 (0.78–4.45)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">2 (2.8)</td>
									<td align="center">1 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (0.6–91.0)</td>
									<td>
									</td>
									<td align="center">1.01 (0.14–7.34)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.450</td>
									<td>
									</td>
									<td align="center">0.193</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">46 (63.9)</td>
									<td align="center">25 (54.4)</td>
									<td>
									</td>
									<td align="center">45.7 (31.0–59.2)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">22 (30.6)</td>
									<td align="center">15 (68.2)</td>
									<td>
									</td>
									<td align="center">31.8 (14.2–51.1)</td>
									<td>
									</td>
									<td align="center">1.49 (0.78–2.82)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">4 (5.6)</td>
									<td align="center">3 (75.0)</td>
									<td>
									</td>
									<td align="center">25.0 (0.9–66.5)</td>
									<td>
									</td>
									<td align="center">2.55 (0.76–8.50)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.573</td>
									<td>
									</td>
									<td align="center">0.492</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">11 (15.3)</td>
									<td align="center">5 (45.5)</td>
									<td>
									</td>
									<td align="center">54.6 (22.9–78.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">43 (59.7)</td>
									<td align="center">27 (62.8)</td>
									<td>
									</td>
									<td align="center">37.2 (23.1–51.3)</td>
									<td>
									</td>
									<td align="center">1.77 (0.68–4.59)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">18 (25.0)</td>
									<td align="center">11 (61.1)</td>
									<td>
									</td>
									<td align="center">38.9 (17.5–60.0)</td>
									<td>
									</td>
									<td align="center">1.70 (0.59–4.89)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.324</td>
									<td>
									</td>
									<td align="center">0.628</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">14 (19.4)</td>
									<td align="center">11 (78.6)</td>
									<td>
									</td>
									<td align="center">21.4 (5.2–44.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">21 (29.2)</td>
									<td align="center">12 (57.1)</td>
									<td>
									</td>
									<td align="center">42.9 (21.9–62.3)</td>
									<td>
									</td>
									<td align="center">0.67 (0.30–1.53)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">11 (15.3)</td>
									<td align="center">7 (63.6)</td>
									<td>
									</td>
									<td align="center">36.4 (11.2–62.7)</td>
									<td>
									</td>
									<td align="center">0.76 (0.29–1.95)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">13 (18.1)</td>
									<td align="center">5 (38.5)</td>
									<td>
									</td>
									<td align="center">61.5 (30.8–81.8)</td>
									<td>
									</td>
									<td align="center">0.36 (0.12–1.04)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">13 (18.1)</td>
									<td align="center">8 (61.5)</td>
									<td>
									</td>
									<td align="center">38.5 (14.1–62.8)</td>
									<td>
									</td>
									<td align="center">0.67 (0.27–1.67)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Nasopharyngeal cancer (C11)</bold></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.386</td>
									<td>
									</td>
									<td align="center">0.499</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">8 (33.3)</td>
									<td align="center">3 (37.5)</td>
									<td>
									</td>
									<td align="center">62.5 (22.9–86.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">16 (66.7)</td>
									<td align="center">9 (56.3)</td>
									<td>
									</td>
									<td align="center">43.8 (19.8–65.6)</td>
									<td>
									</td>
									<td align="center">1.56 (0.42–5.91)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.050</td>
									<td>
									</td>
									<td align="center">0.062</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>65 years or less</td>
									<td align="center">16 (66.7)</td>
									<td align="center">8 (50.0)</td>
									<td>
									</td>
									<td align="center">100.0</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>66 years or older</td>
									<td align="center">8 (33.3)</td>
									<td align="center">8 (50.0)</td>
									<td>
									</td>
									<td align="center">25.0 (0.9–66.5)</td>
									<td>
									</td>
									<td align="center">1.29 (0.39–4.29)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">1.000</td>
									<td>
									</td>
									<td align="center">0.996</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">12 (50.0)</td>
									<td align="center">6 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (20.9–73.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">10 (41.7)</td>
									<td align="center">5 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (18.4–75.3)</td>
									<td>
									</td>
									<td align="center">1.06 (0.32–3.46)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">2 (8.3)</td>
									<td align="center">1 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (0.6–91.0)</td>
									<td>
									</td>
									<td align="center">1.01 (0.12–8.45)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.307</td>
									<td>
									</td>
									<td align="center">0.398</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">23 (95.8)</td>
									<td align="center">12 (52.2)</td>
									<td>
									</td>
									<td align="center">47.8 (26.8–66.1)</td>
									<td>
									</td>
									<td align="center">-</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">1 (4.2)</td>
									<td align="center">-</td>
									<td>
									</td>
									<td align="center">-</td>
									<td>
									</td>
									<td align="center">-</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.231</td>
									<td>
									</td>
									<td align="center">0.312</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">12 (50.0)</td>
									<td align="center">4 (33.3)</td>
									<td>
									</td>
									<td align="center">66.7 (33.7–86.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">10 (41.7)</td>
									<td align="center">7 (70.0)</td>
									<td>
									</td>
									<td align="center">30.0 (7.1–57.8)</td>
									<td>
									</td>
									<td align="center">2.52 (0.74–8.64)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">2 (8.3)</td>
									<td align="center">1 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (0.6–91.0)</td>
									<td>
									</td>
									<td align="center">1.80 (0.18–14.42)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.865</td>
									<td>
									</td>
									<td align="center">0.869</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">5 (20.8)</td>
									<td align="center">2 (40.0)</td>
									<td>
									</td>
									<td align="center">60.0 (12.6–88.2)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">11 (45.8)</td>
									<td align="center">6 (54.6)</td>
									<td>
									</td>
									<td align="center">45.5 (16.7–70.7)</td>
									<td>
									</td>
									<td align="center">1.54 (0.31–7.66)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">8 (33.4)</td>
									<td align="center">4 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (15.2–77.5)</td>
									<td>
									</td>
									<td align="center">1.34 (0.25–7.35)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.525</td>
									<td>
									</td>
									<td align="center">0.601</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">6 (25.0)</td>
									<td align="center">4 (66.7)</td>
									<td>
									</td>
									<td align="center">33.3 (4.6–67.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">5 (20.8)</td>
									<td align="center">3 (60.0)</td>
									<td>
									</td>
									<td align="center">40.0 (5.2–75.3)</td>
									<td>
									</td>
									<td align="center">0.85 (0.19–3.80)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">8 (33.3)</td>
									<td align="center">4 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (15.2–77.5)</td>
									<td>
									</td>
									<td align="center">0.54 (0.14–2.18)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">2 (8.3)</td>
									<td align="center">-</td>
									<td>
									</td>
									<td align="center">100.0</td>
									<td>
									</td>
									<td align="center">-</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">3 (12.5)</td>
									<td align="center">1 (33.3)</td>
									<td>
									</td>
									<td align="center">66.7 (5.4–94.5)</td>
									<td>
									</td>
									<td align="center">0.44 (0.05–3.99)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Laryngeal cancer (C32)</bold></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.385</td>
									<td>
									</td>
									<td align="center">0.352</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">16 (18.2)</td>
									<td align="center">5 (31.3)</td>
									<td>
									</td>
									<td align="center">68.8 (40.5–85.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">72 (81.8)</td>
									<td align="center">31 (43.1)</td>
									<td>
									</td>
									<td align="center">56.9 (44.7–67.4)</td>
									<td>
									</td>
									<td align="center">1.56 (0.61–4.01)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.430</td>
									<td>
									</td>
									<td align="center">0.434</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">11 (12.5)</td>
									<td align="center">2 (18.2)</td>
									<td>
									</td>
									<td align="center">81.8 (44.7–95.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">33 (37.5)</td>
									<td align="center">14 (42.4)</td>
									<td>
									</td>
									<td align="center">57.6 (39.1–72.3)</td>
									<td>
									</td>
									<td align="center">2.94 (0.67–12.95)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">22 (25.0)</td>
									<td align="center">10 (45.5)</td>
									<td>
									</td>
									<td align="center">54.6 (32.1–72.4)</td>
									<td>
									</td>
									<td align="center">3.23 (0.71–14.73)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">22 (25.0)</td>
									<td align="center">10 (45.5)</td>
									<td>
									</td>
									<td align="center">54.6 (32.1–72.4)</td>
									<td>
									</td>
									<td align="center">3.18 (0.70–14.54)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.529</td>
									<td>
									</td>
									<td align="center">0.599</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">43 (48.9)</td>
									<td align="center">15 (34.9)</td>
									<td>
									</td>
									<td align="center">65.1 (49.0–77.3)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">34 (38.6)</td>
									<td align="center">16 (47.1)</td>
									<td>
									</td>
									<td align="center">52.9 (35.1–68.0)</td>
									<td>
									</td>
									<td align="center">1.47 (0.73–2.98)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">11 (12.5)</td>
									<td align="center">5 (45.5)</td>
									<td>
									</td>
									<td align="center">54.6 (22.9–78.0)</td>
									<td>
									</td>
									<td align="center">-</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.529</td>
									<td>
									</td>
									<td align="center">0.974</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">78 (88.6)</td>
									<td align="center">32 (41.0)</td>
									<td>
									</td>
									<td align="center">59.0 (47.3–68.9)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">7 (8.0)</td>
									<td align="center">3 (42.9)</td>
									<td>
									</td>
									<td align="center">57.1 (17.2–83.7)</td>
									<td>
									</td>
									<td align="center">1.44 (0.44–4.73)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">3 (3.4)</td>
									<td align="center">1 (33.3)</td>
									<td>
									</td>
									<td align="center">66.7 (5.4–94.5)</td>
									<td>
									</td>
									<td align="center">-</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.924</td>
									<td>
									</td>
									<td align="center">0.924</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">54 (61.4)</td>
									<td align="center">22 (40.7)</td>
									<td>
									</td>
									<td align="center">59.3 (45.0–71.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">23 (26.1)</td>
									<td align="center">10 (43.5)</td>
									<td>
									</td>
									<td align="center">56.5 (34.3–73.8)</td>
									<td>
									</td>
									<td align="center">1.04 (0.49–2.22)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">11 (12.5)</td>
									<td align="center">4 (36.4)</td>
									<td>
									</td>
									<td align="center">63.6 (29.7–84.5)</td>
									<td>
									</td>
									<td align="center">-</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.005</td>
									<td>
									</td>
									<td align="center">0.004</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">31 (35.2)</td>
									<td align="center">7 (22.6)</td>
									<td>
									</td>
									<td align="center">77.4 (58.4–88.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">28 (31.8)</td>
									<td align="center">18 (64.3)</td>
									<td>
									</td>
									<td align="center">35.7 (18.9–53.0)</td>
									<td>
									</td>
									<td align="center">3.79 (1.58–9.08)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">29 (33.0)</td>
									<td align="center">11 (40.9)</td>
									<td>
									</td>
									<td align="center">62.1 (42.1–76.9)</td>
									<td>
									</td>
									<td align="center">1.77 (0.69–4.57)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.337</td>
									<td>
									</td>
									<td align="center">0.383</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">15 (17.1)</td>
									<td align="center">8 (53.3)</td>
									<td>
									</td>
									<td align="center">46.7 (21.2–68.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">16 (18.2)</td>
									<td align="center">5 (31.3)</td>
									<td>
									</td>
									<td align="center">68.8 (40.5–85.6)</td>
									<td>
									</td>
									<td align="center">0.50 (0.16–1.54)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">22 (25.0)</td>
									<td align="center">11 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (28.2–68.4)</td>
									<td>
									</td>
									<td align="center">0.83 (0.33–2.06)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">18 (20.5)</td>
									<td align="center">8 (44.4)</td>
									<td>
									</td>
									<td align="center">55.6 (30.5–74.8)</td>
									<td>
									</td>
									<td align="center">0.65 (0.24–1.72)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">17 (19.3)</td>
									<td align="center">4 (23.5)</td>
									<td>
									</td>
									<td align="center">76.5 (48.8–90.5)</td>
									<td>
									</td>
									<td align="center">0.34 (0.10–1.14)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Cancer of the Trachea, Bronchi and Lungs (C33-C34)</bold><sup><bold>d</bold></sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.038</td>
									<td>
									</td>
									<td align="center">0.044</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">199 (37.8)</td>
									<td align="center">144 (72.4)</td>
									<td>
									</td>
									<td align="center">27.6 (21.6–34.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">328 (62.2)</td>
									<td align="center">263 (80.2)</td>
									<td>
									</td>
									<td align="center">19.8 (15.7–24.3)</td>
									<td>
									</td>
									<td align="center">1.23 (1.01–1.51)</td>
									<td align="center">1.19 (0.97–1.46)</td>
								</tr>
								<tr>
									<td>age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.080</td>
									<td>
									</td>
									<td align="center">0.018</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">42 (8.0)</td>
									<td align="center">31 (73.8)</td>
									<td>
									</td>
									<td align="center">26.2 (14.1–40.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">117 (22.2)</td>
									<td align="center">81 (69.2)</td>
									<td>
									</td>
									<td align="center">30.8 (22.7–39.2)</td>
									<td>
									</td>
									<td align="center">0.96 (0.63–1.45)</td>
									<td align="center">0.96 (0.63–1.46)</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">166 (31.6)</td>
									<td align="center">132 (79.5)</td>
									<td>
									</td>
									<td align="center">20.5 (14.7–26.9)</td>
									<td>
									</td>
									<td align="center">1.27 (0.86–1.88)</td>
									<td align="center">1.18 (0.80–1.75)</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">201 (38.2)</td>
									<td align="center">163 (81.1)</td>
									<td>
									</td>
									<td align="center">18.9 (13.8–24.6)</td>
									<td>
									</td>
									<td align="center">1.42 (0.97–2.09)</td>
									<td align="center">1.34 (0.92–1.98)</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.258</td>
									<td>
									</td>
									<td align="center">0.013</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">241 (45.7)</td>
									<td align="center">179 (74.3)</td>
									<td>
									</td>
									<td align="center">25.7 (20.4–31.4)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">227 (43.1)</td>
									<td align="center">183 (80.6)</td>
									<td>
									</td>
									<td align="center">19.4 (14.5–24.8)</td>
									<td>
									</td>
									<td align="center">1.36 (1.11–1.67)</td>
									<td align="center">1.29 (1.05–1.59)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">59 (11.2)</td>
									<td align="center">45 (77.2)</td>
									<td>
									</td>
									<td align="center">23.7 (13.9–35.1)</td>
									<td>
									</td>
									<td align="center">1.10 (0.79–1.52)</td>
									<td align="center">1.29 (0.93–1.81)</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.617</td>
									<td>
									</td>
									<td align="center">0.445</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">478 (90.7)</td>
									<td align="center">368 (77.0)</td>
									<td>
									</td>
									<td align="center">23.0 (19.4–26.9)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">26 (4.9)</td>
									<td align="center">22 (84.6)</td>
									<td>
									</td>
									<td align="center">15.4 (4.8–31.5)</td>
									<td>
									</td>
									<td align="center">1.29 (0.84–1.98)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">23 (4.4)</td>
									<td align="center">17 (73.9)</td>
									<td>
									</td>
									<td align="center">26.1 (10.6–44.7)</td>
									<td>
									</td>
									<td align="center">0.89 (0.55–1.45)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.637</td>
									<td>
									</td>
									<td align="center">0.692</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">309 (58.6)</td>
									<td align="center">243 (78.6)</td>
									<td>
									</td>
									<td align="center">21.4 (17.0–26.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">168 (31.9)</td>
									<td align="center">127 (75.6)</td>
									<td>
									</td>
									<td align="center">24.4 (18.2–31.1)</td>
									<td>
									</td>
									<td align="center">0.99 (0.80–1.23)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">50 (9.5)</td>
									<td align="center">37 (74.0)</td>
									<td>
									</td>
									<td align="center">26.0 (14.9–38.6)</td>
									<td>
									</td>
									<td align="center">0.86 (0.61–1.22)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">60 (11.4)</td>
									<td align="center">36 (60.0)</td>
									<td>
									</td>
									<td align="center">40.0 (27.7–52.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">302 (57.3)</td>
									<td align="center">254 (84.1)</td>
									<td>
									</td>
									<td align="center">15.9 (12.0–20.3)</td>
									<td>
									</td>
									<td align="center">2.06 (1.45–2.92)</td>
									<td align="center">2.14 (1.40–2.85)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">165 (31.3)</td>
									<td align="center">117 (70.9)</td>
									<td>
									</td>
									<td align="center">29.1 (22.4–36.1)</td>
									<td>
									</td>
									<td align="center">1.34 (0.92–1.94)</td>
									<td align="center">1.38 (0.90–1.91)</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.487</td>
									<td>
									</td>
									<td align="center">0.503</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">93 (17.7)</td>
									<td align="center">72 (77.4)</td>
									<td>
									</td>
									<td align="center">22.6 (14.7–31.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">112 (21.3)</td>
									<td align="center">92 (82.1)</td>
									<td>
									</td>
									<td align="center">17.9 (11.4–25.5)</td>
									<td>
									</td>
									<td align="center">1.17 (0.86–1.59)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">105 (19.9)</td>
									<td align="center">77 (73.3)</td>
									<td>
									</td>
									<td align="center">26.7 (18.6–35.4)</td>
									<td>
									</td>
									<td align="center">0.93 (0.68–1.29)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">102 (19.4)</td>
									<td align="center">81 (79.4)</td>
									<td>
									</td>
									<td align="center">20.6 (13.4–28.9)</td>
									<td>
									</td>
									<td align="center">1.18 (0.86–1.62)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">115 (21.8)</td>
									<td align="center">85 (73.9)</td>
									<td>
									</td>
									<td align="center">26.1 (18.5–34.3)</td>
									<td>
									</td>
									<td align="center">1.03 (0.76–1.42)</td>
									<td align="center">-</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN4">
								<p>S(t): probability of survival as a function of time; 95%CI: 95% confidence interval; HR: proportional hazards ratio.</p>
							</fn>
							<fn id="TFN5">
								<p><sup>a</sup> p-value of the c<sup>2</sup> test (chi-square).</p>
							</fn>
							<fn id="TFN6">
								<p><sup>b</sup> p-value of the Log-rank test..</p>
							</fn>
							<fn id="TFN7">
								<p><sup>c</sup> HR adjusted for age group, race, education and disease extension.</p>
							</fn>
							<fn id="TFN8">
								<p><sup>d</sup> HR adjusted for sex, age group, education and disease extension.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
			</sec>
			<sec>
				<title>Other pharynxes (C09-10; C12-14)</title>
				<p>There were 72 cases related to other pharynxes, or 2.6% of the total. Of these, 59.7% died by the end of follow-up and the probability of survival was 40.3% (95%CI: 29.0–51.3) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). It was more frequent in males, with less education and in those with a partner. No variable was associated with survival and no adjusted analysis was performed (<xref ref-type="table" rid="t2">Table 2</xref>).</p>
			</sec>
			<sec>
				<title>Nasopharynx (C11)</title>
				<p>Nasopharyngeal diagnoses accounted for 0.9%, with 24 cases. Of these, 50% died and the probability of survival was 50.0% (95%CI: 29.1–67.8) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). There were more records in men, aged 65 years or younger, and with nine years or more of schooling. Only the age range variable had a p-value &lt; 0.20, in which the group aged 66 years or older showed a worse probability of survival (<xref ref-type="table" rid="t2">Table 2</xref>).</p>
			</sec>
			<sec>
				<title>Esophagus (C15)</title>
				<p>In the period, there were 104 records of esophageal cancer, or 3.7% of the total, and 67.6% died. The probability of survival was 32.4% (95%CI: 23.7–41.1) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). The worst survival was found among males, of other races/colors, without a partner, with a metastatic diagnosis. The adjusted analysis included the variables gender, race, marital status, disease extension, and year of diagnosis. Only other grouped colors/races remained as a worse prognostic factor, with an increase of 2.5 in the risk of death (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
				<p>
					<table-wrap id="t3">
						<label>Table 3</label>
						<caption>
							<title>Description, survival and proportional risks of death of registered cases of esophageal (C15), stomach (C16), colon and rectum (C18-21), liver (C22) and pancreas (C25) cancers, Florianópolis, 2008–2017.</title>
						</caption>
						<table frame="hsides" rules="groups">
							<colgroup>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th rowspan="3">Variables</th>
									<th rowspan="3">n (%)</th>
									<th>Deaths</th>
									<th rowspan="3">p<sup>a</sup></th>
									<th rowspan="3">S(t) (95%CI)</th>
									<th rowspan="3">p<sup>b</sup></th>
									<th rowspan="3">HR (95%CI)</th>
									<th rowspan="3">Adjusted HR (95%CI)</th>
								</tr>
								<tr>
									<th>
										<hr/>
									</th>
								</tr>
								<tr>
									<th>n (%)</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td colspan="8"><bold>Esophageal cancer (C15)</bold><sup>c</sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.140</td>
									<td>
									</td>
									<td align="center">0.127</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">22 (21.0)</td>
									<td align="center">12 (54.6)</td>
									<td>
									</td>
									<td align="center">45.5 (24.4–64.3)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">83 (79.1)</td>
									<td align="center">59 (71.1)</td>
									<td>
									</td>
									<td align="center">28.9 (19.6–38.9)</td>
									<td>
									</td>
									<td align="center">1.62 (0.87–3.01)</td>
									<td align="center">1.64 (0.82–3.28)</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.577</td>
									<td>
									</td>
									<td align="center">0.351</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">9 (8.6)</td>
									<td align="center">7 (77.8)</td>
									<td>
									</td>
									<td align="center">22.2 (3.4–51.3)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">39 (37.1)</td>
									<td align="center">28 (71.8)</td>
									<td>
									</td>
									<td align="center">28.2 (15.3–42.7)</td>
									<td>
									</td>
									<td align="center">0.64 (0.28–1.48)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">24 (32.4)</td>
									<td align="center">20 (58.8)</td>
									<td>
									</td>
									<td align="center">41.2 (24.8–56.9)</td>
									<td>
									</td>
									<td align="center">0.47 (0.20–1.12)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">23 (21.9)</td>
									<td align="center">16 (69.6)</td>
									<td>
									</td>
									<td align="center">30.4 (13.5–49.3)</td>
									<td>
									</td>
									<td align="center">0.67 (0.28–1.64)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.457</td>
									<td>
									</td>
									<td align="center">0.486</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">31 (29.5)</td>
									<td align="center">21 (67.7)</td>
									<td>
									</td>
									<td align="center">32.3 (16.9–48.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">56 (53.3)</td>
									<td align="center">40 (71.4)</td>
									<td>
									</td>
									<td align="center">28.6 (17.5–40.7)</td>
									<td>
									</td>
									<td align="center">1.34 (0.79–2.27)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">18 (17.1)</td>
									<td align="center">10 (55.6)</td>
									<td>
									</td>
									<td align="center">44.4 (21.6–65.1)</td>
									<td>
									</td>
									<td align="center">1.01 (0.47–2.14)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.015</td>
									<td>
									</td>
									<td align="center">0.002</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">83 (79.1)</td>
									<td align="center">54 (65.1)</td>
									<td>
									</td>
									<td align="center">34.9 (24.9–45.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">16 (15.2)</td>
									<td align="center">15 (93.8)</td>
									<td>
									</td>
									<td align="center">6.3 (0.4–24.7)</td>
									<td>
									</td>
									<td align="center">2.54 (1.42–4.56)</td>
									<td align="center">2.50 (1.27–4.90)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">6 (5.7)</td>
									<td align="center">2 (33.3)</td>
									<td>
									</td>
									<td align="center">66.7 (19.5–90.4)</td>
									<td>
									</td>
									<td align="center">0.43 (0.10–1.76)</td>
									<td align="center">0.57 (0.09–3.35)</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.073</td>
									<td>
									</td>
									<td align="center">0.074</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">64 (61.0)</td>
									<td align="center">44 (68.8)</td>
									<td>
									</td>
									<td align="center">31.3 (20.4–42.7)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">27 (25.7)</td>
									<td align="center">21 (77.8)</td>
									<td>
									</td>
									<td align="center">22.2 (9.0–39.0)</td>
									<td>
									</td>
									<td align="center">1.52 (0.90–2.56)</td>
									<td align="center">1.39 (0.80–2.43)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">14 (13.3)</td>
									<td align="center">6 (42.9)</td>
									<td>
									</td>
									<td align="center">57.1 (28.4–78.0)</td>
									<td>
									</td>
									<td align="center">0.57 (0.24–1.35)</td>
									<td align="center">1.26 (0.38–4.17)</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.009</td>
									<td>
									</td>
									<td align="center">0.046</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">24 (22.9)</td>
									<td align="center">13 (54.2)</td>
									<td>
									</td>
									<td align="center">45.8 (25.6–64.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">37 (35.2)</td>
									<td align="center">32 (86.5)</td>
									<td>
									</td>
									<td align="center">13.5 (4.9–26.4)</td>
									<td>
									</td>
									<td align="center">1.96 (1.02–3.74)</td>
									<td align="center">2.09 (0.91–4.82)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">44 (41.9)</td>
									<td align="center">26 (59.1)</td>
									<td>
									</td>
									<td align="center">40.9 (26.5–54.8)</td>
									<td>
									</td>
									<td align="center">1.14 (0.59–2.22)</td>
									<td align="center">1.31 (0.58–2.96)</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.012</td>
									<td>
									</td>
									<td align="center">0.021</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">20 (19.1)</td>
									<td align="center">9 (45.0)</td>
									<td>
									</td>
									<td align="center">55.0 (31.3–73.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">18 (17.1)</td>
									<td align="center">17 (94.4)</td>
									<td>
									</td>
									<td align="center">5.6 (0.4–22.4)</td>
									<td>
									</td>
									<td align="center">3.43 (1.51–7.82)</td>
									<td align="center">2.61 (0.96–7.05)</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">18 (17.1)</td>
									<td align="center">10 (55.6)</td>
									<td>
									</td>
									<td align="center">44.4 (21.6–65.1)</td>
									<td>
									</td>
									<td align="center">1.32 (0.54–3.25)</td>
									<td align="center">1.25 (0.44–3.57)</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">15 (14.3)</td>
									<td align="center">12 (80.0)</td>
									<td>
									</td>
									<td align="center">20.0 (4.9–42.4)</td>
									<td>
									</td>
									<td align="center">2.16 (0.91–5.15)</td>
									<td align="center">1.67 (0.56–4.94)</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">34 (32.4)</td>
									<td align="center">23 (67.7)</td>
									<td>
									</td>
									<td align="center">32.4 (17.6–48)</td>
									<td>
									</td>
									<td align="center">1.72 (0.79–3.71)</td>
									<td align="center">1.23 (0.45–3.35)</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Stomach cancer (C16)</bold><sup><bold>d</bold></sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.099</td>
									<td>
									</td>
									<td align="center">0.094</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">142 (42.6)</td>
									<td align="center">78 (54.9)</td>
									<td>
									</td>
									<td align="center">45.1 (36.8–53.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">191 (57.4)</td>
									<td align="center">122 (63.9)</td>
									<td>
									</td>
									<td align="center">36.1 (29.4–42.9)</td>
									<td>
									</td>
									<td align="center">1.27 (0.96–1.69)</td>
									<td align="center">1.21 (0.91–1.61)</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>59 years or younger</td>
									<td align="center">125 (37.5)</td>
									<td align="center">54 (43.2)</td>
									<td>
									</td>
									<td align="center">56.8 (47.7–64.9)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>60 years or older</td>
									<td align="center">208 (62.5)</td>
									<td align="center">146 (70.2)</td>
									<td>
									</td>
									<td align="center">29.8 (23.7–36.1)</td>
									<td>
									</td>
									<td align="center">2.18 (1.59–2.98)</td>
									<td align="center">2.22 (1.62–3.03)</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.214</td>
									<td>
									</td>
									<td align="center">0.229</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">121 (36.3)</td>
									<td align="center">71 (58.7)</td>
									<td>
									</td>
									<td align="center">41.3 (32.5–49.9)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">182 (54.7)</td>
									<td align="center">115 (63.2)</td>
									<td>
									</td>
									<td align="center">36.8 (29.9–43.8)</td>
									<td>
									</td>
									<td align="center">1.18 (0.88–1.59)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">30 (9.0)</td>
									<td align="center">14 (46.7)</td>
									<td>
									</td>
									<td align="center">53.3 (34.3–69.1)</td>
									<td>
									</td>
									<td align="center">0.78 (0.44–1.38)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.229</td>
									<td>
									</td>
									<td align="center">0.277</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">293 (88.0)</td>
									<td align="center">177 (60.4)</td>
									<td>
									</td>
									<td align="center">39.6 (34.0–45.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">29 (8.7)</td>
									<td align="center">19 (65.5)</td>
									<td>
									</td>
									<td align="center">34.5 (18.2–51.5)</td>
									<td>
									</td>
									<td align="center">1.18 (0.74–1.90)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">11 (3.3)</td>
									<td align="center">4 (36.4)</td>
									<td>
									</td>
									<td align="center">63.6 (29.7–84.5)</td>
									<td>
									</td>
									<td align="center">0.50 (0.18–1.34)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.195</td>
									<td>
									</td>
									<td align="center">0.215</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">209 (62.8)</td>
									<td align="center">124 (59.3)</td>
									<td>
									</td>
									<td align="center">40.7 (34.0–47.2)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">98 (29.4)</td>
									<td align="center">64 (65.3)</td>
									<td>
									</td>
									<td align="center">34.7 (25.5–44.1)</td>
									<td>
									</td>
									<td align="center">1.16 (0.86–1.57)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">26 (7.8)</td>
									<td align="center">12 (46.2)</td>
									<td>
									</td>
									<td align="center">53.9 (33.3–70.6)</td>
									<td>
									</td>
									<td align="center">0.21 (0.38–1.24)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">0.002</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">54 (16.2)</td>
									<td align="center">20 (37)</td>
									<td>
									</td>
									<td align="center">63.0 (48.7–74.3)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">135 (40.5)</td>
									<td align="center">93 (68.9)</td>
									<td>
									</td>
									<td align="center">31.1 (23.5–39.0)</td>
									<td>
									</td>
									<td align="center">2.31 (1.42–3.75)</td>
									<td align="center">2.39 (1.46–3.88)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">144 (43.2)</td>
									<td align="center">87 (60.4)</td>
									<td>
									</td>
									<td align="center">39.6 (31.6–47.5)</td>
									<td>
									</td>
									<td align="center">2.00 (1.23–3.25)</td>
									<td align="center">1.92 (1.18–3.13)</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.594</td>
									<td>
									</td>
									<td align="center">0.714</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">55 (16.5)</td>
									<td align="center">36 (65.5)</td>
									<td>
									</td>
									<td align="center">34.6 (22.4–47.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">54 (16.2)</td>
									<td align="center">34 (63.0)</td>
									<td>
									</td>
									<td align="center">37.0 (24.4–49.7)</td>
									<td>
									</td>
									<td align="center">0.95 (0.59–1.52)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">77 (23.1)</td>
									<td align="center">42 (54.6)</td>
									<td>
									</td>
									<td align="center">45.5 (34.1–56.1)</td>
									<td>
									</td>
									<td align="center">0.76 (0.49–1.19)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">75 (22.5)</td>
									<td align="center">42 (56.0)</td>
									<td>
									</td>
									<td align="center">44.0 (32.6–54.8)</td>
									<td>
									</td>
									<td align="center">0.80 (0.51–1.25)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">72 (21.6)</td>
									<td align="center">46 (63.9)</td>
									<td>
									</td>
									<td align="center">36.1 (25.2–47.1)</td>
									<td>
									</td>
									<td align="center">0.91 (0.59–1.40)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Colon and rectal cancer (C18-21)</bold><sup><bold>e</bold></sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.742</td>
									<td>
									</td>
									<td align="center">0.906</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">403 (49.6)</td>
									<td align="center">142 (35.2)</td>
									<td>
									</td>
									<td align="center">64.8 (59.9–69.2)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">410 (50.4)</td>
									<td align="center">149 (36.3)</td>
									<td>
									</td>
									<td align="center">63.7 (58.8–68.1)</td>
									<td>
									</td>
									<td align="center">1.01 (0.81–1.28)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">157 (19.3)</td>
									<td align="center">41 (26.1)</td>
									<td>
									</td>
									<td align="center">73.9 (66.3–80.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">186 (22.9)</td>
									<td align="center">50 (26.9)</td>
									<td>
									</td>
									<td align="center">73.1 (66.1–78.9)</td>
									<td>
									</td>
									<td align="center">1.01 (0.67–1.53)</td>
									<td align="center">1.17 (0.77–1.78)</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">206 (25.3)</td>
									<td align="center">76 (36.9)</td>
									<td>
									</td>
									<td align="center">63.1 (56.1–69.3)</td>
									<td>
									</td>
									<td align="center">1.48 (1.02–2.17)</td>
									<td align="center">1.61 (1.10–2.37)</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">264 (32.5)</td>
									<td align="center">124 (47.0)</td>
									<td>
									</td>
									<td align="center">53.0 (46.8–58.8)</td>
									<td>
									</td>
									<td align="center">2.15 (1.51–3.05)</td>
									<td align="center">2.54 (1.77–3.65)</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">443 (54.5)</td>
									<td align="center">150 (33.9)</td>
									<td>
									</td>
									<td align="center">66.1 (61.5–70.3)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">254 (31.2)</td>
									<td align="center">117 (46.1)</td>
									<td>
									</td>
									<td align="center">53.9 (47.6–59.8)</td>
									<td>
									</td>
									<td align="center">1.48 (1.17–1.89)</td>
									<td align="center">1.29 (1.01–1.66)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">116 (14.3)</td>
									<td align="center">24 (20.7)</td>
									<td>
									</td>
									<td align="center">79.3 (70.7–85.6)</td>
									<td>
									</td>
									<td align="center">0.58 (0.38–0.89)</td>
									<td align="center">0.64 (0.32–1.29)</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.028</td>
									<td>
									</td>
									<td align="center">0.045</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">703 (86.5)</td>
									<td align="center">262 (37.3)</td>
									<td>
									</td>
									<td align="center">62.7 (59.0–66.2)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">43 (5.3)</td>
									<td align="center">15 (34.9)</td>
									<td>
									</td>
									<td align="center">65.1 (49.0–77.3)</td>
									<td>
									</td>
									<td align="center">0.95 (0.56–1.60)</td>
									<td align="center">1.05 (0.62–1.80)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">67 (8.2)</td>
									<td align="center">14 (20.9)</td>
									<td>
									</td>
									<td align="center">79.1 (67.3–87.1)</td>
									<td>
									</td>
									<td align="center">0.51 (0.30–0.88)</td>
									<td align="center">1.32 (0.60–2.91)</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">436 (53.6)</td>
									<td align="center">150 (34.4)</td>
									<td>
									</td>
									<td align="center">65.6 (60.9–69.9)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">268 (33.0)</td>
									<td align="center">117 (43.7)</td>
									<td>
									</td>
									<td align="center">56.3 (50.2–62.0)</td>
									<td>
									</td>
									<td align="center">1.41 (1.11–1.80)</td>
									<td align="center">1.33 (1.05–1.71)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">109 (13.4)</td>
									<td align="center">24 (22.0)</td>
									<td>
									</td>
									<td align="center">78.0 (69.0–84.7)</td>
									<td>
									</td>
									<td align="center">0.62 (0.40–0.95)</td>
									<td align="center">0.80 (0.38–1.66)</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>In situ</td>
									<td align="center">31 (3.8)</td>
									<td align="center">5 (16.1)</td>
									<td>
									</td>
									<td align="center">83.9 (65.5–93.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">175 (21.5)</td>
									<td align="center">39 (22.3)</td>
									<td>
									</td>
									<td align="center">77.7 (70.8–83.2)</td>
									<td>
									</td>
									<td align="center">1.42 (0.56–3.61)</td>
									<td align="center">1.23 (0.49–3.16)</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">297 (36.5)</td>
									<td align="center">158 (53.2)</td>
									<td>
									</td>
									<td align="center">46.8 (41.0–52.4)</td>
									<td>
									</td>
									<td align="center">4.13 (1.69–10.06)</td>
									<td align="center">4.74 (1.92–11.66)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">310 (38.1)</td>
									<td align="center">89 (28.7)</td>
									<td>
									</td>
									<td align="center">71.3 (65.9–76.0)</td>
									<td>
									</td>
									<td align="center">1.94 (0.79–4.78)</td>
									<td align="center">1.95 (0.78–4.83)</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.008</td>
									<td>
									</td>
									<td align="center">0.005</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">136 (16.7)</td>
									<td align="center">48 (35.3)</td>
									<td>
									</td>
									<td align="center">64.7 (56.1–72.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">176 (21.7)</td>
									<td align="center">55 (31.3)</td>
									<td>
									</td>
									<td align="center">68.8 (61.3–75.0)</td>
									<td>
									</td>
									<td align="center">0.85 (0.58–1.25)</td>
									<td align="center">0.50 (0.33–0.75)</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">165 (20.3)</td>
									<td align="center">73 (44.2)</td>
									<td>
									</td>
									<td align="center">55.8 (47.9–63.0)</td>
									<td>
									</td>
									<td align="center">1.37 (0.95–1.97)</td>
									<td align="center">0.79 (0.53–1.18)</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">148 (18.2)</td>
									<td align="center">62 (41.9)</td>
									<td>
									</td>
									<td align="center">58.1 (49.7–65.6)</td>
									<td>
									</td>
									<td align="center">1.20 (0.82–1.75)</td>
									<td align="center">0.55 (0.36–0.84)</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">188 (23.1)</td>
									<td align="center">53 (28.2)</td>
									<td>
									</td>
									<td align="center">71.8 (64.8–77.7)</td>
									<td>
									</td>
									<td align="center">0.75 (0.51–1.11)</td>
									<td align="center">0.38 (0.25–0.59)</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Liver cancer (C22)</bold><sup><bold>f</bold></sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.727</td>
									<td>
									</td>
									<td align="center">0.407</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">29 (28.2)</td>
									<td align="center">24 (82.8)</td>
									<td>
									</td>
									<td align="center">17.2 (6.3–32.7)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">74 (71.8)</td>
									<td align="center">59 (79.7)</td>
									<td>
									</td>
									<td align="center">20.3 (12.0–30.0)</td>
									<td>
									</td>
									<td align="center">0.82 (0.51–1.32)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.022</td>
									<td>
									</td>
									<td align="center">0.182</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">18 (17.5)</td>
									<td align="center">10 (55.6)</td>
									<td>
									</td>
									<td align="center">44.4 (21.6–65.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">25 (24.3)</td>
									<td align="center">23 (92.0)</td>
									<td>
									</td>
									<td align="center">8.0 (1.4–22.5)</td>
									<td>
									</td>
									<td align="center">2.04 (0.97–4.31)</td>
									<td align="center">1.84 (0.86–3.94)</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">23 (22.3)</td>
									<td align="center">19 (82.6)</td>
									<td>
									</td>
									<td align="center">17.4 (5.4–35.0)</td>
									<td>
									</td>
									<td align="center">1.79 (0.83–3.86)</td>
									<td align="center">1.77 (0.82–3.82)</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">37 (35.9)</td>
									<td align="center">31 (83.8)</td>
									<td>
									</td>
									<td align="center">16.2 (6.6–29.6)</td>
									<td>
									</td>
									<td align="center">2.14 (1.05–4.38)</td>
									<td align="center">2.19 (1.06–4.53)</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.579</td>
									<td>
									</td>
									<td align="center">0.678</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">53 (51.4)</td>
									<td align="center">41 (77.4)</td>
									<td>
									</td>
									<td align="center">22.6 (12.5–34.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">36 (35.0)</td>
									<td align="center">31 (86.1)</td>
									<td>
									</td>
									<td align="center">13.9 (5.1–27.1)</td>
									<td>
									</td>
									<td align="center">1.23 (0.77–1.96)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">14 (13.6)</td>
									<td align="center">11 (78.6)</td>
									<td>
									</td>
									<td align="center">21.4 (5.2–44.8)</td>
									<td>
									</td>
									<td align="center">1.07 (0.55–2.09)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.606</td>
									<td>
									</td>
									<td align="center">0.010</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">94 (91.3)</td>
									<td align="center">75 (79.8)</td>
									<td>
									</td>
									<td align="center">20.2 (12.8–28.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">4 (3.8)</td>
									<td align="center">4 (100.0)</td>
									<td>
									</td>
									<td align="center">-</td>
									<td>
									</td>
									<td align="center">4.33 (1.53–12.26)</td>
									<td align="center">4.11 (1.40–12.07)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">5 (4.9)</td>
									<td align="center">4 (80.0)</td>
									<td>
									</td>
									<td align="center">20 (0.8–58.2)</td>
									<td>
									</td>
									<td align="center">1.07 (0.39–2.94)</td>
									<td align="center">0.85 (0.30–2.44)</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.529</td>
									<td>
									</td>
									<td align="center">0.507</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">54 (52.4)</td>
									<td align="center">44 (81.5)</td>
									<td>
									</td>
									<td align="center">18.5 (9.5–29.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">36 (35.0)</td>
									<td align="center">30 (83.3)</td>
									<td>
									</td>
									<td align="center">16.7 (6.8–30.4)</td>
									<td>
									</td>
									<td align="center">1.15 (0.72–1.83)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">13 (12.6)</td>
									<td align="center">9 (69.2)</td>
									<td>
									</td>
									<td align="center">30.8 (9.5–55.4)</td>
									<td>
									</td>
									<td align="center">0.74 (0.36–1.52)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.284</td>
									<td>
									</td>
									<td align="center">0.746</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">11 (10.7)</td>
									<td align="center">7 (63.6)</td>
									<td>
									</td>
									<td align="center">36.4 (11.2–62.7)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">40 (38.8)</td>
									<td align="center">34 (85.0)</td>
									<td>
									</td>
									<td align="center">15.0 (6.1–27.6)</td>
									<td>
									</td>
									<td align="center">1.33 (0.59–3.00)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">52 (50.5)</td>
									<td align="center">42 (80.8)</td>
									<td>
									</td>
									<td align="center">19.2 (9.9–30.9)</td>
									<td>
									</td>
									<td align="center">1.36 (0.61–3.03)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.212</td>
									<td>
									</td>
									<td align="center">0.203</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">25 (24.2)</td>
									<td align="center">18 (72.0)</td>
									<td>
									</td>
									<td align="center">28.0 (12.4–46)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">19 (18.4)</td>
									<td align="center">14 (73.7)</td>
									<td>
									</td>
									<td align="center">26.3 (9.6–46.8)</td>
									<td>
									</td>
									<td align="center">1.01 (0.50–2.03)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">22 (21.4)</td>
									<td align="center">21 (95.5)</td>
									<td>
									</td>
									<td align="center">4.6 (0.3–18.9)</td>
									<td>
									</td>
									<td align="center">1.84 (0.98–3.47)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">15 (14.6)</td>
									<td align="center">11 (73.3)</td>
									<td>
									</td>
									<td align="center">26.7 (8.3–49.6)</td>
									<td>
									</td>
									<td align="center">1.05 (0.50–2.23)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">22 (21.4)</td>
									<td align="center">19 (86.4)</td>
									<td>
									</td>
									<td align="center">13.6 (3.4–30.9)</td>
									<td>
									</td>
									<td align="center">1.57 (0.82–3.00)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Pancreatic cancer (C25)</bold><sup><bold>f</bold></sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.642</td>
									<td>
									</td>
									<td align="center">0.293</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">62 (55.4)</td>
									<td align="center">54 (87.1)</td>
									<td>
									</td>
									<td align="center">12.9 (6.0–22.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">50 (44.6)</td>
									<td align="center">42 (85.0)</td>
									<td>
									</td>
									<td align="center">16.0 (7.5–27.4)</td>
									<td>
									</td>
									<td align="center">0.81 (0.54–1.21)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.340</td>
									<td>
									</td>
									<td align="center">0.072</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">10 (8.9)</td>
									<td align="center">7 (70.0)</td>
									<td>
									</td>
									<td align="center">30.0 (7.1–57.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">24 (21.4)</td>
									<td align="center">20 (83.3)</td>
									<td>
									</td>
									<td align="center">16.7 (5.2–33.7)</td>
									<td>
									</td>
									<td align="center">1.30 (0.55–3.08)</td>
									<td align="center">1.19 (0.49–2.87)</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">24 (21.4)</td>
									<td align="center">20 (83.3)</td>
									<td>
									</td>
									<td align="center">16.7 (5.2–33.7)</td>
									<td>
									</td>
									<td align="center">1.21 (0.51–2.85)</td>
									<td align="center">1.19 (0.50–2.82)</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">54 (48.2)</td>
									<td align="center">49 (90.7)</td>
									<td>
									</td>
									<td align="center">9.3 (3.4–18.7)</td>
									<td>
									</td>
									<td align="center">2.05 (0.93–4.54)</td>
									<td align="center">1.91 (0.85–4.29)</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.057</td>
									<td>
									</td>
									<td align="center">0.467</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">50 (44.6)</td>
									<td align="center">46 (92.0)</td>
									<td>
									</td>
									<td align="center">8.0 (2.6–17.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">54 (48.2)</td>
									<td align="center">42 (77.8)</td>
									<td>
									</td>
									<td align="center">22.2 (12.3–34)</td>
									<td>
									</td>
									<td align="center">0.79 (0.52–1.20)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">8 (7.2)</td>
									<td align="center">8 (100.0)</td>
									<td>
									</td>
									<td align="center">–</td>
									<td>
									</td>
									<td align="center">0.73 (0.34–1.54)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.236</td>
									<td>
									</td>
									<td align="center">0.638</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">97 (86.6)</td>
									<td align="center">81 (83.5)</td>
									<td>
									</td>
									<td align="center">16.5 (9.9–24.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">10 (8.9)</td>
									<td align="center">10 (100.0)</td>
									<td>
									</td>
									<td align="center">–</td>
									<td>
									</td>
									<td align="center">1.35 (0.70–2.62)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">5 (4.5)</td>
									<td align="center">5 (100.0)</td>
									<td>
									</td>
									<td align="center">–</td>
									<td>
									</td>
									<td align="center">0.89 (0.36–2.21)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.987</td>
									<td>
									</td>
									<td align="center">0.623</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">65 (58.0)</td>
									<td align="center">56 (86.2)</td>
									<td>
									</td>
									<td align="center">13.9 (6.8–23.3)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">40 (35.7)</td>
									<td align="center">34 (85.0)</td>
									<td>
									</td>
									<td align="center">15.0 (6.1–27.6)</td>
									<td>
									</td>
									<td align="center">1.23 (0.80–1.88)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">7 (6.3)</td>
									<td align="center">6 (85.7)</td>
									<td>
									</td>
									<td align="center">14.3 (0.7–46.5)</td>
									<td>
									</td>
									<td align="center">0.97 (0.42–2.24)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.638</td>
									<td>
									</td>
									<td align="center">0.172</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">8 (7.1)</td>
									<td align="center">7 (87.5)</td>
									<td>
									</td>
									<td align="center">12.5 (0.7–42.3)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">73 (65.2)</td>
									<td align="center">64 (87.7)</td>
									<td>
									</td>
									<td align="center">12.3 (6.1–21.0)</td>
									<td>
									</td>
									<td align="center">1.75 (0.80–3.82)</td>
									<td align="center">1.48 (0.67–3.45)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">31 (27.7)</td>
									<td align="center">25 (80.7)</td>
									<td>
									</td>
									<td align="center">19.4 (7.9–34.6)</td>
									<td>
									</td>
									<td align="center">1.24 (0.54–2.87)</td>
									<td align="center">0.87 (0.45–2.59)</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.764</td>
									<td>
									</td>
									<td align="center">0.885</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">14 (12.5)</td>
									<td align="center">12 (85.7)</td>
									<td>
									</td>
									<td align="center">14.3 (2.3–36.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">21 (18.8)</td>
									<td align="center">19 (90.5)</td>
									<td>
									</td>
									<td align="center">9.5 (1.6–26.1)</td>
									<td>
									</td>
									<td align="center">1.15 (0.56–2.37)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">28 (25.0)</td>
									<td align="center">25 (89.3)</td>
									<td>
									</td>
									<td align="center">10.7 (2.7–25.1)</td>
									<td>
									</td>
									<td align="center">1.09 (0.55–2.17)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">28 (25.0)</td>
									<td align="center">22 (78.6)</td>
									<td>
									</td>
									<td align="center">21.4 (8.7–37.8)</td>
									<td>
									</td>
									<td align="center">0.85 (0.42–1.72)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">21 (18.8)</td>
									<td align="center">18 (85.7)</td>
									<td>
									</td>
									<td align="center">14.3 (3.6–32.1)</td>
									<td>
									</td>
									<td align="center">1.06 (0.51–2.21)</td>
									<td align="center">-</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN9">
								<p>S(t): probability of survival as a function of time; 95%CI: 95% confidence interval; HR: proportional hazards ratio.</p>
							</fn>
							<fn id="TFN10">
								<p><sup>a</sup> p-value of the chi-square.</p>
							</fn>
							<fn id="TFN11">
								<p><sup>b</sup> p-value of the Log-rank test.</p>
							</fn>
							<fn id="TFN12">
								<p><sup>c</sup> HR adjusted for sex, race, marital status, disease extension, and year of diagnosis.</p>
							</fn>
							<fn id="TFN13">
								<p><sup>d</sup> HR adjusted for sex, age group, and disease extent.</p>
							</fn>
							<fn id="TFN14">
								<p><sup>e</sup> HR adjusted for age group, race, marital status, disease extension, and year of diagnosis.</p>
							</fn>
							<fn id="TFN15">
								<p><sup>f</sup> HR adjusted for age group and disease extension.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
			</sec>
			<sec>
				<title>Stomach (C16)</title>
				<p>Stomach cancer was the third most frequent, with 333 cases (11.8% of the total). Of these, 60.1% died, and the probability of survival was 39.9% (95%CI: 34.7–45.2) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). The worst odds of survival were associated with being 60 years of age or older and having a metastatic diagnosis. The adjusted analysis included the variables gender, age group and disease extension. The risk of death was independently increased among those aged 60 years or older and those with a metastatic diagnosis or those recorded as having no information on disease extension (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
			</sec>
			<sec>
				<title>Colon and rectum (C18-21)</title>
				<p>Colon and rectal cancer was the most frequent, with 813 records (28.7% of the total), of which 35.8% died. The probability of survival at five years was 64.2% (95%CI: 60.8–67.4) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). The worst survival rates were among people aged 70 years or older, with nine years or more of schooling, of white race/color, and with a metastatic diagnosis. In the adjusted analysis, being over 60 years of age, eight years or less of schooling, not having a partner and having a metastatic diagnosis independently increased the risk of death (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
			</sec>
			<sec>
				<title>Liver (C22)</title>
				<p>Liver cancer had 103 records (3.6% of the total), of which 80.6% died. This cancer was more frequent in men, white people and those with a partner. The 5-year survival probability was 19.4% (95%CI: 12.5–27.6), the second lowest (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). This was associated with age group and race. In the adjusted analysis, being 70 years of age or older increased the risk of death by 2.19, while being in the category other color/race increased it by four times (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
			</sec>
			<sec>
				<title>Pancreas (C25)</title>
				<p>Pancreatic cancer had 112 registered cases (4.0% of the total) and at follow-up, 85.7% died. It had the worst five-year survival probability, with 14.3% (95%CI: 8.6–21.4) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). Survival probabilities were low in all categories of variables analyzed. Age group and disease extension were associated with survival. These variables were included in the adjusted analysis, but none independently increased the risk of death (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
			</sec>
			<sec>
				<title>Larynx (C32)</title>
				<p>Laryngeal cancer was recorded in 88 people (3.1% of the total). At follow-up, 40.9% died, and the 5-year survival probability was 59.1% (95%CI: 48.1–68.5) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). There was a greater number of records in men, aged 50 to 59 years, with nine years or more of schooling and with a partner. No variables were associated with survival (<xref ref-type="table" rid="t2">Table 2</xref>).</p>
			</sec>
			<sec>
				<title>Trachea, bronchi and lungs (C33-C34)</title>
				<p>Cancer of the trachea, bronchi and lung was the third most frequent, with 527 cases (18.6% of the total). At follow-up, 77.2% died and the 5-year survival probability was the third worst, 22.8% (95%CI: 19.3–26.4) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). The diagnosis was more frequent in men, over 60 years of age, white, with a partner and metastatic extension. The adjusted analysis included the variables gender, age group, schooling and disease extension. The independent risk factors for death were eight years of schooling or less (18% increase) and metastatic staging (2.14 increase) (<xref ref-type="table" rid="t2">Table 2</xref>).</p>
			</sec>
			<sec>
				<title>Kidney (C64-C66)</title>
				<p>Kidney cancer had 177 records (6.3% of the total). In five years, 24.3% of the sample died, and the probability of survival in the same period was 75.7% (95%CI: 68.7–81.4) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). It was more frequent in men, of white race and with a partner. The worst survival rates were recorded among those aged 70 years or older, of other races/colors, without a partner and with a metastatic diagnosis. In the analysis adjusted for age, education, race, marital status and disease extension, the following were independent risk factors for death: being 70 years of age or older (HR = 3.77; 95%CI: 1.01–14.06) and being white (HR = 3.69; 95%CI: 1.20–11.29) (<xref ref-type="table" rid="t4">Table 4</xref>).</p>
				<p>
					<table-wrap id="t4">
						<label>Table 4</label>
						<caption>
							<title>Description, survival and proportional risks of death of registered cases of kidney (C64-C66), bladder (C67) and acute myeloid leukemia (C92.0) cancers, Florianópolis, 2008–2017.</title>
						</caption>
						<table frame="hsides" rules="groups">
							<colgroup>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left" rowspan="3">Variables</th>
									<th rowspan="3">n (%)</th>
									<th>Deaths</th>
									<th rowspan="3">p<sup>a</sup></th>
									<th rowspan="3">S(t) (95%CI)</th>
									<th rowspan="3">p<sup>b</sup></th>
									<th rowspan="3">HR (95%CI)</th>
									<th rowspan="3">Adjusted HR (95%CI)</th>
								</tr>
								<tr>
									<th>
										<hr/>
									</th>
								</tr>
								<tr>
									<th>n (%)</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td colspan="8"><bold>Kidney cancer (C64-C66)</bold><sup><bold>c</bold></sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.421</td>
									<td>
									</td>
									<td align="center">0.441</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">71 (40.1)</td>
									<td align="center">15 (21.1)</td>
									<td>
									</td>
									<td align="center">78.9 (67.4–86.7)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">106 (59.9)</td>
									<td align="center">28 (26.4)</td>
									<td>
									</td>
									<td align="center">73.6 (64.1–80.9)</td>
									<td>
									</td>
									<td align="center">1.28 (0.68–2.39)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.011</td>
									<td>
									</td>
									<td align="center">0.010</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">31 (17.5)</td>
									<td align="center">3 (9.7)</td>
									<td>
									</td>
									<td align="center">90.3 (72.9–96.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">51 (28.8)</td>
									<td align="center">9 (17.7)</td>
									<td>
									</td>
									<td align="center">82.4 (68.8–90.4)</td>
									<td>
									</td>
									<td align="center">1.89 (0.51–6.99)</td>
									<td align="center">1.54 (0.40–5.96)</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">62 (35.0)</td>
									<td align="center">17 (27.4)</td>
									<td>
									</td>
									<td align="center">72.6 (59.7–82.0)</td>
									<td>
									</td>
									<td align="center">3.12 (0.92–10.66)</td>
									<td align="center">2.57 (0.73–9.12)</td>
								</tr>
								<tr>
									<td>70 years or older</td>
									<td align="center">33 (18.6)</td>
									<td align="center">14 (42.4)</td>
									<td>
									</td>
									<td align="center">57.6 (39.1–72.3)</td>
									<td>
									</td>
									<td align="center">5.33 (1.53–18.55)</td>
									<td align="center">3.77 (1.01–14.06)</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.129</td>
									<td>
									</td>
									<td align="center">0.158</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">91 (51.4)</td>
									<td align="center">24 (26.4)</td>
									<td>
									</td>
									<td align="center">73.6 (63.3–81.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">51 (28.8)</td>
									<td align="center">15 (29.4)</td>
									<td>
									</td>
									<td align="center">70.6 (56.0–81.1)</td>
									<td>
									</td>
									<td align="center">1.19 (0.62–2.26)</td>
									<td align="center">1.06 (0.54–2.07)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">35 (19.8)</td>
									<td align="center">4 (11.4)</td>
									<td>
									</td>
									<td align="center">88.6 (72.4–95.6)</td>
									<td>
									</td>
									<td align="center">0.42 (0.15–1.21)</td>
									<td align="center">0.94 (0.20–4.48)</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.023</td>
									<td>
									</td>
									<td align="center">0.020</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">152 (85.8)</td>
									<td align="center">38 (25.0)</td>
									<td>
									</td>
									<td align="center">75.0 (67.3–81.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">7 (4.0)</td>
									<td align="center">4 (57.1)</td>
									<td>
									</td>
									<td align="center">42.9 (9.8–73.4)</td>
									<td>
									</td>
									<td align="center">2.77 (0.99–7.78)</td>
									<td align="center">3.69 (1.20–11.29)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">18 (10.2)</td>
									<td align="center">1 (5.6)</td>
									<td>
									</td>
									<td align="center">94.4 (66.6–99.2)</td>
									<td>
									</td>
									<td align="center">0.20 (0.03–1.49)</td>
									<td align="center">0.40 (0.04–3.60)</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.061</td>
									<td>
									</td>
									<td align="center">0.073</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">92 (52.0)</td>
									<td align="center">23 (25.0)</td>
									<td>
									</td>
									<td align="center">75.0 (64.8–82.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">44 (24.9)</td>
									<td align="center">15 (34.1)</td>
									<td>
									</td>
									<td align="center">65.9 (50.0–77.9)</td>
									<td>
									</td>
									<td align="center">1.45 (0.76–2.78)</td>
									<td align="center">1.57 (0.80–3.12)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">41 (23.8)</td>
									<td align="center">5 (12.2)</td>
									<td>
									</td>
									<td align="center">87.8 (73.2–94.7)</td>
									<td>
									</td>
									<td align="center">0.47 (0.18–1.23)</td>
									<td align="center">0.96 (0.24–3.87)</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">33 (18.6)</td>
									<td align="center">6 (18.2)</td>
									<td>
									</td>
									<td align="center">81.8 (63.9–91.4)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">45 (25.4)</td>
									<td align="center">22 (48.9)</td>
									<td>
									</td>
									<td align="center">51.1 (35.8–64.5)</td>
									<td>
									</td>
									<td align="center">3.36 (1.36–8.29)</td>
									<td align="center">1.99 (0.75–5.29)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">99 (55.9)</td>
									<td align="center">15 (15.2)</td>
									<td>
									</td>
									<td align="center">84.9 (76.1–90.6)</td>
									<td>
									</td>
									<td align="center">0.81 (0.31–2.07)</td>
									<td align="center">0.57 (0.20–1.56)</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.956</td>
									<td>
									</td>
									<td align="center">0.969</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">37 (20.9)</td>
									<td align="center">8 (21.6)</td>
									<td>
									</td>
									<td align="center">78.4 (61.4–88.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">34 (19.2)</td>
									<td align="center">9 (26.5)</td>
									<td>
									</td>
									<td align="center">73.5 (55.3–85.3)</td>
									<td>
									</td>
									<td align="center">1.31 (0.50–3.39)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">49 (27.7)</td>
									<td align="center">13 (26.5)</td>
									<td>
									</td>
									<td align="center">73.5 (58.7–83.6)</td>
									<td>
									</td>
									<td align="center">1.22 (0.51–2.95)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">34 (19.2)</td>
									<td align="center">7 (20.6)</td>
									<td>
									</td>
									<td align="center">79.4 (61.6–89.6)</td>
									<td>
									</td>
									<td align="center">0.99 (0.36–2.73)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">23 (13.0)</td>
									<td align="center">6 (26.1)</td>
									<td>
									</td>
									<td align="center">73.9 (50.9–87.3)</td>
									<td>
									</td>
									<td align="center">1.24 (0.43–3.56)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Bladder cancer (C67)</bold><sup><bold>d</bold></sup></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.938</td>
									<td>
									</td>
									<td align="center">0.987</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">73 (25.9)</td>
									<td align="center">22 (30.1)</td>
									<td>
									</td>
									<td align="center">69.9 (57.9–79.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">209 (74.1)</td>
									<td align="center">64 (30.6)</td>
									<td>
									</td>
									<td align="center">69.4 (62.6–75.1)</td>
									<td>
									</td>
									<td align="center">1.00 (0.62–1.63)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.002</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>49 years or younger</td>
									<td align="center">25 (8.9)</td>
									<td align="center">2 (8.0)</td>
									<td>
									</td>
									<td align="center">92.0 (71.6–97.9)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>50 to 59 years</td>
									<td align="center">55 (19.5)</td>
									<td align="center">12 (21.8)</td>
									<td>
									</td>
									<td align="center">78.2 (64.8–87.0)</td>
									<td>
									</td>
									<td align="center">2.85 (0.64–12.75)</td>
									<td align="center">3.00 (0.66–13.52)</td>
								</tr>
								<tr>
									<td>60 to 69 years</td>
									<td align="center">71 (25.2)</td>
									<td align="center">17 (23.9)</td>
									<td>
									</td>
									<td align="center">76.1 (64.3–84.4)</td>
									<td>
									</td>
									<td align="center">3.21 (0.74–13.90)</td>
									<td align="center">3.25 (0.74–14.19)</td>
								</tr>
								<tr>
									<td>270 years or older</td>
									<td align="center">131 (46.5)</td>
									<td align="center">55 (42.0)</td>
									<td>
									</td>
									<td align="center">58.0 (49.1–65.9)</td>
									<td>
									</td>
									<td align="center">6.22 (1.52–25.51)</td>
									<td align="center">6.19 (1.49–25.82)</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.131</td>
									<td>
									</td>
									<td align="center">0.134</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">115 (40.8)</td>
									<td align="center">35 (30.4)</td>
									<td>
									</td>
									<td align="center">69.6 (60.3–77.1)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">109 (38.7)</td>
									<td align="center">39 (35.8)</td>
									<td>
									</td>
									<td align="center">64.2 (54.5–72.4)</td>
									<td>
									</td>
									<td align="center">1.24 (0.79–1.96)</td>
									<td align="center">1.09 (0.68–1.73)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">58 (20.6)</td>
									<td align="center">12 (20.7)</td>
									<td>
									</td>
									<td align="center">79.3 (66.5–87.7)</td>
									<td>
									</td>
									<td align="center">0.65 (0.34–1.26)</td>
									<td align="center">0.89 (0.36–2.19)</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.129</td>
									<td>
									</td>
									<td align="center">0.164</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">237 (84.0)</td>
									<td align="center">78 (32.9)</td>
									<td>
									</td>
									<td align="center">67.1 (60.7–72.7)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">12 (4.3)</td>
									<td align="center">2 (16.7)</td>
									<td>
									</td>
									<td align="center">83.3 (48.2–95.6)</td>
									<td>
									</td>
									<td align="center">0.47 (0.11–1.90)</td>
									<td align="center">0.65 (0.16–2.68)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">33 (11.7)</td>
									<td align="center">6 (18.2)</td>
									<td>
									</td>
									<td align="center">81.8 (63.9–91.4)</td>
									<td>
									</td>
									<td align="center">0.51 (0.22–1.18)</td>
									<td align="center">0.85 (0.27–2.68)</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.368</td>
									<td>
									</td>
									<td align="center">0.256</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">151 (53.6)</td>
									<td align="center">45 (29.8)</td>
									<td>
									</td>
									<td align="center">70.2 (62.2–76.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">78 (27.7)</td>
									<td align="center">28 (35.9)</td>
									<td>
									</td>
									<td align="center">64.1 (52.4–73.6)</td>
									<td>
									</td>
									<td align="center">1.36 (0.85–2.18)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">53 (18.8)</td>
									<td align="center">13 (24.5)</td>
									<td>
									</td>
									<td align="center">75.5 (61.5–85.0)</td>
									<td>
									</td>
									<td align="center">0.83 (0.45–1.54)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Extension of disease</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td align="center">&lt; 0.001</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>In situ</td>
									<td align="center">17 (6.0)</td>
									<td align="center">5 (29.4)</td>
									<td>
									</td>
									<td align="center">70.6 (43.2–86.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">1.00</td>
								</tr>
								<tr>
									<td>Localized</td>
									<td align="center">95 (33.7)</td>
									<td align="center">19 (20.0)</td>
									<td>
									</td>
									<td align="center">80.0 (70.5–86.7)</td>
									<td>
									</td>
									<td align="center">0.66 (0.25–1.78)</td>
									<td align="center">0.59 (0.22–1.58)</td>
								</tr>
								<tr>
									<td>Metastatic</td>
									<td align="center">36 (12.8)</td>
									<td align="center">22 (61.1)</td>
									<td>
									</td>
									<td align="center">38.9 (23.3–54.2)</td>
									<td>
									</td>
									<td align="center">2.79 (1.06–7.37)</td>
									<td align="center">2.38 (0.89–6.33)</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">134 (47.5)</td>
									<td align="center">40 (29.9)</td>
									<td>
									</td>
									<td align="center">70.2 (61.6–77.1)</td>
									<td>
									</td>
									<td align="center">1.05 (0.41–2.66)</td>
									<td align="center">1.00 (0.39–2.56)</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.567</td>
									<td>
									</td>
									<td align="center">0.605</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">67 (23.8)</td>
									<td align="center">16 (23.9)</td>
									<td>
									</td>
									<td align="center">76.1 (64.0–84.6)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">58 (20.6)</td>
									<td align="center">20 (34.5)</td>
									<td>
									</td>
									<td align="center">65.5 (51.8–76.2)</td>
									<td>
									</td>
									<td align="center">1.53 (0.79–2.96)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">54 (19.2)</td>
									<td align="center">18 (33.3)</td>
									<td>
									</td>
									<td align="center">66.7 (52.4–77.5)</td>
									<td>
									</td>
									<td align="center">1.44 (0.74–2.83)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">54 (19.2)</td>
									<td align="center">19 (35.2)</td>
									<td>
									</td>
									<td align="center">64.8 (50.6–75.9)</td>
									<td>
									</td>
									<td align="center">1.57 (0.81–3.05)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">49 (17.4)</td>
									<td align="center">13 (26.5)</td>
									<td>
									</td>
									<td align="center">73.5 (58.7–83.6)</td>
									<td>
									</td>
									<td align="center">1.13 (0.54–2.34)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td colspan="8"><bold>Acute myeloid leukemia (C92.0)</bold></td>
								</tr>
								<tr>
									<td>Sex</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.934</td>
									<td>
									</td>
									<td align="center">0.819</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Female</td>
									<td align="center">15 (53.6)</td>
									<td align="center">9 (60.0)</td>
									<td>
									</td>
									<td align="center">40.0 (16.5–62.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Male</td>
									<td align="center">13 (46.4)</td>
									<td align="center">8 (61.5)</td>
									<td>
									</td>
									<td align="center">38.5 (14.1–62.8)</td>
									<td>
									</td>
									<td align="center">1.12 (0.43–2.90)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Age group</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.247</td>
									<td>
									</td>
									<td align="center">0.205</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>65 years or less</td>
									<td align="center">15 (55.6)</td>
									<td align="center">8 (53.3)</td>
									<td>
									</td>
									<td align="center">46.7 (21.2–68.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>66 years or older</td>
									<td align="center">12 (44.4)</td>
									<td align="center">9 (75.0)</td>
									<td>
									</td>
									<td align="center">25.0 (6.0–50.5)</td>
									<td>
									</td>
									<td align="center">1.84 (0.71–4.81)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Schooling</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.010</td>
									<td>
									</td>
									<td align="center">0.015</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>9 years or more</td>
									<td align="center">16 (57.1)</td>
									<td align="center">13 (81.3)</td>
									<td>
									</td>
									<td align="center">18.8 (4.6–40.3)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>8 years or less</td>
									<td align="center">7 (25.0)</td>
									<td align="center">1 (14.3)</td>
									<td>
									</td>
									<td align="center">85.7 (33.4–97.9)</td>
									<td>
									</td>
									<td align="center">0.09 (0.01–0.72)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">5 (17.9)</td>
									<td align="center">3 (60.0)</td>
									<td>
									</td>
									<td align="center">40.0 (5.2–75.3)</td>
									<td>
									</td>
									<td align="center">0.45 (0.12–1.61)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Race</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.444</td>
									<td>
									</td>
									<td align="center">0.432</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>White</td>
									<td align="center">24 (85.7)</td>
									<td align="center">14 (62.5)</td>
									<td>
									</td>
									<td align="center">37.5 (19.0–56.0)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>Others</td>
									<td align="center">1 (3.6)</td>
									<td align="center">1 (100.0)</td>
									<td>
									</td>
									<td align="center">-</td>
									<td>
									</td>
									<td align="center">1.96 (0.25–15.37)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">3 (10.7)</td>
									<td align="center">1 (33.3)</td>
									<td>
									</td>
									<td align="center">66.7 (5.4–94.5)</td>
									<td>
									</td>
									<td align="center">0.35 (0.05–2.64)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Marital status</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.819</td>
									<td>
									</td>
									<td align="center">0.827</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>With partner</td>
									<td align="center">12 (42.9)</td>
									<td align="center">8 (66.7)</td>
									<td>
									</td>
									<td align="center">33.3 (10.3–58.8)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>No partner</td>
									<td align="center">12 (42.9)</td>
									<td align="center">7 (58.3)</td>
									<td>
									</td>
									<td align="center">41.7 (15.3–66.5)</td>
									<td>
									</td>
									<td align="center">0.82 (0.30–2.27)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>No information</td>
									<td align="center">4 (14.3)</td>
									<td align="center">2 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (5.8–84.5)</td>
									<td>
									</td>
									<td align="center">0.63 (0.13–3.01)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>Year of diagnosis</td>
									<td>
									</td>
									<td>
									</td>
									<td align="center">0.584</td>
									<td>
									</td>
									<td align="center">0.714</td>
									<td>
									</td>
									<td>
									</td>
								</tr>
								<tr>
									<td>2008</td>
									<td align="center">4 (14.3)</td>
									<td align="center">2 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (5.8–84.5)</td>
									<td>
									</td>
									<td align="center">1.00</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2009</td>
									<td align="center">5 (17.9)</td>
									<td align="center">4 (80.0)</td>
									<td>
									</td>
									<td align="center">20.0 (0.8–58.2)</td>
									<td>
									</td>
									<td align="center">1.62 (0.30–8.90)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2010</td>
									<td align="center">6 (21.4)</td>
									<td align="center">3 (50.0)</td>
									<td>
									</td>
									<td align="center">50.0 (11.1–80.4)</td>
									<td>
									</td>
									<td align="center">0.72 (0.12–4.34)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2011</td>
									<td align="center">8 (28.6)</td>
									<td align="center">6 (75.0)</td>
									<td>
									</td>
									<td align="center">25.0 (3.7–55.8)</td>
									<td>
									</td>
									<td align="center">1.40 (0.28–6.96)</td>
									<td align="center">-</td>
								</tr>
								<tr>
									<td>2012</td>
									<td align="center">5 (17.9)</td>
									<td align="center">2 (40.0)</td>
									<td>
									</td>
									<td align="center">60.0 (12.6–88.2)</td>
									<td>
									</td>
									<td align="center">0.65 (0.09–4.62)</td>
									<td align="center">-</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN16">
								<p>S(t): probability of survival as a function of time; 95%CI: 95% confidence interval; HR: proportional hazards ratio.</p>
							</fn>
							<fn id="TFN17">
								<p><sup>a</sup> p-value of the chi-square.</p>
							</fn>
							<fn id="TFN18">
								<p><sup>b</sup> p-value of the Log-rank test.</p>
							</fn>
							<fn id="TFN19">
								<p><sup>c</sup> HR adjusted for age group, schooling, race, marital status and disease extension.</p>
							</fn>
							<fn id="TFN20">
								<p><sup>d</sup> HR adjusted for age group, schooling, race and disease extension.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
			</sec>
			<sec>
				<title>Bladder (C67)</title>
				<p>Bladder cancer had 282 recorded cases (10.0% of the total). In five years, 30.5% died and the probability of survival was 69.5% (95%CI: 63.8–74.5) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). It was more frequent in men, aged 70 years or older, with nine years or more of schooling, white, with a partner and a localized diagnosis. The variables associated with survival were age group and disease extension. The adjusted analysis included the variables age, education, race and disease extension. Only being 70 years of age or older was an independent factor for a worse prognosis, with a six-fold increase in the risk of death (<xref ref-type="table" rid="t4">Table 4</xref>).</p>
			</sec>
			<sec>
				<title>Acute myeloid leukemia (C92.0)</title>
				<p>AML was recorded in 28 cases and, of these, 60.7% died. At five years, the survival probability was 39.3% (95%CI: 21.7–56.5) (<xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref>). The distribution of cases was similar across sex and age, more frequent in those with nine years of schooling or more and who were white. None of the characteristics were associated with survival.</p>
			</sec>
		</sec>
		<sec sec-type="discussion">
			<title>DISCUSSION</title>
			<p>The findings of the present research demonstrate that survival and prognostic factors vary according to each type of tobacco-related cancer in the city of Florianópolis (SC). The highest probability of survival was found in kidney cancer (75.7%), while the lowest in pancreatic (14.3%), liver (19.4%) and trachea, bronchi and lung cancer (22.8% %). The values obtained can be justified by the fact that longevity in Santa Catarina is 3.2 years above the national average, and the state has a triple burden of disease as an epidemiological profile of the elderly population, with a strong predominance of chronic conditions<sup><xref ref-type="bibr" rid="B13">13</xref></sup>. Brazil is among the countries with the greatest reduction in the prevalence of smoking in the population from 1990 to 2015, due to the adoption of public policies<sup><xref ref-type="bibr" rid="B3">3</xref></sup>. It should be noted that there is a higher prevalence of adult smokers aged 18 years and over (14.7%) in the South region, which contributes as a risk factor for the increase of these diseases, and many of the risk factors for death are smoking-related, such as being older and having less schooling.</p>
			<p>The most frequent neoplasms found in this study were cancer of the colon and rectum, stomach and trachea, bronchi and lung, which is similar to the pattern found in the South and Southeast regions, placing them among the five most frequent types. Studies that analyze the survival and prognostic factors of these groups of neoplasms are scarce. Since they exhibit different behaviors, each type of cancer will be discussed separately.</p>
			<sec>
				<title>Lip and oral cavity cancer</title>
				<p>The findings of this study show a survival probability of 57.9% and 65% for men and women, respectively. Another study carried out in Rio Grande do Norte, which only evaluated data on lip cancer, found that the 5-year survival rate was 88.9% for men and 87.3% for women<sup><xref ref-type="bibr" rid="B14">14</xref></sup>. People diagnosed with cancers of the lip, mouth and pharynx (ICD-10 C00-C14) had a survival rate of 33.3% at the end of 5-year follow-up in Santa Catarina, and staging at diagnosis was the greatest risk factor for death<sup><xref ref-type="bibr" rid="B15">15</xref></sup>. However, cases of lip and oral cavity were classified in the same group. In both studies, most cases were diagnosed in males and at an advanced age, corroborating these results. In the initial stage, cancer of the lip and oral cavity is usually asymptomatic, which leads to late diagnosis and metastasis<sup><xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B16">16</xref></sup>, worsening survival and quality of life.</p>
			</sec>
			<sec>
				<title>Oropharyngeal cancer</title>
				<p>Research has shown a greater incidence of this type of cancer in males, aged between 50 and 60 years, and low survival rates, which is in line with the findings of this study<sup><xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref></sup>.</p>
				<p>A study carried out in southern Brazil with the aim of observing survival after cancer of the oropharynx and mouth identified worse survival rates in individuals with oropharyngeal tumors, associating this data with the presence of cervical metastasis and greater tumor dissemination, in addition to location in regions of difficult visualization and diagnosis, which contributes negatively to survival rates<sup><xref ref-type="bibr" rid="B18">18</xref></sup>.</p>
				<p>The literature also indicates that alcohol abuse and the presence of advanced stage disease act as main risk factors for worse survival outcomes<sup><xref ref-type="bibr" rid="B17">17</xref></sup>.</p>
			</sec>
			<sec>
				<title>Esophageal cancer</title>
				<p>A systematic review carried out in 2015 showed that the 5-year survival for esophageal cancer varies between 10% and 15%, which is considered low. Also, that it is a rare disease before 30 years of age<sup><xref ref-type="bibr" rid="B19">19</xref></sup>. In the present study, the highest frequency was in the age group 50-59 years. A survey was also carried out with diagnostic data between 1997 and 2006 in Germany and the United States (USA), in which the 5-year survival was 18% in Germany and 17% in the USA<sup><xref ref-type="bibr" rid="B20">20</xref></sup>, lower than that found in this study. The low probability of survival from esophageal cancer is a reflection of late diagnosis, which in most cases is due to the absence of clinical signs in the initial stage<sup><xref ref-type="bibr" rid="B21">21</xref></sup>, although our results do not present worse prognostic factors.</p>
			</sec>
			<sec>
				<title>Stomach cancer</title>
				<p>The 5-year survival rate for stomach cancer is around 31%, as found in studies carried out in the United States and Germany, which is consistent with the findings of this study<sup><xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref></sup>. In Florianópolis, survival rates below 50% were also found for both sexes (45.1% for women and 36.1% for men)<sup><xref ref-type="bibr" rid="B23">23</xref></sup>.</p>
				<p>Despite advances in diagnosis and treatment, the disease remains highly lethal, the fifth most frequently diagnosed cancer and the third most lethal. Average survival rates reflect the fact that most people are diagnosed with the presence of metastases. It is a disease with histological and etiological heterogeneity<sup><xref ref-type="bibr" rid="B22">22</xref></sup>; therefore, primary prevention through the control of well-established risk factors (such as smoking, excessive alcohol consumption, high-salt food intake) is essential to reduce incidence rates, and warnings about signs and symptoms are essential for early diagnosis .</p>
			</sec>
			<sec>
				<title>Colon and rectal cancer</title>
				<p>The findings of the present study are in line with research that identified an overall 5-year survival rate for people with colorectal cancer between 63 and 65% and worse prognosis in the age group over 70 years<sup><xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref></sup>.</p>
				<p>Survival rates may vary depending on the stage and primary location of the disease. In metastatic or stage IV neoplasms, the relative survival rate is low, which was also identified in this study. Therefore, tumors in a metastatic setting make treatment more complex and tend to have a worse outlook<sup><xref ref-type="bibr" rid="B25">25</xref></sup>. In addition, it is noteworthy that the higher survival may be related to the early initiation of treatment, regardless of other characteristics<sup><xref ref-type="bibr" rid="B24">24</xref></sup>.</p>
			</sec>
			<sec>
				<title>Liver cancer</title>
				<p>Despite some improvements in liver cancer survival rates in recent decades, the overall prognosis for this disease remains poor. A study carried out in the United States in 2017 reveals a 5-year survival rate of 21% in general, ranging from 4% for distant stage disease to 37% for localized disease<sup><xref ref-type="bibr" rid="B26">26</xref></sup>, which is close to the data found in this study.</p>
				<p>The literature shows higher survival rates for these individuals, which may be related to better control of risk factors, early detection and treatment, pointing to the quality of health care provided<sup><xref ref-type="bibr" rid="B24">24</xref></sup>.</p>
			</sec>
			<sec>
				<title>Pancreatic cancer</title>
				<p>Pancreatic cancer has a high lethality and despite not being among the ten most common types, it represents the eighth leading cause of death. In most cases, the diagnosis is made at a late stage, which makes the possibility of curative treatment difficult. The known survival rate is around 5% in five years<sup><xref ref-type="bibr" rid="B28">28</xref></sup>. In the present study, the survival rate was slightly higher, 12.9% for women and 16.0% for men, which still reflects a low survival rate.</p>
				<p>As for independent risk factors for death, only advanced age was significant for these findings, which is supported by the literature in relation to the predominance of individuals affected in the sixth decade of life<sup><xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref></sup>.</p>
			</sec>
			<sec>
				<title>Bronchial, trachea and lung cancer</title>
				<p>In this study, bronchial, trachea and lung cancer was the second most diagnosed. However, worldwide, this is the most incident type, with 2.1 million cases, affecting more men and usually detected in more advanced cases<sup><xref ref-type="bibr" rid="B4">4</xref></sup>.</p>
				<p>Research carried out in Florianópolis showed similar results to those found here, with survival rates of 22.5%<sup><xref ref-type="bibr" rid="B23">23</xref></sup>. Such rates are higher than those reported in a survey carried out in Spain, which in five years reached 14%<sup><xref ref-type="bibr" rid="B30">30</xref></sup>.</p>
				<p>The risk of lung cancer and consequent death from the disease is related to greater intensity of exposure to smoking, in addition to factors such as occupational exposure to chemical or physical agents<sup><xref ref-type="bibr" rid="B30">30</xref></sup>.</p>
			</sec>
			<sec>
				<title>Bladder cancer</title>
				<p>Bladder cancer is the most frequent in the urinary tract and affects men more often, results similar to those of this study<sup><xref ref-type="bibr" rid="B4">4</xref></sup>. The 5-year overall survival identified in this study is between the 60% and 80% described in the literature <sup><xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B31">31</xref></sup>.</p>
				<p>Among newly diagnosed cases, approximately 30% have presented with locally advanced or metastatic disease. However, the population’s greater access to diagnostic imaging methods has increased early diagnoses, whose rates reflect much more favorable results<sup><xref ref-type="bibr" rid="B31">31</xref></sup>.</p>
			</sec>
			<sec>
				<title>Acute myeloid leukemia</title>
				<p>AML is one of the four most frequent types of leukemia and the one that most affects adults<sup><xref ref-type="bibr" rid="B4">4</xref></sup>. The findings of this study are similar to those found in a study carried out in the United States, which showed that individuals diagnosed with AML and aged 75 years or older had lower survival rates compared to other age groups<sup><xref ref-type="bibr" rid="B32">32</xref></sup>.</p>
				<p>Another study carried out in the USA shows that elderly people with AML have more comorbidities and higher rates of complications as compared to controls without cancer. Thus, the presence of comorbidities, previous organ dysfunction and a perception of unfitness for intensive chemotherapy interfere in the survival rates of this population<sup><xref ref-type="bibr" rid="B33">33</xref></sup>.</p>
			</sec>
		</sec>
		<sec sec-type="conclusions">
			<title>FINAL CONSIDERATIONS</title>
			<p>This study presented the survival rate and prognostic factors for 13 types of cancer that are tobacco-related. Worse prognostic factors and survival rates differ across types. Staging was the most frequent risk factor for worse prognosis, demonstrating the importance of campaigns to warn about primary prevention and early diagnosis. Smoking remains one of the main risk factors for several NCDs, including cancer, and thus directly impacts the burden of disease, with social and economic costs and loss of quality of life.</p>
			<p>The study has limitations related to the use of secondary data, which results in the absence of information that could complement it, such as data on socioeconomic profile and smoking status. Likewise, the occurrence of incomplete data due to lack of information or typing error in the SIM makes data analysis difficult and can interfere with the research results. Also noteworthy is the lack of information about smoking during life, as this could reinforce for the population the importance of smoking as a risk factor for the development and evolution of the disease.</p>
			<p>Among the positive points we highlight the RCBP quality indices, the percentage of histological verification – 92.6%, the percentage of cases identified only by the death certificate – 2.68%, and the percentage of cases diagnosed with unknown primary location (C80.9) – 0.83%, during the period from 2008 to 2012. In addition, the Santa Catarina SIM has high completeness.</p>
			<p>Florianópolis follows the behavior of the south of the country, as already identified in other studies, such as the international panorama for some types of cancer. The National Policy for Cancer Prevention and Control is based on data from national and international studies to guide its actions. In this sense, this study can contribute to the adaptation of policies and actions to local realities, since there is a very large sociocultural, economic and population diversity in the country. Such realities directly impact the data found in the different Brazilian regions. For cancer control, it is essential to know the local characteristics, which dialogue with the social characteristics and access to health in the territory. Understanding the behavior of the disease through survival analysis is one of the ways to support the accomplishment of prevention, promotion and awareness work.</p>
			<p>The findings of this study also reinforce the need for public investment in tobacco control policy, in order to expand and guarantee the population’s access to policies at the local level, since all the neoplasms discussed here are related to tobacco use and integrate NCD coping plans. Despite the laws that support cases of suspicion or diagnosis of neoplasia, the anti-smoking law of the municipality of Florianópolis and the Tobacco Control Policy, it is necessary to extrapolate the data found to health professionals and managers, aiming at strengthening and consolidating the measures of prevention, early detection, screening and appropriate treatment for cancer.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>REFERENCES</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. World Health Organization. WHO report on the tobacco epidemic 2019: offer help to quit tobacco use. Geneva (CH): WHO; 2019 [cited 2021 May 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789241516204">https://www.who.int/publications/i/item/9789241516204</ext-link>
				</mixed-citation>
				<element-citation publication-type="report">
					<person-group person-group-type="author">
						<collab>World Health Organization</collab>
					</person-group>
					<source>WHO report on the tobacco epidemic 2019: offer help to quit tobacco use</source>
					<publisher-loc>Geneva (CH)</publisher-loc>
					<publisher-name>WHO</publisher-name>
					<year>2019</year>
					<date-in-citation content-type="cited-date">cited 2021 May 10</date-in-citation>
					<ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789241516204">https://www.who.int/publications/i/item/9789241516204</ext-link>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Miranda-Filho A, Piñeros M, Bray F. The descriptive epidemiology of lung cancer and tobacco control: a global overview 2018. Salud Publica Mex. 2019;61(3):219-29. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.21149/10140">https://doi.org/10.21149/10140</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Miranda</surname>
							<given-names>A</given-names>
							<suffix>Filho</suffix>
						</name>
						<name>
							<surname>Piñeros</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Bray</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>The descriptive epidemiology of lung cancer and tobacco control: a global overview 2018</article-title>
					<source>Salud Publica Mex</source>
					<year>2019</year>
					<volume>61</volume>
					<issue>3</issue>
					<fpage>219</fpage>
					<lpage>229</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.21149/10140">https://doi.org/10.21149/10140</ext-link>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. GBD Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global burden of disease study 2015. Lancet. 2017;389(10082):1885906. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(17)30819-X">https://doi.org/10.1016/S0140-6736(17)30819-X</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<collab>GBD Tobacco Collaborators</collab>
					</person-group>
					<article-title>Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global burden of disease study 2015</article-title>
					<source>Lancet</source>
					<year>2017</year>
					<volume>389</volume>
					<issue>10082</issue>
					<size units="pages">1885906</size>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(17)30819-X">https://doi.org/10.1016/S0140-6736(17)30819-X</ext-link>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Instituto Nacional do Câncer. Estimativa 2020: inciência de câncer no Brasil. Rio de Janeiro: INCA; 2019 [cited 2021 May 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil">https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>Instituto Nacional do Câncer</collab>
					</person-group>
					<source>Estimativa 2020: inciência de câncer no Brasil</source>
					<publisher-loc>Rio de Janeiro</publisher-loc>
					<publisher-name>INCA</publisher-name>
					<year>2019</year>
					<date-in-citation content-type="cited-date">cited 2021 May 10</date-in-citation>
					<ext-link ext-link-type="uri" xlink:href="https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil">https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil</ext-link>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Romero Y, Trapani D, Johnson S, Tittenbrun Z, Given L, Hohman K, et al. National cancer control plans: a global analysis. Lancet Oncol. 2018;19(10):e546-55. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(18)30681-8">https://doi.org/10.1016/S1470-2045(18)30681-8</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Romero</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Trapani</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Johnson</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Tittenbrun</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Given</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Hohman</surname>
							<given-names>K</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>National cancer control plans: a global analysis</article-title>
					<source>Lancet Oncol</source>
					<year>2018</year>
					<volume>19</volume>
					<issue>10</issue>
					<fpage>e546</fpage>
					<lpage>e555</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(18)30681-8">https://doi.org/10.1016/S1470-2045(18)30681-8</ext-link>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Ferreira JC, Patino CM. O que é análise de sobrevida e quando devo utilizá-la? J Bras Pneumol. 2016;42(1):77. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S1806-37562016000000013">https://doi.org/10.1590/S1806-37562016000000013</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ferreira</surname>
							<given-names>JC</given-names>
						</name>
						<name>
							<surname>Patino</surname>
							<given-names>CM</given-names>
						</name>
					</person-group>
					<article-title>O que é análise de sobrevida e quando devo utilizá-la?</article-title>
					<source>J Bras Pneumol</source>
					<year>2016</year>
					<volume>42</volume>
					<issue>1</issue>
					<size units="pages">77</size>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S1806-37562016000000013">https://doi.org/10.1590/S1806-37562016000000013</ext-link>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Instituto Brasileiro de Geografia e Estatística. Panorama: Santa Catarina. Rio de Janeiro: IBGE; 2010.</mixed-citation>
				<element-citation publication-type="report">
					<person-group person-group-type="author">
						<collab>Instituto Brasileiro de Geografia e Estatística</collab>
					</person-group>
					<source>Panorama: Santa Catarina</source>
					<publisher-loc>Rio de Janeiro</publisher-loc>
					<publisher-name>IBGE</publisher-name>
					<year>2010</year>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Percy C, Van Holten V, Muir C, editores. CID-O  Classificação Internacional de Doenças para Oncologia. 2. ed. São Paulo: Editora da Universidade de São Paulo; Fundação Oncocentro de São Paulo; 2005.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Percy</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Van Holten</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Muir</surname>
							<given-names>C</given-names>
						</name>
						<role>editores</role>
					</person-group>
					<source>CID-O  Classificação Internacional de Doenças para Oncologia</source>
					<edition>2</edition>
					<publisher-loc>São Paulo</publisher-loc>
					<publisher-name>Editora da Universidade de São Paulo; Fundação Oncocentro de São Paulo</publisher-name>
					<year>2005</year>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Lyon (FR): International Agency for Research on Cancer; 2012 [cited 2021 May 10]. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; nº. 100E). Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK304391/">https://www.ncbi.nlm.nih.gov/books/NBK304391/</ext-link>
				</mixed-citation>
				<element-citation publication-type="report">
					<person-group person-group-type="author">
						<collab>IARC Working Group on the Evaluation of Carcinogenic Risks to Humans</collab>
					</person-group>
					<source>Personal habits and indoor combustions</source>
					<publisher-loc>Lyon (FR)</publisher-loc>
					<publisher-name>International Agency for Research on Cancer</publisher-name>
					<year>2012</year>
					<date-in-citation content-type="cited-date">cited 2021 May 10</date-in-citation>
					<comment>IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; nº. 100E</comment>
					<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK304391/">https://www.ncbi.nlm.nih.gov/books/NBK304391/</ext-link>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Atlanta, GA: CDC; 2014.</mixed-citation>
				<element-citation publication-type="report">
					<person-group person-group-type="author">
						<collab>National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health</collab>
					</person-group>
					<source>The health consequences of smoking-50 years of progress: a report of the Surgeon General</source>
					<publisher-loc>Atlanta, GA</publisher-loc>
					<publisher-name>CDC</publisher-name>
					<year>2014</year>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. São José BP, Corrêa RA, Malta DC, Passos VMA, França EB, Teixeira RA, et al. Mortalidade e incapacidade por doenças relacionadas à exposição ao tabaco no Brasil, 1990 a 2015. Rev Bras Epidemiol. 2017;20 Supl 1:75-89. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/1980-5497201700050007">https://doi.org/10.1590/1980-5497201700050007</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>São José</surname>
							<given-names>BP</given-names>
						</name>
						<name>
							<surname>Corrêa</surname>
							<given-names>RA</given-names>
						</name>
						<name>
							<surname>Malta</surname>
							<given-names>DC</given-names>
						</name>
						<name>
							<surname>Passos</surname>
							<given-names>VMA</given-names>
						</name>
						<name>
							<surname>França</surname>
							<given-names>EB</given-names>
						</name>
						<name>
							<surname>Teixeira</surname>
							<given-names>RA</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Mortalidade e incapacidade por doenças relacionadas à exposição ao tabaco no Brasil, 1990 a 2015</article-title>
					<source>Rev Bras Epidemiol</source>
					<year>2017</year>
					<volume>20</volume>
					<supplement>Supl 1</supplement>
					<fpage>75</fpage>
					<lpage>89</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/1980-5497201700050007">https://doi.org/10.1590/1980-5497201700050007</ext-link>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Coutinho ESF, Coeli CM. Acurácia da metodologia de relacionamento probabilístico de registros para identificação de óbitos em estudos de sobrevida. Cad Saude Publica. 2006;22(10):2249-52. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S0102-311X2006001000031">https://doi.org/10.1590/S0102-311X2006001000031</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Coutinho</surname>
							<given-names>ESF</given-names>
						</name>
						<name>
							<surname>Coeli</surname>
							<given-names>CM</given-names>
						</name>
					</person-group>
					<article-title>Acurácia da metodologia de relacionamento probabilístico de registros para identificação de óbitos em estudos de sobrevida</article-title>
					<source>Cad Saude Publica</source>
					<year>2006</year>
					<volume>22</volume>
					<issue>10</issue>
					<fpage>2249</fpage>
					<lpage>2252</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S0102-311X2006001000031">https://doi.org/10.1590/S0102-311X2006001000031</ext-link>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Secretaria de Estado da Saúde de Santa Catarina. Plano Estadual de Saúde 2020 - 2023. Florianópolis, SC; 2019.</mixed-citation>
				<element-citation publication-type="report">
					<person-group person-group-type="author">
						<collab>Secretaria de Estado da Saúde de Santa Catarina</collab>
					</person-group>
					<source>Plano Estadual de Saúde 2020 - 2023</source>
					<publisher-loc>Florianópolis, SC</publisher-loc>
					<year>2019</year>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Freire GCB. Análise de sobrevida dos casos de carcinoma epidermóide de lábio (CEL) do Rio Grande do Norte. Natal, RN: Departamento de Odontologia da Universidade Federal do Rio Grande do Norte; 2017. Monografia de Graduação.</mixed-citation>
				<element-citation publication-type="thesis">
					<person-group person-group-type="author">
						<name>
							<surname>Freire</surname>
							<given-names>GCB</given-names>
						</name>
					</person-group>
					<source>Análise de sobrevida dos casos de carcinoma epidermóide de lábio (CEL) do Rio Grande do Norte</source>
					<publisher-loc>Natal, RN</publisher-loc>
					<publisher-name>Departamento de Odontologia da Universidade Federal do Rio Grande do Norte</publisher-name>
					<year>2017</year>
					<comment>Monografia de Graduação</comment>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Schneider IJC, Flores ME, Nickel DA, Martins LGT, Traebert J. Survival rates of patients with cancer of the lip, mouth and pharynx: a cohort study of 10 years. Rev Bras Epidemiol. 2014;17(3):680-91. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/1809-4503201400030009">https://doi.org/10.1590/1809-4503201400030009</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Schneider</surname>
							<given-names>IJC</given-names>
						</name>
						<name>
							<surname>Flores</surname>
							<given-names>ME</given-names>
						</name>
						<name>
							<surname>Nickel</surname>
							<given-names>DA</given-names>
						</name>
						<name>
							<surname>Martins</surname>
							<given-names>LGT</given-names>
						</name>
						<name>
							<surname>Traebert</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Survival rates of patients with cancer of the lip, mouth and pharynx: a cohort study of 10 years</article-title>
					<source>Rev Bras Epidemiol</source>
					<year>2014</year>
					<volume>17</volume>
					<issue>3</issue>
					<fpage>680</fpage>
					<lpage>691</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/1809-4503201400030009">https://doi.org/10.1590/1809-4503201400030009</ext-link>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16. Amorim MM. Análise do perfil e fatores relacionados a sobrevida de adultos jovens e idosos portadores de câncer oral [dissertação]. Feira de Santana, BA: Departamento de Saúde da Universidade Federal de Feira de Santana; 2018.</mixed-citation>
				<element-citation publication-type="thesis">
					<person-group person-group-type="author">
						<name>
							<surname>Amorim</surname>
							<given-names>MM</given-names>
						</name>
					</person-group>
					<source>Análise do perfil e fatores relacionados a sobrevida de adultos jovens e idosos portadores de câncer oral</source>
					<comment>dissertação</comment>
					<publisher-loc>Feira de Santana, BA</publisher-loc>
					<publisher-name>Departamento de Saúde da Universidade Federal de Feira de Santana</publisher-name>
					<year>2018</year>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17. Rodrigo JP, López F, Llorente JL, Álvarez-Marcos C, Suárez C. Resultados de la laringectomía total en carcinoma localmente avanzado de laringe en la era de la organopreservación. Acta Otorrinolaringol Esp. 2015;66(3):132-8. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.otorri.2014.06.001">https://doi.org/10.1016/j.otorri.2014.06.001</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Rodrigo</surname>
							<given-names>JP</given-names>
						</name>
						<name>
							<surname>López</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Llorente</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Álvarez-Marcos</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Suárez</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Resultados de la laringectomía total en carcinoma localmente avanzado de laringe en la era de la organopreservación</article-title>
					<source>Acta Otorrinolaringol Esp</source>
					<year>2015</year>
					<volume>66</volume>
					<issue>3</issue>
					<fpage>132</fpage>
					<lpage>138</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.otorri.2014.06.001">https://doi.org/10.1016/j.otorri.2014.06.001</ext-link>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18. Moro JS, Maroneze MC, Ardenghi TM, Barin LM, Danesi CC. Oral and oropharyngeal cancer: epidemiology and survival analysis. Einstein (São Paulo). 2018;16(2):eAO4248. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S1679-45082018AO4248">https://doi.org/10.1590/S1679-45082018AO4248</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Moro</surname>
							<given-names>JS</given-names>
						</name>
						<name>
							<surname>Maroneze</surname>
							<given-names>MC</given-names>
						</name>
						<name>
							<surname>Ardenghi</surname>
							<given-names>TM</given-names>
						</name>
						<name>
							<surname>Barin</surname>
							<given-names>LM</given-names>
						</name>
						<name>
							<surname>Danesi</surname>
							<given-names>CC</given-names>
						</name>
					</person-group>
					<article-title>Oral and oropharyngeal cancer: epidemiology and survival analysis</article-title>
					<source>Einstein (São Paulo)</source>
					<year>2018</year>
					<volume>16</volume>
					<issue>2</issue>
					<elocation-id>eAO4248</elocation-id>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S1679-45082018AO4248">https://doi.org/10.1590/S1679-45082018AO4248</ext-link>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>19. Oliveira-Borges EC, Silva AF, Graças AM, Melo FFS, Barcelos AA, Myiata S. O câncer de esôfago: uma revisão. Rev Univ Vale Rio Verde. 2015;13(1):773-90. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5892/ruvrd.v10i1.2471">https://doi.org/10.5892/ruvrd.v10i1.2471</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Oliveira-Borges</surname>
							<given-names>EC</given-names>
						</name>
						<name>
							<surname>Silva</surname>
							<given-names>AF</given-names>
						</name>
						<name>
							<surname>Graças</surname>
							<given-names>AM</given-names>
						</name>
						<name>
							<surname>Melo</surname>
							<given-names>FFS</given-names>
						</name>
						<name>
							<surname>Barcelos</surname>
							<given-names>AA</given-names>
						</name>
						<name>
							<surname>Myiata</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>O câncer de esôfago: uma revisão</article-title>
					<source>Rev Univ Vale Rio Verde</source>
					<year>2015</year>
					<volume>13</volume>
					<issue>1</issue>
					<fpage>773</fpage>
					<lpage>790</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5892/ruvrd.v10i1.2471">https://doi.org/10.5892/ruvrd.v10i1.2471</ext-link>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>20. Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, et al. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncol. 2012;51(7):906-14. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/0284186X.2012.673732">https://doi.org/10.3109/0284186X.2012.673732</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hiripi</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Jansen</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Gondos</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Emrich</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Holleczek</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Katalinic</surname>
							<given-names>A</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Survival of stomach and esophagus cancer patients in Germany in the early 21st century</article-title>
					<source>Acta Oncol</source>
					<year>2012</year>
					<volume>51</volume>
					<issue>7</issue>
					<fpage>906</fpage>
					<lpage>914</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/0284186X.2012.673732">https://doi.org/10.3109/0284186X.2012.673732</ext-link>
				</element-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation>21. Huang FL, Yu SJ. Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210-5. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.asjsur.2016.10.005">https://doi.org/10.1016/j.asjsur.2016.10.005</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Huang</surname>
							<given-names>FL</given-names>
						</name>
						<name>
							<surname>Yu</surname>
							<given-names>SJ</given-names>
						</name>
					</person-group>
					<article-title>Esophageal cancer: risk factors, genetic association, and treatment</article-title>
					<source>Asian J Surg</source>
					<year>2018</year>
					<volume>41</volume>
					<issue>3</issue>
					<fpage>210</fpage>
					<lpage>215</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.asjsur.2016.10.005">https://doi.org/10.1016/j.asjsur.2016.10.005</ext-link>
				</element-citation>
			</ref>
			<ref id="B22">
				<label>22</label>
				<mixed-citation>22. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26-38. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5114/pg.2018.80001">https://doi.org/10.5114/pg.2018.80001</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Rawla</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Barsouk</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Epidemiology of gastric cancer: global trends, risk factors and prevention</article-title>
					<source>Prz Gastroenterol</source>
					<year>2019</year>
					<volume>14</volume>
					<issue>1</issue>
					<fpage>26</fpage>
					<lpage>38</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5114/pg.2018.80001">https://doi.org/10.5114/pg.2018.80001</ext-link>
				</element-citation>
			</ref>
			<ref id="B23">
				<label>23</label>
				<mixed-citation>23. Schneider IJC, Schmidt TP, Patrício PSMS, Bomfim RA, Garcia LP, Nunes RD, et al. Survival and burden of cancer: a population-based analysis in a medium size city in Brazil. Res Soc Dev. 2021;10(5):1-14. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.33448/rsd-v10i5.15140">https://doi.org/10.33448/rsd-v10i5.15140</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Schneider</surname>
							<given-names>IJC</given-names>
						</name>
						<name>
							<surname>Schmidt</surname>
							<given-names>TP</given-names>
						</name>
						<name>
							<surname>Patrício</surname>
							<given-names>PSMS</given-names>
						</name>
						<name>
							<surname>Bomfim</surname>
							<given-names>RA</given-names>
						</name>
						<name>
							<surname>Garcia</surname>
							<given-names>LP</given-names>
						</name>
						<name>
							<surname>Nunes</surname>
							<given-names>RD</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Survival and burden of cancer: a population-based analysis in a medium size city in Brazil</article-title>
					<source>Res Soc Dev</source>
					<year>2021</year>
					<volume>10</volume>
					<issue>5</issue>
					<fpage>1</fpage>
					<lpage>14</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.33448/rsd-v10i5.15140">https://doi.org/10.33448/rsd-v10i5.15140</ext-link>
				</element-citation>
			</ref>
			<ref id="B24">
				<label>24</label>
				<mixed-citation>24. Aguiar Junior S, Oliveira MM, Silva DRM, Mello CAL, Calsavara VF, Curado MP. Survival of patients with colorectal cancer in a cancer center. Arq Gastroenterol. 2020;57(2):172-7. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S0004-2803.202000000-32">https://doi.org/10.1590/S0004-2803.202000000-32</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Aguiar</surname>
							<given-names>S</given-names>
							<suffix>Junior</suffix>
						</name>
						<name>
							<surname>Oliveira</surname>
							<given-names>MM</given-names>
						</name>
						<name>
							<surname>Silva</surname>
							<given-names>DRM</given-names>
						</name>
						<name>
							<surname>Mello</surname>
							<given-names>CAL</given-names>
						</name>
						<name>
							<surname>Calsavara</surname>
							<given-names>VF</given-names>
						</name>
						<name>
							<surname>Curado</surname>
							<given-names>MP</given-names>
						</name>
					</person-group>
					<article-title>Survival of patients with colorectal cancer in a cancer center</article-title>
					<source>Arq Gastroenterol</source>
					<year>2020</year>
					<volume>57</volume>
					<issue>2</issue>
					<fpage>172</fpage>
					<lpage>177</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S0004-2803.202000000-32">https://doi.org/10.1590/S0004-2803.202000000-32</ext-link>
				</element-citation>
			</ref>
			<ref id="B25">
				<label>25</label>
				<mixed-citation>25. França VG, Bertolazzi LG. Sobrevida de pacientes com neoplasia maligna de colo conforme localização primária à direita ou esquerda. Arch Health Sci. 2019;26(3):163. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17696/2318-3691.26.3.2019.1661">https://doi.org/10.17696/2318-3691.26.3.2019.1661</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>França</surname>
							<given-names>VG</given-names>
						</name>
						<name>
							<surname>Bertolazzi</surname>
							<given-names>LG</given-names>
						</name>
					</person-group>
					<article-title>Sobrevida de pacientes com neoplasia maligna de colo conforme localização primária à direita ou esquerda</article-title>
					<source>Arch Health Sci</source>
					<year>2019</year>
					<volume>26</volume>
					<issue>3</issue>
					<size units="pages">163</size>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17696/2318-3691.26.3.2019.1661">https://doi.org/10.17696/2318-3691.26.3.2019.1661</ext-link>
				</element-citation>
			</ref>
			<ref id="B26">
				<label>26</label>
				<mixed-citation>26. Islami F, Miller KD, Siegel RL, Fedewa SA, Ward EM, Jemal A. Disparities in liver cancer occurrence in the United States by race/ethnicity and state. CA Cancer J Clin. 2017;67(4):273-89. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3322/caac.21402">https://doi.org/10.3322/caac.21402</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Islami</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Miller</surname>
							<given-names>KD</given-names>
						</name>
						<name>
							<surname>Siegel</surname>
							<given-names>RL</given-names>
						</name>
						<name>
							<surname>Fedewa</surname>
							<given-names>SA</given-names>
						</name>
						<name>
							<surname>Ward</surname>
							<given-names>EM</given-names>
						</name>
						<name>
							<surname>Jemal</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Disparities in liver cancer occurrence in the United States by race/ethnicity and state</article-title>
					<source>CA Cancer J Clin</source>
					<year>2017</year>
					<volume>67</volume>
					<issue>4</issue>
					<fpage>273</fpage>
					<lpage>289</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3322/caac.21402">https://doi.org/10.3322/caac.21402</ext-link>
				</element-citation>
			</ref>
			<ref id="B27">
				<label>27</label>
				<mixed-citation>27. Kikuchi LOO. Análise da sobrevida de pacientes com carcinoma hepatocelular atendidos no Instituto do Câncer do Estado de São Paulo [tese]. São Paulo, SP: Faculdade de Medicina da Universidade de São Paulo; 2015.</mixed-citation>
				<element-citation publication-type="thesis">
					<person-group person-group-type="author">
						<name>
							<surname>Kikuchi</surname>
							<given-names>LOO</given-names>
						</name>
					</person-group>
					<source>Análise da sobrevida de pacientes com carcinoma hepatocelular atendidos no Instituto do Câncer do Estado de São Paulo</source>
					<comment>tese</comment>
					<publisher-loc>São Paulo, SP</publisher-loc>
					<publisher-name>Faculdade de Medicina da Universidade de São Paulo</publisher-name>
					<year>2015</year>
				</element-citation>
			</ref>
			<ref id="B28">
				<label>28</label>
				<mixed-citation>28. Soldan M. Rastreamento do câncer de pâncreas. Rev Col Bras Cir. 2017;44(2):109-11. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/0100-69912017002015">https://doi.org/10.1590/0100-69912017002015</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Soldan</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Rastreamento do câncer de pâncreas</article-title>
					<source>Rev Col Bras Cir</source>
					<year>2017</year>
					<volume>44</volume>
					<issue>2</issue>
					<fpage>109</fpage>
					<lpage>111</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/0100-69912017002015">https://doi.org/10.1590/0100-69912017002015</ext-link>
				</element-citation>
			</ref>
			<ref id="B29">
				<label>29</label>
				<mixed-citation>29. Silva WCF, Lima AGS, Silva HVC, Santos RA. Perfil clínico-epidemiológico e sobrevida global em pacientes com adenocarcinoma de pâncreas em um hospital de referência em Oncologia. Rev Bras Cancerol. 2021;67(1):e-16967. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.32635/2176-9745.RBC.2021v67n1.967">https://doi.org/10.32635/2176-9745.RBC.2021v67n1.967</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Silva</surname>
							<given-names>WCF</given-names>
						</name>
						<name>
							<surname>Lima</surname>
							<given-names>AGS</given-names>
						</name>
						<name>
							<surname>Silva</surname>
							<given-names>HVC</given-names>
						</name>
						<name>
							<surname>Santos</surname>
							<given-names>RA</given-names>
						</name>
					</person-group>
					<article-title>Perfil clínico-epidemiológico e sobrevida global em pacientes com adenocarcinoma de pâncreas em um hospital de referência em Oncologia</article-title>
					<source>Rev Bras Cancerol</source>
					<year>2021</year>
					<volume>67</volume>
					<issue>1</issue>
					<elocation-id>e-16967</elocation-id>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.32635/2176-9745.RBC.2021v67n1.967">https://doi.org/10.32635/2176-9745.RBC.2021v67n1.967</ext-link>
				</element-citation>
			</ref>
			<ref id="B30">
				<label>30</label>
				<mixed-citation>30. Camacho Sosa K, Alonso Lemus L, Ramirez Rodríguez D, Carreño Rolando IE, Mendoza Jorge E, García Soto J. Supervivencia de pacientes con cáncer de pulmón de células no pequeñas en estadios avanzados. Matanzas. Rev Med Electron. 2021 [cited 2021 May 10];43(1):2795-807. Available from: <ext-link ext-link-type="uri" xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1684-18242021000102795">http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1684-18242021000102795</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Camacho Sosa</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Alonso Lemus</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Ramirez Rodríguez</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Carreño Rolando</surname>
							<given-names>IE</given-names>
						</name>
						<name>
							<surname>Mendoza Jorge</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>García Soto</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Supervivencia de pacientes con cáncer de pulmón de células no pequeñas en estadios avanzados. Matanzas</article-title>
					<source>Rev Med Electron</source>
					<year>2021</year>
					<date-in-citation content-type="cited-date">cited 2021 May 10</date-in-citation>
					<volume>43</volume>
					<issue>1</issue>
					<fpage>2795</fpage>
					<lpage>2807</lpage>
					<ext-link ext-link-type="uri" xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1684-18242021000102795">http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1684-18242021000102795</ext-link>
				</element-citation>
			</ref>
			<ref id="B31">
				<label>31</label>
				<mixed-citation>31. Medeiros RB, Chaves NR, Vilela RA, Cruz DA. Câncer de bexiga. In: Santos M, editor, Strava T, Faria LDBB, Pinheiro RN. Diretrizes oncológicas 2. 2. ed. rev. ampl. São Paulo: Doctor Press; 2018. p.367-76.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Medeiros</surname>
							<given-names>RB</given-names>
						</name>
						<name>
							<surname>Chaves</surname>
							<given-names>NR</given-names>
						</name>
						<name>
							<surname>Vilela</surname>
							<given-names>RA</given-names>
						</name>
						<name>
							<surname>Cruz</surname>
							<given-names>DA</given-names>
						</name>
					</person-group>
					<chapter-title>Câncer de bexiga</chapter-title>
					<person-group person-group-type="author">
						<name>
							<surname>Santos</surname>
							<given-names>M</given-names>
						</name>
						<role>editor</role>
						<name>
							<surname>Strava</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Faria</surname>
							<given-names>LDBB</given-names>
						</name>
						<name>
							<surname>Pinheiro</surname>
							<given-names>RN</given-names>
						</name>
					</person-group>
					<source>Diretrizes oncológicas 2</source>
					<edition>2</edition>
					<publisher-loc>São Paulo</publisher-loc>
					<publisher-name>Doctor Press</publisher-name>
					<year>2018</year>
				</element-citation>
			</ref>
			<ref id="B32">
				<label>32</label>
				<mixed-citation>32. Utuama O, Mukhtar F, Pham YTH, Dabo B, Manani P, Moser J, et al. Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period. PLoS One. 2019;14(8):e0220864. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0220864">https://doi.org/10.1371/journal.pone.0220864</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Utuama</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Mukhtar</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Pham</surname>
							<given-names>YTH</given-names>
						</name>
						<name>
							<surname>Dabo</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Manani</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Moser</surname>
							<given-names>J</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period</article-title>
					<source>PLoS One</source>
					<year>2019</year>
					<volume>14</volume>
					<issue>8</issue>
					<elocation-id>e0220864</elocation-id>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0220864">https://doi.org/10.1371/journal.pone.0220864</ext-link>
				</element-citation>
			</ref>
			<ref id="B33">
				<label>33</label>
				<mixed-citation>33. Dhopeshwarkar N, Iqbal S, Wang X, Salas M. A retrospective study of comorbidities and complications in elderly acute myeloid leukemia patients in the United States. Clin Lymphoma Myeloma Leuk. 2019;19(8):e436-56. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clml.2019.04.012">https://doi.org/10.1016/j.clml.2019.04.012</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dhopeshwarkar</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Iqbal</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Wang</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Salas</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>A retrospective study of comorbidities and complications in elderly acute myeloid leukemia patients in the United States</article-title>
					<source>Clin Lymphoma Myeloma Leuk</source>
					<year>2019</year>
					<volume>19</volume>
					<issue>8</issue>
					<fpage>e436</fpage>
					<lpage>e456</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clml.2019.04.012">https://doi.org/10.1016/j.clml.2019.04.012</ext-link>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="financial-disclosure" id="fn2">
				<p><bold>Funding:</bold> <italic>Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina</italic>, <italic>Programa de Pesquisa para o SUS: Gestão Compartilhada em Saúde</italic> (PPSUS – Research Program for the SUS: Shared Management in Health - Grant No. 2016RT2206).</p>
			</fn>
		</fn-group>
	</back>
	<sub-article article-type="translation" id="TRpt" xml:lang="pt">
		<front-stub>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artigo Original</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Neoplasias relacionadas ao tabaco: análise de sobrevivência e risco de óbito de dados populacionais de Florianópolis, SC</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-6339-7832</contrib-id>
					<name>
						<surname>Schneider</surname>
						<given-names>Ione Jayce Ceola</given-names>
					</name>
					<xref ref-type="aff" rid="aff1002"><sup>I</sup></xref>
					<xref ref-type="aff" rid="aff2002"><sup>II</sup></xref>
					<xref ref-type="aff" rid="aff3002"><sup>III</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-9055-0588</contrib-id>
					<name>
						<surname>Schmidt</surname>
						<given-names>Tauana Prestes</given-names>
					</name>
					<xref ref-type="aff" rid="aff2002"><sup>II</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-8972-2231</contrib-id>
					<name>
						<surname>Correa</surname>
						<given-names>Vanessa Pereira</given-names>
					</name>
					<xref ref-type="aff" rid="aff2002"><sup>II</sup></xref>
					<xref ref-type="aff" rid="aff3002"><sup>III</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-8321-2700</contrib-id>
					<name>
						<surname>Santos</surname>
						<given-names>Ana Maria Martins dos</given-names>
					</name>
					<xref ref-type="aff" rid="aff2002"><sup>II</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-2787-6136</contrib-id>
					<name>
						<surname>Rocha</surname>
						<given-names>Bruna Vanti da</given-names>
					</name>
					<xref ref-type="aff" rid="aff2002"><sup>II</sup></xref>
					<xref ref-type="aff" rid="aff3002"><sup>III</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-8601-7166</contrib-id>
					<name>
						<surname>Garcia</surname>
						<given-names>Leandro Pereira</given-names>
					</name>
					<xref ref-type="aff" rid="aff4002"><sup>IV</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-0846-1376</contrib-id>
					<name>
						<surname>Ceccon</surname>
						<given-names>Roger Flores</given-names>
					</name>
					<xref ref-type="aff" rid="aff1002"><sup>I</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1002">
				<label>I</label>
				<country country="BR">Brasil</country>
				<institution content-type="original"> Universidade Federal de Santa Catarina. Departamento de Ciências da Saúde. Araranguá, SC, Brasil</institution>
			</aff>
			<aff id="aff2002">
				<label>II</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Universidade Federal de Santa Catarina. Programa de Pós-Graduação em Ciências da Reabilitação. Araranguá, SC, Brasil</institution>
			</aff>
			<aff id="aff3002">
				<label>III</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Universidade Federal de Santa Catarina. Programa de Pós-Graduação em Saúde Coletiva. Florianópolis, SC, Brasil</institution>
			</aff>
			<aff id="aff4002">
				<label>IV</label>
				<country country="BR">Brasil</country>
				<institution content-type="original"> Secretaria Municipal de Saúde de Florianópolis. Florianópolis, SC, Brasil</institution>
			</aff>
			<author-notes>
				<corresp id="c01002"> Correspondência: Ione Jayce Ceola Schneider Rodovia Governador Jorge Lacerda, 3.201 88906-072 Araranguá, SC, Brasil E-mail: ione.schneider@ufsc.br </corresp>
				<fn id="fn1002">
					<p><bold>Contribuição dos Autores:</bold> Concepção e planejamento do estudo: IJCS, TPS. Coleta, análise e interpretação dos dados: IJCS, TPS, VPC, AMMS, LPG. Elaboração ou revisão do manuscrito: IJCS, TPS, VPC, AMMS, BVR, LPG, RFC. Aprovação da versão final: IJCS, TPS, VPC, AMMS, BVR, LPG, RFC. Responsabilidade pública pelo conteúdo do artigo: IJCS, RFC.</p>
					<p><bold>Conflito de Interesses:</bold> Os autores declaram não haver conflito de interesses.</p>
				</fn>
			</author-notes>
			<abstract>
				<title>RESUMO</title>
				<sec>
					<title>OBJETIVO</title>
					<p> Estimar a probabilidade de sobrevivência e os fatores prognósticos das neoplasias relacionados ao tabagismo em uma coorte de base populacional.</p>
				</sec>
				<sec>
					<title>MÉTODOS</title>
					<p> Trata-se de uma coorte com dados do Registro de Câncer de Base Populacional de Florianópolis, região Sul do Brasil, de 2008 a 2012. Utilizou-se o <italic>software Stata</italic> 16.0 para estimar as probabilidades de sobrevivência em cinco anos após o diagnóstico, pelo método de Kaplan Meier, e os riscos de óbito, pela regressão de Cox.</p>
				</sec>
				<sec>
					<title>RESULTADOS</title>
					<p> Foram incluídos 2.829 registros de câncer relacionados ao tabagismo, mais prevalentes entre pessoas do sexo masculino, com mais de 70 anos, nove anos ou mais de escolaridade, cor branca, com companheiro e diagnóstico metastático. Os agrupamentos mais frequentes foram cólon e reto (28,7%), traqueia, brônquios e pulmões (18,6%) e estômago (11,8%). No acompanhamento, 1.450 foram a óbito. O câncer de pâncreas foi o que apresentou pior probabilidade de sobrevivência (14,3%), seguido pelo câncer de fígado (19,4%).</p>
				</sec>
				<sec>
					<title>CONCLUSÃO</title>
					<p> Os fatores de risco para o óbito e as taxas de sobrevivência diferem entre os 13 tipos de câncer relacionados ao tabaco. O diagnóstico precoce e a prevenção primária são estratégias que devem ser aprimoradas para melhorar a sobrevivência e diminuir a carga relacionada a esses tipos de câncer.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="pt">
				<kwd>Tabagismo</kwd>
				<kwd>Neoplasias, epidemiologia</kwd>
				<kwd>Análise de Sobrevida</kwd>
				<kwd>Fatores de Risco</kwd>
				<kwd>Mortalidade</kwd>
				<kwd>Modelos de Riscos Proporcionais</kwd>
			</kwd-group>
		</front-stub>
		<body>
			<sec sec-type="intro">
				<title>INTRODUÇÃO</title>
				<p>O tabagismo caracteriza-se como um importante problema de saúde pública e é considerado o segundo fator de risco modificável mais prevalente para doenças crônicas não transmissíveis (DCNT) e para a mortalidade global. No Brasil, atualmente, são mais de 7 milhões de fumantes ativos e 1,2 milhão de fumantes passivos. Além do mais, 428 pessoas morrem diariamente em decorrência da dependência da nicotina, 56,9 bilhões de reais são gastos anualmente com despesas médicas e perda de produtividade e 156.216 mortes anuais poderiam ser evitadas pela diminuição do uso do tabaco<sup><xref ref-type="bibr" rid="B1">1</xref></sup>.</p>
				<p>A incidência de câncer relacionado ao tabaco tem aumentado de maneira significativa nos últimos anos, principalmente tumores na cavidade oral, faringe, esôfago, estômago, cólon, reto, fígado, pâncreas, laringe, pulmão, brônquios, traqueia, rins, bexiga urinária e colo uterino, além de leucemia mieloide aguda (LMA)<sup><xref ref-type="bibr" rid="B2">2</xref></sup>. Em 2015, o câncer foi uma das principais causas de anos de vida perdidos por incapacidade atribuíveis ao tabagismo e constituiu-se como a causa de 20% do total de mortes pela doença<sup><xref ref-type="bibr" rid="B3">3</xref></sup>.</p>
				<p>No mundo, é definida que 18 milhões de pessoas foram diagnosticadas com câncer e 9,6 milhões foram a óbito no ano de 2018, a maioria do sexo masculino e em países de baixa e média renda<sup><xref ref-type="bibr" rid="B4">4</xref></sup>. No Brasil, a incidência é de mais 500 mil novos casos, a mortalidade ultrapassou 100 mil óbitos no mesmo período e a taxa de sobrevida esperada para todos os cânceres é de aproximadamente 50% em cinco anos<sup><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref></sup>.</p>
				<p>A sobrevida é definida como o período pelo qual um paciente permanece vivo após o diagnóstico da doença ou início do tratamento. Embora seja um importante indicador para mensurar a magnitude do tabagismo e do câncer na população, a sobrevida após o diagnóstico de tumores causados pelo tabaco ainda é desconhecida no Brasil. Além do mais, a análise da sobrevida possibilita avaliar as ações na área oncológica implementadas no país nos últimos anos, bem como seus fatores prognósticos. Ainda, o estudo da sobrevida permite conhecer o comportamento da doença, possibilitando uma abordagem que proporcione melhor qualidade de vida aos indivíduos acometidos<sup><xref ref-type="bibr" rid="B6">6</xref></sup>.</p>
				<p>Há poucos relatos na literatura científica acerca da sobrevivência de pessoas com câncer relacionado ao tabaco, embora evidencie-se que o maior consumo de cigarro está associado à pior progressão da doença<sup><xref ref-type="bibr" rid="B2">2</xref></sup>.</p>
				<p>Assim, o objetivo deste trabalho foi estimar a probabilidade de sobrevivência e os fatores prognósticos das neoplasias relacionadas ao tabagismo em uma coorte de base populacional.</p>
			</sec>
			<sec sec-type="methods">
				<title>MÉTODOS</title>
				<p>Trata-se de uma coorte de base populacional com dados do Registro Municipal de Câncer de Florianópolis, município localizado na região Sul do país. É a capital do estado de Santa Catarina, tem aproximadamente 500 mil habitantes e caracteriza-se por seu Índice de Desenvolvimento Humano (IDH) muito alto: 0,815, atribuído principalmente à longevidade e renda<sup><xref ref-type="bibr" rid="B7">7</xref></sup>. O município conta com alta cobertura e experiência consolidada na atenção primária, refletindo em bons resultados de rastreamento e detecção precoce das condições de saúde de sua população. Além disso, o atendimento aos pacientes oncológicos, na média e alta complexidade, é contemplado por mais de seis centros hospitalares, além de associações que se dedicam à conscientização e busca por direitos das pessoas com câncer.</p>
				<p>A população do estudo é composta por indivíduos cadastrados no Registro de Câncer de Base Populacional de Florianópolis, no período de 1 de janeiro de 2008 a 31 de dezembro de 2012, com diagnóstico de neoplasia relacionada ao tabagismo. Os cânceres incluídos foram aqueles com código de Classificação Internacional de Doenças para a Oncologia (CID-O)<sup><xref ref-type="bibr" rid="B8">8</xref></sup> considerado relacionado ao tabagismo<sup><xref ref-type="bibr" rid="B9">9</xref></sup>. Entre eles estão os de lábio e cavidade oral (C00-C08); nasofaringe (C11); outras faringes (C09-C10, C12-C14); esôfago (C15); estômago (C16); cólon e reto (C18-C21); fígado (C22); pâncreas (C25); laringe (C32); traqueia, brônquios e pulmões (C33-C34); rim (C64-C66); bexiga (C67) e leucemia mieloide aguda (C92.0). Foram excluídos os casos que tiveram o meio de diagnóstico registrado como não informado ou que o diagnóstico foi exclusivamente realizado pelo serviço de verificação de óbito (SVO). Os casos de câncer de colo do útero e ovário, apesar de serem relacionados ao tabaco, não foram incluídos nas análises, mesmo apresentando o tabaco como fator causal. O muco cervical de fumantes é mais mutagênico e sugere associação com danos no DNA em mulheres com câncer de colo do útero. Já no câncer de ovário, os dados sugerem estar associado apenas ao tipo mucinoso, no qual o tabagismo pode contribuir para uma progressão da forma benigna para a maligna mais rapidamente. Esses dois últimos não foram adicionados às análises por se referirem exclusivamente ao sexo feminino e o Brasil ter políticas públicas específicas para saúde da mulher, especialmente com ação estratégica de rastreamento do câncer de colo de útero.</p>
				<p>Para possibilitar o acompanhamento dos casos registrados no RCBP e estimar a sobrevivência, são necessárias informações referentes aos óbitos, como data e causa básica. Para isso, foi utilizado o Sistema de Informação sobre Mortalidade (SIM) do Ministério da Saúde, com as informações referentes ao município de Florianópolis no período de 1 de janeiro de 2008 a 31 de dezembro de 2017. A criação do banco de dados foi fundamentada na técnica de relacionamento probabilístico de registros, que permite a integração de bases de dados de natureza diversa, contribuindo para a melhoria da qualidade dos dados registrados<sup><xref ref-type="bibr" rid="B12">12</xref></sup>. Para tal, utilizou-se o <italic>software</italic> OpenRecLink 3.1. Para o pareamento dos dados, foram utilizadas as seguintes variáveis do SIM: número da declaração de óbito, nome, data de nascimento, nome da mãe, data de óbito, causa básica da morte; e do banco do RCBP: número do registro, nome, data de nascimento, nome da mãe. Os parâmetros do relacionamento seguiram as instruções do <italic>software</italic>. Após o relacionamento dos bancos de dados, foi criado um banco único contendo todas as informações pertinentes ao estudo, permitindo a análise dos dados.</p>
				<p>O tempo de sobrevivência foi calculado como o intervalo, em meses, entre a data do diagnóstico e a data do óbito ou final do acompanhamento. O tempo máximo de acompanhamento foi de 60 meses. Todos os casos não encontrados no SIM foram considerados vivos ao final do acompanhamento e censurados.</p>
				<p>As variáveis independentes foram sexo (feminino, masculino), faixa etária (com pontos de corte para cada tipo de câncer), raça/cor (branca, preto/pardo/indígena/amarelo, sem informação), escolaridade (9 anos ou mais, 8 anos ou menos, sem informação), estado conjugal (com companheiro, sem companheiro, sem informação), extensão do câncer (localizado, metástase, sem informação) e ano do diagnóstico (2008, 2009, 2010, 2011, 2012).</p>
				<p>Inicialmente, foi realizada análise descritiva com frequência absoluta e relativa das variáveis independentes. Após, foi realizada a análise bivariada entre as variáveis independentes e a variável status (censura/óbito) para estimar a incidência de óbitos em cada categoria e utilizado o teste qui-quadrado de Pearson para testar a associação entre as variáveis. Essas análises foram realizadas para todos os casos e para cada tipo de câncer.</p>
				<p>Para cada tipo de câncer, a probabilidade de sobrevivência foi estimada pelo método de Kaplan-Meier. Para comparar as curvas de sobrevivência estratificadas pelas variáveis independentes, foi utilizado o teste log-rank. A estimação do efeito das variáveis independentes foi realizada pelo modelo semiparamétrico de riscos proporcionais de Cox bruta e ajustada. As variáveis com valor de p &lt; 0,20 foram incluídas na análise ajustada. Para a análise dos dados e construção dos gráficos de sobrevida, foi utilizado o programa estatístico <italic>Stata</italic> (<italic>Stata Corp, v.16.0. Stata Statistical Software. College Station: StataCorp LP</italic>, 2021).</p>
				<p>Esta pesquisa foi fundamentada nos princípios éticos, com base na Resolução n° 466, de 12 de dezembro de 2012, do Conselho Nacional de Saúde, e aprovada sob o CAAE: 53518116.1.0000.0121.</p>
				<p>Esse trabalho é resultado do projeto financiado pela Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina, no Programa de Pesquisa para o SUS: Gestão Compartilhada em Saúde (PPSUS) (Termo de Outorga n° 2016RT2206).</p>
			</sec>
			<sec sec-type="results">
				<title>RESULTADOS</title>
				<sec>
					<title>Descrição Geral</title>
					<p>No período de 1 de janeiro de 2008 a 31 de dezembro de 2012, 3.012 casos de câncer relacionados ao tabaco foram registrados pelo RCBP no município de Florianópolis. Desses, 189 foram excluídos por terem sido diagnosticados pelo SVO ou pelo método diagnóstico não estar disponível. Dessa forma, a população deste estudo é composta por 2.829 registros (<xref ref-type="table" rid="t1002">Tabela 1</xref>).</p>
					<p>
						<table-wrap id="t1002">
							<label>Tabela 1</label>
							<caption>
								<title>Descrição e sobrevivência dos casos registrados de câncer relacionado ao tabaco, Florianópolis, 2008–2017.</title>
							</caption>
							<table frame="hsides" rules="groups">
								<colgroup>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left" rowspan="3">Variáveis</th>
										<th rowspan="3">n (%)</th>
										<th>Óbitos</th>
										<th rowspan="3">p<sup>a</sup></th>
										<th rowspan="3">S(t) (IC95%)</th>
										<th rowspan="3">p<sup>b</sup></th>
									</tr>
									<tr>
										<th>
											<hr/>
										</th>
									</tr>
									<tr>
										<th>n (%)</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,009</td>
										<td>
										</td>
										<td align="center">0,019</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">1.104 (39,0)</td>
										<td align="center">532 (48,2)</td>
										<td>
										</td>
										<td align="center">51,8 (48,8–54,7)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">1.725 (61,0)</td>
										<td align="center">918 (53,2)</td>
										<td>
										</td>
										<td align="center">46,8 (44,4–49,1)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">414 (14,6)</td>
										<td align="center">144 (34,8)</td>
										<td>
										</td>
										<td align="center">65,2 (60,4–69,6)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">684 (24,2)</td>
										<td align="center">311 (45,4)</td>
										<td>
										</td>
										<td align="center">54,6 (50,8–58,2)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">766 (27,1)</td>
										<td align="center">395 (51,6)</td>
										<td>
										</td>
										<td align="center">48,4 (44,9–51,9)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">962 (34,0)</td>
										<td align="center">600 (62,4)</td>
										<td>
										</td>
										<td align="center">37,6 (34,6–40,7)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0 ,001</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">1.311 (46,3)</td>
										<td align="center">640 (48,8)</td>
										<td>
										</td>
										<td align="center">51,2 (48,4–53,9)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">1.146 (40,5)</td>
										<td align="center">665 (58,0)</td>
										<td>
										</td>
										<td align="center">42,0 (39,1–44,8)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">372 (13,2)</td>
										<td align="center">145 (39,0)</td>
										<td>
										</td>
										<td align="center">61,0 (55,9–65,8)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">2.472 (87,4)</td>
										<td align="center">1.282 (51,9)</td>
										<td>
										</td>
										<td align="center">48,1 (46,2–50,1)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">172 (6,1)</td>
										<td align="center">108 (62,8)</td>
										<td>
										</td>
										<td align="center">37,2 (30,0–44,4)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">185 (6,5)</td>
										<td align="center">60 (32,4)</td>
										<td>
										</td>
										<td align="center">67,6 (60,3–73,8)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">1.598 (56,5)</td>
										<td align="center">824 (51,6)</td>
										<td>
										</td>
										<td align="center">48,4 (46,0–50,9)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">884 (31,3)</td>
										<td align="center">499 (56,5)</td>
										<td>
										</td>
										<td align="center">43,6 (40,3–46,8)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">347 (12,3)</td>
										<td align="center">127 (36,6)</td>
										<td>
										</td>
										<td align="center">63,4 (58,1–68,2)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
									</tr>
									<tr>
										<td>In situ</td>
										<td align="center">48 (1,7)</td>
										<td align="center">10 (20,8)</td>
										<td>
										</td>
										<td align="center">79,2 (64,7–88,2)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">541 (19,1)</td>
										<td align="center">173 (32,0)</td>
										<td>
										</td>
										<td align="center">68,0 (63,9–71,8)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">1.104 (39,0)</td>
										<td align="center">761 (68,9)</td>
										<td>
										</td>
										<td align="center">31,1 (28,4–33,8)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Não se aplica</td>
										<td align="center">28 (1,0)</td>
										<td align="center">17 (60,7)</td>
										<td>
										</td>
										<td align="center">39,3 (21,7–56,5)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">1.108 (39,2)</td>
										<td align="center">489 (44,1)</td>
										<td>
										</td>
										<td align="center">55,9 (52,9–58,7)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Agrupamento</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
									</tr>
									<tr>
										<td>Lábio e cavidade oral (C00-C08)</td>
										<td align="center">165 (5,8)</td>
										<td align="center">65 (39,4)</td>
										<td>
										</td>
										<td align="center">60,6 (52,7–67,6)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Outras faringes (C09-10; C12-14)</td>
										<td align="center">72 (2,6)</td>
										<td align="center">43 (59,7)</td>
										<td>
										</td>
										<td align="center">40,3 (29,0–51,3)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Nasofaringe (C11)</td>
										<td align="center">24 (0,9)</td>
										<td align="center">12 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (29,1–67,8)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Esôfago (C15)</td>
										<td align="center">104 (3,7)</td>
										<td align="center">71 (67,6)</td>
										<td>
										</td>
										<td align="center">32,4 (23,7–41,4)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Estômago (C16)</td>
										<td align="center">333 (11,8)</td>
										<td align="center">200 (60,1)</td>
										<td>
										</td>
										<td align="center">39,9 (34,7–45,2)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Colón e reto (C18-21)</td>
										<td align="center">813 (28,7)</td>
										<td align="center">291 (35,8)</td>
										<td>
										</td>
										<td align="center">64,2 (60,8–67,4)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Fígado (C22)</td>
										<td align="center">103 (3,6)</td>
										<td align="center">83 (80,6)</td>
										<td>
										</td>
										<td align="center">19,4 (12,5–27,6)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Pâncreas (C25)</td>
										<td align="center">112 (4,0)</td>
										<td align="center">96 (85,7)</td>
										<td>
										</td>
										<td align="center">14,3 (8,6–21,4)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Laringe (C32)</td>
										<td align="center">88 (3,1)</td>
										<td align="center">36 (40,9)</td>
										<td>
										</td>
										<td align="center">59,1 (48,1–68,5)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Traqueia, brônquios e pulmão (C33-C34)</td>
										<td align="center">527 (18,6)</td>
										<td align="center">407 (77,2)</td>
										<td>
										</td>
										<td align="center">22,8 (19,3–26,4)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Rim (C64-C66)</td>
										<td align="center">177 (6,3)</td>
										<td align="center">43 (24,3)</td>
										<td>
										</td>
										<td align="center">75,7 (68,7–81,4)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Bexiga (C67)</td>
										<td align="center">282 (10,0)</td>
										<td align="center">86 (30,5)</td>
										<td>
										</td>
										<td align="center">69,5 (63,8–74,5)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Leucemia mieloide aguda (C92.0)</td>
										<td align="center">28 (1,0)</td>
										<td align="center">17 (60,7)</td>
										<td>
										</td>
										<td align="center">39,3 (21,7–56,5)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,623</td>
										<td>
										</td>
										<td align="center">0,690</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">514 (18,2)</td>
										<td align="center">257 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (45,6–54,2)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">575 (20,3)</td>
										<td align="center">298 (51,8)</td>
										<td>
										</td>
										<td align="center">48,2 (44,0–52,2)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">597 (21,1)</td>
										<td align="center">316 (52,9)</td>
										<td>
										</td>
										<td align="center">47,1 (43,0–51,0)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">542 (19,2)</td>
										<td align="center">285 (52,5)</td>
										<td>
										</td>
										<td align="center">47,5 (43,3–51,6)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">600 (21,2)</td>
										<td align="center">294 (49,0)</td>
										<td>
										</td>
										<td align="center">51,0 (46,9–54,9)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Status</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Censura</td>
										<td align="center">1.379 (48,8)</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Óbito</td>
										<td align="center">1.450 (51,3)</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN1002">
									<p><sup>a</sup> Valor de p do teste qui-quadrado.</p>
								</fn>
								<fn id="TFN2002">
									<p><sup>b</sup> Valor de p do teste Log-rank.</p>
								</fn>
								<fn id="TFN3002">
									<p>S(t): probabilidade de sobrevivência em função do tempo; IC95%: intervalo de confiança de 95%.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
					<p>Os casos incluídos foram em sua maioria do sexo masculino (61,0%), acima dos 70 anos (34,0%), com 9 anos ou mais de estudo (46,3%), da raça/cor branca (87,4%), com companheiro (56,5%) e com diagnóstico metastático (39,0%). No acompanhamento, 51,3% dos casos foram a óbito no período de cinco anos. Com exceção da variável ano do diagnóstico, as demais (sexo, faixa etária, escolaridade, raça, situação conjugal, extensão da doença) foram associadas ao óbito (<xref ref-type="table" rid="t1002">Tabela 1</xref>). O tipo mais frequente foi de cólon e reto (28,7%), seguido pelo de traqueia, brônquios e pulmão (18,6%) e estômago (11,8%) (<xref ref-type="table" rid="t1002">Tabela 1</xref>).</p>
				</sec>
				<sec>
					<title>Lábio e cavidade oral (C00-C08)</title>
					<p>Foram registradas 165 pessoas com câncer de lábio e cavidade oral, ou 5,8% do total de casos incluídos. Ao final do acompanhamento, 39,4% delas foram a óbito e a probabilidade de sobrevivência ao final foi de 60,6% (IC95% 52,7–67,6) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). Foi mais frequente no sexo masculino, em pessoas de 50 a 59 anos, com oito anos ou menos de escolaridade, da raça branca. Faixa etária, raça e extensão da doença foram associadas à sobrevivência. Na análise ajustada, foram incluídas as variáveis faixa etária, escolaridade, raça, situação conjugal e extensão da doença. Apenas outras cores/raças se mantiveram como fator prognóstico, com aumento de 2,6 no risco de óbito (<xref ref-type="table" rid="t2002">Tabela 2</xref>).</p>
					<p>
						<fig id="f01002">
							<label>Figura 1</label>
							<caption>
								<title>Sobrevivência dos casos registrados de câncer relacionado ao tabaco, Florianópolis, 2008–2017.</title>
							</caption>
							<graphic xlink:href="1518-8787-rsp-56-16-gf01-pt.tif"/>
						</fig>
					</p>
					<p>
						<table-wrap id="t2002">
							<label>Tabela 2</label>
							<caption>
								<title>Descrição, sobrevivência e riscos proporcionais de óbito dos casos registrados de cânceres de lábio e cavidade oral (C00-C08), outras faringes (C09-10; C12-14), nasofaringe (C11), laringe (C32) e traqueia, brônquios e pulmão (C33-C34). Florianópolis, 2008–2017.</title>
							</caption>
							<table frame="hsides" rules="groups">
								<colgroup>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left" rowspan="3">Variáveis</th>
										<th rowspan="3">n (%)</th>
										<th>Óbitos</th>
										<th rowspan="3">p<sup>a</sup></th>
										<th rowspan="3">S(t) (IC95%)</th>
										<th rowspan="3">p<sup>b</sup></th>
										<th rowspan="3">HR bruta (IC95%)</th>
										<th rowspan="3">HR ajustada (IC95%)</th>
									</tr>
									<tr>
										<th>
											<hr/>
										</th>
									</tr>
									<tr>
										<th>n (%)</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td><bold>Lábio e cavidade oral (C00-C08)</bold><sup><bold>c</bold></sup></td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,342</td>
										<td>
										</td>
										<td align="center">0,258</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">58 (35,2)</td>
										<td align="center">20 (34,5)</td>
										<td>
										</td>
										<td align="center">65,5 (51,8–76,2)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">107 (64,9)</td>
										<td align="center">45 (42,1)</td>
										<td>
										</td>
										<td align="center">57,9 (48,0–66,6)</td>
										<td>
										</td>
										<td align="center">1,35 (0,80–2,29)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,016</td>
										<td>
										</td>
										<td align="center">0,022</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">35 (21,2)</td>
										<td align="center">10 (28,6)</td>
										<td>
										</td>
										<td align="center">71,4 (53,4–83,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">48 (29,1)</td>
										<td align="center">22 (45,8)</td>
										<td>
										</td>
										<td align="center">54,2 (39,2–67,0)</td>
										<td>
										</td>
										<td align="center">1,77 (0,84–3,75)</td>
										<td align="center">1,40 (0,64–3,03)</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">35 (21,2)</td>
										<td align="center">8 (22,9)</td>
										<td>
										</td>
										<td align="center">77,1 (59,5–87,9)</td>
										<td>
										</td>
										<td align="center">0,75 (0,30–1,91)</td>
										<td align="center">0,63 (0,24–1,62)</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">47 (28,5)</td>
										<td align="center">25 (53,2)</td>
										<td>
										</td>
										<td align="center">46,8 (32,2–32,2)</td>
										<td>
										</td>
										<td align="center">2,14 (1,03–4,45)</td>
										<td align="center">1,94 (0,92–4,10)</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,228</td>
										<td>
										</td>
										<td align="center">0,131</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">69 (41,8)</td>
										<td align="center">22 (31,9)</td>
										<td>
										</td>
										<td align="center">68,1 (55,7–77,7)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">84 (50,9)</td>
										<td align="center">37 (44,1)</td>
										<td>
										</td>
										<td align="center">56,0 (44,7–65,8)</td>
										<td>
										</td>
										<td align="center">1,50 (0,88–2,54)</td>
										<td align="center">1,13 (0,66–1,95)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">12 (7,3)</td>
										<td align="center">6 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (20,9–73,6)</td>
										<td>
										</td>
										<td align="center">2,25 (0,91–5,56)</td>
										<td align="center">2,12 (0,48–9,27)</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,040</td>
										<td>
										</td>
										<td align="center">0,015</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">148 (89,7)</td>
										<td align="center">54 (36,5)</td>
										<td>
										</td>
										<td align="center">63,5 (55,2–70,7)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">9 (5,5)</td>
										<td align="center">7 (77,8)</td>
										<td>
										</td>
										<td align="center">22,2 (3,4–51,3)</td>
										<td>
										</td>
										<td align="center">2,80 (1,27–6,17)</td>
										<td align="center">2,61 (1,16–5,86)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">8 (4,9)</td>
										<td align="center">4 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (15,2–77,5)</td>
										<td>
										</td>
										<td align="center">2,00 (0,72–5,52)</td>
										<td align="center">1,14 (0,20–6,45)</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,929</td>
										<td>
										</td>
										<td align="center">0,948</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">94 (57,0)</td>
										<td align="center">36 (38,3)</td>
										<td>
										</td>
										<td align="center">61,7 (51,1–70,7)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">58 (35,2)</td>
										<td align="center">24 (41,4)</td>
										<td>
										</td>
										<td align="center">58,6 (44,9–70,0)</td>
										<td>
										</td>
										<td align="center">1,05 (0,63–1,76)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">13 (7,9)</td>
										<td align="center">5 (38,5)</td>
										<td>
										</td>
										<td align="center">61,5 (30,8–81,8)</td>
										<td>
										</td>
										<td align="center">1,15 (0,45–2,94)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,014</td>
										<td>
										</td>
										<td align="center">0,014</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">34 (20,6)</td>
										<td align="center">12 (35,3)</td>
										<td>
										</td>
										<td align="center">64,7 (46,3–78,2)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">57 (34,6)</td>
										<td align="center">31 (54,4)</td>
										<td>
										</td>
										<td align="center">45,6 (32,4–57,9)</td>
										<td>
										</td>
										<td align="center">1,75 (0,90–3,41)</td>
										<td align="center">1,76 (0,90–3,46)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">74 (44,9)</td>
										<td align="center">22 (29,7)</td>
										<td>
										</td>
										<td align="center">70,3 (58,5–79,3)</td>
										<td>
										</td>
										<td align="center">0,81 (0,40–1,64)</td>
										<td align="center">0,81 (0,39–1,66)</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,842</td>
										<td>
										</td>
										<td align="center">0,851</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">28 (17,0)</td>
										<td align="center">13 (46,4)</td>
										<td>
										</td>
										<td align="center">53,6 (33,8–69,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">36 (21,8)</td>
										<td align="center">14 (38,9)</td>
										<td>
										</td>
										<td align="center">61,1 (43,4–74,8)</td>
										<td>
										</td>
										<td align="center">0,78 (0,36–1,65)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">32 (19,4)</td>
										<td align="center">12 (37,5)</td>
										<td>
										</td>
										<td align="center">62,5 (43,5–76,7)</td>
										<td>
										</td>
										<td align="center">0,75 (0,34–1,63)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">31 (18,8)</td>
										<td align="center">10 (32,3)</td>
										<td>
										</td>
										<td align="center">67,7 (48,4–81,2)</td>
										<td>
										</td>
										<td align="center">0,62 (0,27–0,42)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">38 (23,0)</td>
										<td align="center">16 (42,1)</td>
										<td>
										</td>
										<td align="center">57,9 (40,8–71,7)</td>
										<td>
										</td>
										<td align="center">0,79 (0,38–1,65)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td colspan="4"><bold>Câncer em outras faringes (C09-C10; C12-C14)</bold></td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,717</td>
										<td>
										</td>
										<td align="center">0,936</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">6 (8,3)</td>
										<td align="center">4 (66,7)</td>
										<td>
										</td>
										<td align="center">33,3 (4,6–67,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">66 (91,7)</td>
										<td align="center">39 (59,1)</td>
										<td>
										</td>
										<td align="center">40,9 (29,0–52,4)</td>
										<td>
										</td>
										<td align="center">0,96 (0,34–2,68)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,524</td>
										<td>
										</td>
										<td align="center">0,658</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">9 (12,5)</td>
										<td align="center">5 (55,6)</td>
										<td>
										</td>
										<td align="center">44,4 (13,6–71,9)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">24 (33,3)</td>
										<td align="center">12 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (29,1–67,8)</td>
										<td>
										</td>
										<td align="center">0,79 (0,28–2,24)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">24 (33,3)</td>
										<td align="center">15 (62,5)</td>
										<td>
										</td>
										<td align="center">37,5 (19,0–56,0)</td>
										<td>
										</td>
										<td align="center">1,03 (0,38–2,85)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">15 (20,8)</td>
										<td align="center">11 (73,3)</td>
										<td>
										</td>
										<td align="center">26,7 (8,3–49,6)</td>
										<td>
										</td>
										<td align="center">1,34 (0,46–3,85)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,733</td>
										<td>
										</td>
										<td align="center">0,816</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">26 (36,1)</td>
										<td align="center">17 (65,4)</td>
										<td>
										</td>
										<td align="center">34,6 (17,5–52,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">42 (58,3)</td>
										<td align="center">24 (57,1)</td>
										<td>
										</td>
										<td align="center">42,9 (27,8–57,1)</td>
										<td>
										</td>
										<td align="center">0,82 (0,44–1,52)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">4 (5,6)</td>
										<td align="center">2 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (5,8–84,5)</td>
										<td>
										</td>
										<td align="center">0,85 (0,20–3,68)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,629</td>
										<td>
										</td>
										<td align="center">0,355</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">62 (86,1)</td>
										<td align="center">36 (58,1)</td>
										<td>
										</td>
										<td align="center">41,9 (29,6–53,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">8 (11,1)</td>
										<td align="center">6 (75,0)</td>
										<td>
										</td>
										<td align="center">25,0 (3,7–55,8)</td>
										<td>
										</td>
										<td align="center">1,87 (0,78–4,45)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">2 (2,8)</td>
										<td align="center">1 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (0,6–91,0)</td>
										<td>
										</td>
										<td align="center">1,01 (0,14–7,34)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,450</td>
										<td>
										</td>
										<td align="center">0,193</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">46 (63,9)</td>
										<td align="center">25 (54,4)</td>
										<td>
										</td>
										<td align="center">45,7 (31,0–59,2)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">22 (30,6)</td>
										<td align="center">15 (68,2)</td>
										<td>
										</td>
										<td align="center">31,8 (14,2–51,1)</td>
										<td>
										</td>
										<td align="center">1,49 (0,78–2,82)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">4 (5,6)</td>
										<td align="center">3 (75,0)</td>
										<td>
										</td>
										<td align="center">25,0 (0,9–66,5)</td>
										<td>
										</td>
										<td align="center">2,55 (0,76–8,50)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,573</td>
										<td>
										</td>
										<td align="center">0,492</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">11 (15,3)</td>
										<td align="center">5 (45,5)</td>
										<td>
										</td>
										<td align="center">54,6 (22,9–78,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">43 (59,7)</td>
										<td align="center">27 (62,8)</td>
										<td>
										</td>
										<td align="center">37,2 (23,1–51,3)</td>
										<td>
										</td>
										<td align="center">1,77 (0,68–4,59)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">18 (25,0)</td>
										<td align="center">11 (61,1)</td>
										<td>
										</td>
										<td align="center">38,9 (17,5–60,0)</td>
										<td>
										</td>
										<td align="center">1,70 (0,59–4,89)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,324</td>
										<td>
										</td>
										<td align="center">0,628</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">14 (19,4)</td>
										<td align="center">11 (78,6)</td>
										<td>
										</td>
										<td align="center">21,4 (5,2–44,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">21 (29,2)</td>
										<td align="center">12 (57,1)</td>
										<td>
										</td>
										<td align="center">42,9 (21,9–62,3)</td>
										<td>
										</td>
										<td align="center">0,67 (0,30–1,53)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">11 (15,3)</td>
										<td align="center">7 (63,6)</td>
										<td>
										</td>
										<td align="center">36,4 (11,2–62,7)</td>
										<td>
										</td>
										<td align="center">0,76 (0,29–1,95)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">13 (18,1)</td>
										<td align="center">5 (38,5)</td>
										<td>
										</td>
										<td align="center">61,5 (30,8–81,8)</td>
										<td>
										</td>
										<td align="center">0,36 (0,12–1,04)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">13 (18,1)</td>
										<td align="center">8 (61,5)</td>
										<td>
										</td>
										<td align="center">38,5 (14,1–62,8)</td>
										<td>
										</td>
										<td align="center">0,67 (0,27–1,67)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td><bold>Câncer de nasofaringe (C11)</bold></td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,386</td>
										<td>
										</td>
										<td align="center">0,499</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">8 (33,3)</td>
										<td align="center">3 (37,5)</td>
										<td>
										</td>
										<td align="center">62,5 (22,9–86,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">16 (66,7)</td>
										<td align="center">9 (56,3)</td>
										<td>
										</td>
										<td align="center">43,8 (19,8–65,6)</td>
										<td>
										</td>
										<td align="center">1,56 (0,42–5,91)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,050</td>
										<td>
										</td>
										<td align="center">0,062</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>65 anos ou menos</td>
										<td align="center">16 (66,7)</td>
										<td align="center">8 (50,0)</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">100,0</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>66 anos ou mais</td>
										<td align="center">8 (33,3)</td>
										<td align="center">8 (50,0)</td>
										<td>
										</td>
										<td align="center">25,0 (0,9–66,5)</td>
										<td>
										</td>
										<td align="center">1,29 (0,39–4,29)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">1,000</td>
										<td>
										</td>
										<td align="center">0,996</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">12 (50,0)</td>
										<td align="center">6 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (20,9–73,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">10 (41,7)</td>
										<td align="center">5 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (18,4–75,3)</td>
										<td>
										</td>
										<td align="center">1,06 (0,32–3,46)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">2 (8,3)</td>
										<td align="center">1 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (0,6–91,0)</td>
										<td>
										</td>
										<td align="center">1,01 (0,12–8,45)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,307</td>
										<td>
										</td>
										<td align="center">0,398</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">23 (95,8)</td>
										<td align="center">12 (52,2)</td>
										<td>
										</td>
										<td align="center">47,8 (26,8–66,1)</td>
										<td>
										</td>
										<td align="center">-</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">1 (4,2)</td>
										<td align="center">-</td>
										<td>
										</td>
										<td align="center">-</td>
										<td>
										</td>
										<td align="center">-</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,231</td>
										<td>
										</td>
										<td align="center">0,312</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">12 (50,0)</td>
										<td align="center">4 (33,3)</td>
										<td>
										</td>
										<td align="center">66,7 (33,7–86,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">10 (41,7)</td>
										<td align="center">7 (70,0)</td>
										<td>
										</td>
										<td align="center">30,0 (7,1–57,8)</td>
										<td>
										</td>
										<td align="center">2,52 (0,74–8,64)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">2 (8,3)</td>
										<td align="center">1 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (0,6–91,0)</td>
										<td>
										</td>
										<td align="center">1,80 (0,18–14,42)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,865</td>
										<td>
										</td>
										<td align="center">0,869</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">5 (20,8)</td>
										<td align="center">2 (40,0)</td>
										<td>
										</td>
										<td align="center">60,0 (12,6–88,2)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">11 (45,8)</td>
										<td align="center">6 (54,6)</td>
										<td>
										</td>
										<td align="center">45,5 (16,7–70,7)</td>
										<td>
										</td>
										<td align="center">1,54 (0,31–7,66)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">8 (33,4)</td>
										<td align="center">4 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (15,2–77,5)</td>
										<td>
										</td>
										<td align="center">1,34 (0,25–7,35)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,525</td>
										<td>
										</td>
										<td align="center">0,601</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">6 (25,0)</td>
										<td align="center">4 (66,7)</td>
										<td>
										</td>
										<td align="center">33,3 (4,6–67,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">5 (20,8)</td>
										<td align="center">3 (60,0)</td>
										<td>
										</td>
										<td align="center">40,0 (5,2–75,3)</td>
										<td>
										</td>
										<td align="center">0,85 (0,19–3,8)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">8 (33,3)</td>
										<td align="center">4 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (15,2–77,5)</td>
										<td>
										</td>
										<td align="center">0,54 (0,14–2,18)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">2 (8,3)</td>
										<td align="center">-</td>
										<td>
										</td>
										<td align="center">100,0</td>
										<td>
										</td>
										<td align="center">-</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">3 (12,5)</td>
										<td align="center">1 (33,3)</td>
										<td>
										</td>
										<td align="center">66,7 (5,4–94,5)</td>
										<td>
										</td>
										<td align="center">0,44 (0,05–3,99)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td><bold>Câncer de laringe (C32)</bold></td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,385</td>
										<td>
										</td>
										<td align="center">0,352</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">16 (18,2)</td>
										<td align="center">5 (31,3)</td>
										<td>
										</td>
										<td align="center">68,8 (40,5–85,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">72 (81,8)</td>
										<td align="center">31 (43,1)</td>
										<td>
										</td>
										<td align="center">56,9 (44,7–67,4)</td>
										<td>
										</td>
										<td align="center">1,56 (0,61–4,01)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,430</td>
										<td>
										</td>
										<td align="center">0,434</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">11 (12,5)</td>
										<td align="center">2 (18,2)</td>
										<td>
										</td>
										<td align="center">81,8 (44,7–95,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">33 (37,5)</td>
										<td align="center">14 (42,4)</td>
										<td>
										</td>
										<td align="center">57,6 (39,1–72,3)</td>
										<td>
										</td>
										<td align="center">2,94 (0,67–12,95)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">22 (25,0)</td>
										<td align="center">10 (45,5)</td>
										<td>
										</td>
										<td align="center">54,6 (32,1–72,4)</td>
										<td>
										</td>
										<td align="center">3,23 (0,71–14,73)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">22 (25,0)</td>
										<td align="center">10 (45,5)</td>
										<td>
										</td>
										<td align="center">54,6 (32,1–72,4)</td>
										<td>
										</td>
										<td align="center">3,18 (0,70–14,54)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,529</td>
										<td>
										</td>
										<td align="center">0,599</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">43 (48,9)</td>
										<td align="center">15 (34,9)</td>
										<td>
										</td>
										<td align="center">65,1 (49,0–77,3)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">34 (38,6)</td>
										<td align="center">16 (47,1)</td>
										<td>
										</td>
										<td align="center">52,9 (35,1–68,0)</td>
										<td>
										</td>
										<td align="center">1,47 (0,73–2,98)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">11 (12,5)</td>
										<td align="center">5 (45,5)</td>
										<td>
										</td>
										<td align="center">54,6 (22,9–78,0)</td>
										<td>
										</td>
										<td align="center">-</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,529</td>
										<td>
										</td>
										<td align="center">0,974</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">78 (88,6)</td>
										<td align="center">32 (41,0)</td>
										<td>
										</td>
										<td align="center">59,0 (47,3–68,9)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">7 (8,0)</td>
										<td align="center">3 (42,9)</td>
										<td>
										</td>
										<td align="center">57,1 (17,2–83,7)</td>
										<td>
										</td>
										<td align="center">1,44 (0,44–4,73)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">3 (3,4)</td>
										<td align="center">1 (33,3)</td>
										<td>
										</td>
										<td align="center">66,7 (5,4–94,5)</td>
										<td>
										</td>
										<td align="center">-</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,924</td>
										<td>
										</td>
										<td align="center">0,924</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">54 (61,4)</td>
										<td align="center">22 (40,7)</td>
										<td>
										</td>
										<td align="center">59,3 (45,0–71,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">23 (26,1)</td>
										<td align="center">10 (43,5)</td>
										<td>
										</td>
										<td align="center">56,5 (34,3–73,8)</td>
										<td>
										</td>
										<td align="center">1,04 (0,49–2,22)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">11 (12,5)</td>
										<td align="center">4 (36,4)</td>
										<td>
										</td>
										<td align="center">63,6 (29,7–84,5)</td>
										<td>
										</td>
										<td align="center">-</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,005</td>
										<td>
										</td>
										<td align="center">0,004</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">31 (35,2)</td>
										<td align="center">7 (22,6)</td>
										<td>
										</td>
										<td align="center">77,4 (58,4–88,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">28 (31,8)</td>
										<td align="center">18 (64,3)</td>
										<td>
										</td>
										<td align="center">35,7 (18,9–53,0)</td>
										<td>
										</td>
										<td align="center">3,79 (1,58–9,08)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">29 (33,0)</td>
										<td align="center">11 (40,9)</td>
										<td>
										</td>
										<td align="center">62,1 (42,1–76,9)</td>
										<td>
										</td>
										<td align="center">1,77 (0,69–4,57)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,337</td>
										<td>
										</td>
										<td align="center">0,383</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">15 (17,1)</td>
										<td align="center">8 (53,3)</td>
										<td>
										</td>
										<td align="center">46,7 (21,2–68,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">16 (18,2)</td>
										<td align="center">5 (31,3)</td>
										<td>
										</td>
										<td align="center">68,8 (40,5–85,6)</td>
										<td>
										</td>
										<td align="center">0,50 (0,16–1,54)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">22 (25,0)</td>
										<td align="center">11 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (28,2–68,4)</td>
										<td>
										</td>
										<td align="center">0,83 (0,33–2,06)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">18 (20,5)</td>
										<td align="center">8 (44,4)</td>
										<td>
										</td>
										<td align="center">55,6 (30,5–74,8)</td>
										<td>
										</td>
										<td align="center">0,65 (0,24–1,72)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">17 (19,3)</td>
										<td align="center">4 (23,5)</td>
										<td>
										</td>
										<td align="center">76,5 (48,8–90,5)</td>
										<td>
										</td>
										<td align="center">0,34 (0,10–1,14)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td colspan="5"><bold>Câncer de traqueia, brônquios e pulmão (C33-C34)</bold><sup><bold>d</bold></sup></td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,038</td>
										<td>
										</td>
										<td align="center">0,044</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">199 (37,8)</td>
										<td align="center">144 (72,4)</td>
										<td>
										</td>
										<td align="center">27,6 (21,6–34,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">328 (62,2)</td>
										<td align="center">263 (80,2)</td>
										<td>
										</td>
										<td align="center">19,8 (15,7–24,3)</td>
										<td>
										</td>
										<td align="center">1,23 (1,01–1,51)</td>
										<td align="center">1,19 (0,97–1,46)</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,080</td>
										<td>
										</td>
										<td align="center">0,018</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">42 (8,0)</td>
										<td align="center">31 (73,8)</td>
										<td>
										</td>
										<td align="center">26,2 (14,1–40,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">117 (22,2)</td>
										<td align="center">81 (69,2)</td>
										<td>
										</td>
										<td align="center">30,8 (22,7–39,2)</td>
										<td>
										</td>
										<td align="center">0,96 (0,63–1,45)</td>
										<td align="center">0,96 (0,63–1,46)</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">166 (31,6)</td>
										<td align="center">132 (79,5)</td>
										<td>
										</td>
										<td align="center">20,5 (14,7–26,9)</td>
										<td>
										</td>
										<td align="center">1,27 (0,86–1,88)</td>
										<td align="center">1,18 (0,80–1,75)</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">201 (38,2)</td>
										<td align="center">163 (81,1)</td>
										<td>
										</td>
										<td align="center">18,9 (13,8–24,6)</td>
										<td>
										</td>
										<td align="center">1,42 (0,97–2,09)</td>
										<td align="center">1,34 (0,92–1,98)</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,258</td>
										<td>
										</td>
										<td align="center">0,013</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">241 (45,7)</td>
										<td align="center">179 (74,3)</td>
										<td>
										</td>
										<td align="center">25,7 (20,4–31,4)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">227 (43,1)</td>
										<td align="center">183 (80,6)</td>
										<td>
										</td>
										<td align="center">19,4 (14,5–24,8)</td>
										<td>
										</td>
										<td align="center">1,36 (1,11–1,67)</td>
										<td align="center">1,29 (1,05–1,59)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">59 (11,2)</td>
										<td align="center">45 (77,2)</td>
										<td>
										</td>
										<td align="center">23,7 (13,9–35,1)</td>
										<td>
										</td>
										<td align="center">1,10 (0,79–1,52)</td>
										<td align="center">1,29 (0,93–1,81)</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,617</td>
										<td>
										</td>
										<td align="center">0,445</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">478 (90,7)</td>
										<td align="center">368 (77,0)</td>
										<td>
										</td>
										<td align="center">23,0 (19,4–26,9)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">26 (4,9)</td>
										<td align="center">22 (84,6)</td>
										<td>
										</td>
										<td align="center">15,4 (4,8–31,5)</td>
										<td>
										</td>
										<td align="center">1,29 (0,84–1,98)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">23 (4,4)</td>
										<td align="center">17 (73,9)</td>
										<td>
										</td>
										<td align="center">26,1 (10,6–44,7)</td>
										<td>
										</td>
										<td align="center">0,89 (0,55–1,45)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,637</td>
										<td>
										</td>
										<td align="center">0,692</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">309 (58,6)</td>
										<td align="center">243 (78,6)</td>
										<td>
										</td>
										<td align="center">21,4 (17,0–26,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">168 (31,9)</td>
										<td align="center">127 (75,6)</td>
										<td>
										</td>
										<td align="center">24,4 (18,2–31,1)</td>
										<td>
										</td>
										<td align="center">0,99 (0,8–1,23)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">50 (9,5)</td>
										<td align="center">37 (74,0)</td>
										<td>
										</td>
										<td align="center">26,0 (14,9–38,6)</td>
										<td>
										</td>
										<td align="center">0,86 (0,61–1,22)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">60 (11,4)</td>
										<td align="center">36 (60,0)</td>
										<td>
										</td>
										<td align="center">40,0 (27,7–52,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">302 (57,3)</td>
										<td align="center">254 (84,1)</td>
										<td>
										</td>
										<td align="center">15,9 (12,0–20,3)</td>
										<td>
										</td>
										<td align="center">2,06 (1,45–2,92)</td>
										<td align="center">2,14 (1,40–2,85)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">165 (31,3)</td>
										<td align="center">117 (70,9)</td>
										<td>
										</td>
										<td align="center">29,1 (22,4–36,1)</td>
										<td>
										</td>
										<td align="center">1,34 (0,92–1,94)</td>
										<td align="center">1,38 (0,90–1,91)</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,487</td>
										<td>
										</td>
										<td align="center">0,503</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">93 (17,7)</td>
										<td align="center">72 (77,4)</td>
										<td>
										</td>
										<td align="center">22,6 (14,7–31,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">112 (21,3)</td>
										<td align="center">92 (82,1)</td>
										<td>
										</td>
										<td align="center">17,9 (11,4–25,5)</td>
										<td>
										</td>
										<td align="center">1,17 (0,86–1,59)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">105 (19,9)</td>
										<td align="center">77 (73,3)</td>
										<td>
										</td>
										<td align="center">26,7 (18,6–35,4)</td>
										<td>
										</td>
										<td align="center">0,93 (0,68–1,29)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">102 (19,4)</td>
										<td align="center">81 (79,4)</td>
										<td>
										</td>
										<td align="center">20,6 (13,4–28,9)</td>
										<td>
										</td>
										<td align="center">1,18 (0,86–1,62)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">115 (21,8)</td>
										<td align="center">85 (73,9)</td>
										<td>
										</td>
										<td align="center">26,1 (18,5–34,3)</td>
										<td>
										</td>
										<td align="center">1,03 (0,76–1,42)</td>
										<td align="center">-</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN4002">
									<p>S(t): probabilidade de sobrevivência em função do tempo; IC95%: intervalo de confiança de 95%; HR: razão de riscos proporcionais</p>
								</fn>
								<fn id="TFN5002">
									<p><sup>a</sup> Valor de p do teste qui-quadrado.</p>
								</fn>
								<fn id="TFN6002">
									<p><sup>b</sup> Valor de p do teste Log-rank.</p>
								</fn>
								<fn id="TFN7002">
									<p><sup>c</sup> HR ajustada por faixa etária, raça, escolaridade e extensão de doença.</p>
								</fn>
								<fn id="TFN8002">
									<p><sup>d</sup> HR ajustada por sexo, faixa etária, escolaridade e extensão de doença.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Outras faringes (C09-10; C12-14)</title>
					<p>Foram registrados 72 casos referentes a outras faringes, ou 2,6% do total. Desses, 59,7% foram a óbito até o fim do acompanhamento e a probabilidade de sobrevivência foi de 40,3% (IC95% 29,0–51,3) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). Foi mais frequente no sexo masculino, com menor escolaridade e naqueles com companheiro. Nenhuma variável se mostrou associada à sobrevivência e não foi realizada análise ajustada (<xref ref-type="table" rid="t2002">Tabela 2</xref>).</p>
				</sec>
				<sec>
					<title>Nasofaringe (C11)</title>
					<p>Diagnósticos de nasofaringe representaram 0,9%, com 24 casos. Desses, 50% foram a óbito e a probabilidade de sobrevivência foi de 50,0% (IC95% 29,1–67,8) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). Houve mais registros em homens, com 65 anos ou menos, e nove anos ou mais de escolaridade. Apenas a variável faixa etária apresentou valor de p &lt; 0,20, no qual o grupo com 66 anos ou mais demonstrou pior probabilidade de sobrevivência (<xref ref-type="table" rid="t2002">Tabela 2</xref>).</p>
				</sec>
				<sec>
					<title>Esôfago (C15)</title>
					<p>No período, houve 104 registros de câncer de esôfago, ou 3,7% do total. Foram a óbito 67,6% e a probabilidade de sobrevivência foi de 32,4% (IC95% 23,7–41,1) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). A pior sobrevivência foi encontrada entre aqueles do sexo masculino, de outras raças/cores, sem companheiro, com diagnóstico metastático. A análise ajustada incluiu as variáveis sexo, raça, situação conjugal, extensão da doença e ano do diagnóstico. Apenas outras cores/raças agrupadas se mantiveram como fator de pior prognóstico, com aumento de 2,5 no risco de óbito (<xref ref-type="table" rid="t3002">Tabela 3</xref>).</p>
					<p>
						<table-wrap id="t3002">
							<label>Tabela 3</label>
							<caption>
								<title>Descrição, sobrevivência e riscos proporcionais de óbito dos casos registrados de cânceres esôfago (C15), estômago (C16), colón e reto (C18-21), fígado (C22) e pâncreas (C25), Florianópolis, 2008–2017.</title>
							</caption>
							<table frame="hsides" rules="groups">
								<colgroup>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left" rowspan="3">Variáveis</th>
										<th rowspan="3">n (%)</th>
										<th>Óbitos</th>
										<th rowspan="3">p<sup>a</sup></th>
										<th rowspan="3">S(t) (IC95%)</th>
										<th rowspan="3">p<sup>b</sup></th>
										<th rowspan="3">HR bruta (IC95%)</th>
										<th rowspan="3">HR ajustada (IC95%)</th>
									</tr>
									<tr>
										<th>
											<hr/>
										</th>
									</tr>
									<tr>
										<th>n (%)</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td colspan="5"><bold>Câncer de esôfago (C15)</bold><sup><bold>c</bold></sup></td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,140</td>
										<td>
										</td>
										<td align="center">0,127</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">22 (21,0)</td>
										<td align="center">12 (54,6)</td>
										<td>
										</td>
										<td align="center">45,5 (24,4–64,3)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">83 (79,1)</td>
										<td align="center">59 (71,1)</td>
										<td>
										</td>
										<td align="center">28,9 (19,6–38,9)</td>
										<td>
										</td>
										<td align="center">1,62 (0,87–3,01)</td>
										<td align="center">1,64 (0,82–3,28)</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,577</td>
										<td>
										</td>
										<td align="center">0,351</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">9 (8,6)</td>
										<td align="center">7 (77,8)</td>
										<td>
										</td>
										<td align="center">22,2 (3,4–51,3)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">39 (37,1)</td>
										<td align="center">28 (71,8)</td>
										<td>
										</td>
										<td align="center">28,2 (15,3–42,7)</td>
										<td>
										</td>
										<td align="center">0,64 (0,28–1,48)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">24 (32,4)</td>
										<td align="center">20 (58,8)</td>
										<td>
										</td>
										<td align="center">41,2 (24,8–56,9)</td>
										<td>
										</td>
										<td align="center">0,47 (0,20–1,12)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">23 (21,9)</td>
										<td align="center">16 (69,6)</td>
										<td>
										</td>
										<td align="center">30,4 (13,5–49,3)</td>
										<td>
										</td>
										<td align="center">0,67 (0,28–1,64)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,457</td>
										<td>
										</td>
										<td align="center">0,486</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">31 (29,5)</td>
										<td align="center">21 (67,7)</td>
										<td>
										</td>
										<td align="center">32,3 (16,9–48,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">56 (53,3)</td>
										<td align="center">40 (71,4)</td>
										<td>
										</td>
										<td align="center">28,6 (17,5–40,7)</td>
										<td>
										</td>
										<td align="center">1,34 (0,79–2,27)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">18 (17,1)</td>
										<td align="center">10 (55,6)</td>
										<td>
										</td>
										<td align="center">44,4 (21,6–65,1)</td>
										<td>
										</td>
										<td align="center">1,01 (0,47–2,14)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,015</td>
										<td>
										</td>
										<td align="center">0,002</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">83 (79,1)</td>
										<td align="center">54 (65,1)</td>
										<td>
										</td>
										<td align="center">34,9 (24,9–45,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">16 (15,2)</td>
										<td align="center">15 (93,8)</td>
										<td>
										</td>
										<td align="center">6,3 (0,4–24,7)</td>
										<td>
										</td>
										<td align="center">2,54 (1,42–4,56)</td>
										<td align="center">2,50 (1,27–4,90)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">6 (5,7)</td>
										<td align="center">2 (33,3)</td>
										<td>
										</td>
										<td align="center">66,7 (19,5–90,4)</td>
										<td>
										</td>
										<td align="center">0,43 (0,10–1,76)</td>
										<td align="center">0,57 (0,09–3,35)</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,073</td>
										<td>
										</td>
										<td align="center">0,074</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">64 (61,0)</td>
										<td align="center">44 (68,8)</td>
										<td>
										</td>
										<td align="center">31,3 (20,4–42,7)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">27 (25,7)</td>
										<td align="center">21 (77,8)</td>
										<td>
										</td>
										<td align="center">22,2 (9,0–39,0)</td>
										<td>
										</td>
										<td align="center">1,52 (0,90–2,56)</td>
										<td align="center">1,39 (0,80–2,43)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">14 (13,3)</td>
										<td align="center">6 (42,9)</td>
										<td>
										</td>
										<td align="center">57,1 (28,4–78,0)</td>
										<td>
										</td>
										<td align="center">0,57 (0,24–1,35)</td>
										<td align="center">1,26 (0,38–4,17)</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,009</td>
										<td>
										</td>
										<td align="center">0,046</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">24 (22,9)</td>
										<td align="center">13 (54,2)</td>
										<td>
										</td>
										<td align="center">45,8 (25,6–64,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">37 (35,2)</td>
										<td align="center">32 (86,5)</td>
										<td>
										</td>
										<td align="center">13,5 (4,9–26,4)</td>
										<td>
										</td>
										<td align="center">1,96 (1,02–3,74)</td>
										<td align="center">2,09 (0,91–4,82)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">44 (41,9)</td>
										<td align="center">26 (59,1)</td>
										<td>
										</td>
										<td align="center">40,9 (26,5–54,8)</td>
										<td>
										</td>
										<td align="center">1,14 (0,59–2,22)</td>
										<td align="center">1,31 (0,58–2,96)</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,012</td>
										<td>
										</td>
										<td align="center">0,021</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">20 (19,1)</td>
										<td align="center">9 (45,0)</td>
										<td>
										</td>
										<td align="center">55,0 (31,3–73,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">18 (17,1)</td>
										<td align="center">17 (94,4)</td>
										<td>
										</td>
										<td align="center">5,6 (0,4–22,4)</td>
										<td>
										</td>
										<td align="center">3,43 (1,51–7,82)</td>
										<td align="center">2,61 (0,96–7,05)</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">18 (17,1)</td>
										<td align="center">10 (55,6)</td>
										<td>
										</td>
										<td align="center">44,4 (21,6–65,1)</td>
										<td>
										</td>
										<td align="center">1,32 (0,54–3,25)</td>
										<td align="center">1,25 (0,44–3,57)</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">15 (14,3)</td>
										<td align="center">12 (80,0)</td>
										<td>
										</td>
										<td align="center">20,0 (4,9–42,4)</td>
										<td>
										</td>
										<td align="center">2,16 (0,91–5,15)</td>
										<td align="center">1,67 (0,56–4,94)</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">34 (32,4)</td>
										<td align="center">23 (67,7)</td>
										<td>
										</td>
										<td align="center">32,4 (17,6–48)</td>
										<td>
										</td>
										<td align="center">1,72 (0,79–3,71)</td>
										<td align="center">1,23 (0,45–3,35)</td>
									</tr>
									<tr>
										<td colspan="7"><bold>Câncer de estômago (C16)</bold><sup><bold>d</bold></sup></td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,099</td>
										<td>
										</td>
										<td align="center">0,094</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">142 (42,6)</td>
										<td align="center">78 (54,9)</td>
										<td>
										</td>
										<td align="center">45,1 (36,8–53,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">191 (57,4)</td>
										<td align="center">122 (63,9)</td>
										<td>
										</td>
										<td align="center">36,1 (29,4–42,9)</td>
										<td>
										</td>
										<td align="center">1,27 (0,96–1,69)</td>
										<td align="center">1,21 (0,91–1,61)</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>59 anos ou menos</td>
										<td align="center">125 (37,5)</td>
										<td align="center">54 (43,2)</td>
										<td>
										</td>
										<td align="center">56,8 (47,7–64,9)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>60 anos ou mais</td>
										<td align="center">208 (62,5)</td>
										<td align="center">146 (70,2)</td>
										<td>
										</td>
										<td align="center">29,8 (23,7–36,1)</td>
										<td>
										</td>
										<td align="center">2,18 (1,59–2,98)</td>
										<td align="center">2,22 (1,62–3,03)</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,214</td>
										<td>
										</td>
										<td align="center">0,229</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">121 (36,3)</td>
										<td align="center">71 (58,7)</td>
										<td>
										</td>
										<td align="center">41,3 (32,5–49,9)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">182 (54,7)</td>
										<td align="center">115 (63,2)</td>
										<td>
										</td>
										<td align="center">36,8 (29,9–43,8)</td>
										<td>
										</td>
										<td align="center">1,18 (0,88–1,59)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">30 (9,0)</td>
										<td align="center">14 (46,7)</td>
										<td>
										</td>
										<td align="center">53,3 (34,3–69,1)</td>
										<td>
										</td>
										<td align="center">0,78 (0,44–1,38)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,229</td>
										<td>
										</td>
										<td align="center">0,277</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">293 (88,0)</td>
										<td align="center">177 (60,4)</td>
										<td>
										</td>
										<td align="center">39,6 (34,0–45,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">29 (8,7)</td>
										<td align="center">19 (65,5)</td>
										<td>
										</td>
										<td align="center">34,5 (18,2–51,5)</td>
										<td>
										</td>
										<td align="center">1,18 (0,74–1,90)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">11 (3,3)</td>
										<td align="center">4 (36,4)</td>
										<td>
										</td>
										<td align="center">63,6 (29,7–84,5)</td>
										<td>
										</td>
										<td align="center">0,50 (0,18–1,34)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,195</td>
										<td>
										</td>
										<td align="center">0,215</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">209 (62,8)</td>
										<td align="center">124 (59,3)</td>
										<td>
										</td>
										<td align="center">40,7 (34,0–47,2)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">98 (29,4)</td>
										<td align="center">64 (65,3)</td>
										<td>
										</td>
										<td align="center">34,7 (25,5–44,1)</td>
										<td>
										</td>
										<td align="center">1,16 (0,86–1,57)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">26 (7,8)</td>
										<td align="center">12 (46,2)</td>
										<td>
										</td>
										<td align="center">53,9 (33,3–70,6)</td>
										<td>
										</td>
										<td align="center">0,21 (0,38–1,24)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">0,002</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">54 (16,2)</td>
										<td align="center">20 (37)</td>
										<td>
										</td>
										<td align="center">63,0 (48,7–74,3)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">135 (40,5)</td>
										<td align="center">93 (68,9)</td>
										<td>
										</td>
										<td align="center">31,1 (23,5–39,0)</td>
										<td>
										</td>
										<td align="center">2,31 (1,42–3,75)</td>
										<td align="center">2,39 (1,46–3,88)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">144 (43,2)</td>
										<td align="center">87 (60,4)</td>
										<td>
										</td>
										<td align="center">39,6 (31,6–47,5)</td>
										<td>
										</td>
										<td align="center">2,00 (1,23–3,25)</td>
										<td align="center">1,92 (1,18–3,13)</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,594</td>
										<td>
										</td>
										<td align="center">0,714</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">55 (16,5)</td>
										<td align="center">36 (65,5)</td>
										<td>
										</td>
										<td align="center">34,6 (22,4–47,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">54 (16,2)</td>
										<td align="center">34 (63,0)</td>
										<td>
										</td>
										<td align="center">37,0 (24,4–49,7)</td>
										<td>
										</td>
										<td align="center">0,95 (0,59–1,52)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">77 (23,1)</td>
										<td align="center">42 (54,6)</td>
										<td>
										</td>
										<td align="center">45,5 (34,1–56,1)</td>
										<td>
										</td>
										<td align="center">0,76 (0,49–1,19)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">75 (22,5)</td>
										<td align="center">42 (56)</td>
										<td>
										</td>
										<td align="center">44,0 (32,6–54,8)</td>
										<td>
										</td>
										<td align="center">0,80 (0,51–1,25)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">72 (21,6)</td>
										<td align="center">46 (63,9)</td>
										<td>
										</td>
										<td align="center">36,1 (25,2–47,1)</td>
										<td>
										</td>
										<td align="center">0,91 (0,59–1,40)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td colspan="6"><bold>Câncer de cólon e reto (C18-21)</bold><sup><bold>e</bold></sup></td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,742</td>
										<td>
										</td>
										<td align="center">0,906</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">403 (49,6)</td>
										<td align="center">142 (35,2)</td>
										<td>
										</td>
										<td align="center">64,8 (59,9–69,2)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">410 (50,4)</td>
										<td align="center">149 (36,3)</td>
										<td>
										</td>
										<td align="center">63,7 (58,8–68,1)</td>
										<td>
										</td>
										<td align="center">1,01 (0,81–1,28)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">157 (19,3)</td>
										<td align="center">41 (26,1)</td>
										<td>
										</td>
										<td align="center">73,9 (66,3–80,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">186 (22,9)</td>
										<td align="center">50 (26,9)</td>
										<td>
										</td>
										<td align="center">73,1 (66,1–78,9)</td>
										<td>
										</td>
										<td align="center">1,01 (0,67–1,53)</td>
										<td align="center">1,17 (0,77–1,78)</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">206 (25,3)</td>
										<td align="center">76 (36,9)</td>
										<td>
										</td>
										<td align="center">63,1 (56,1–69,3)</td>
										<td>
										</td>
										<td align="center">1,48 (1,02–2,17)</td>
										<td align="center">1,61 (1,10–2,37)</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">264 (32,5)</td>
										<td align="center">124 (47,0)</td>
										<td>
										</td>
										<td align="center">53,0 (46,8–58,8)</td>
										<td>
										</td>
										<td align="center">2,15 (1,51–3,05)</td>
										<td align="center">2,54 (1,77–3,65)</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">443 (54,5)</td>
										<td align="center">150 (33,9)</td>
										<td>
										</td>
										<td align="center">66,1 (61,5–70,3)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">254 (31,2)</td>
										<td align="center">117 (46,1)</td>
										<td>
										</td>
										<td align="center">53,9 (47,6–59,8)</td>
										<td>
										</td>
										<td align="center">1,48 (1,17–1,89)</td>
										<td align="center">1,29 (1,01–1,66)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">116 (14,3)</td>
										<td align="center">24 (20,7)</td>
										<td>
										</td>
										<td align="center">79,3 (70,7–85,6)</td>
										<td>
										</td>
										<td align="center">0,58 (0,38–0,89)</td>
										<td align="center">0,64 (0,32–1,29)</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,028</td>
										<td>
										</td>
										<td align="center">0,045</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">703 (86,5)</td>
										<td align="center">262 (37,3)</td>
										<td>
										</td>
										<td align="center">62,7 (59,0–66,2)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">43 (5,3)</td>
										<td align="center">15 (34,9)</td>
										<td>
										</td>
										<td align="center">65,1 (49,0–77,3)</td>
										<td>
										</td>
										<td align="center">0,95 (0,56–1,60)</td>
										<td align="center">1,05 (0,62–1,80)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">67 (8,2)</td>
										<td align="center">14 (20,9)</td>
										<td>
										</td>
										<td align="center">79,1 (67,3–87,1)</td>
										<td>
										</td>
										<td align="center">0,51 (0,30–0,88)</td>
										<td align="center">1,32 (0,60–2,91)</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">436 (53,6)</td>
										<td align="center">150 (34,4)</td>
										<td>
										</td>
										<td align="center">65,6 (60,9–69,9)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">268 (33)</td>
										<td align="center">117 (43,7)</td>
										<td>
										</td>
										<td align="center">56,3 (50,2–62,0)</td>
										<td>
										</td>
										<td align="center">1,41 (1,11–1,80)</td>
										<td align="center">1,33 (1,05–1,71)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">109 (13,4)</td>
										<td align="center">24 (22,0)</td>
										<td>
										</td>
										<td align="center">78,0 (69,0–84,7)</td>
										<td>
										</td>
										<td align="center">0,62 (0,40–0,95)</td>
										<td align="center">0,80 (0,38–1,66)</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>In situ</td>
										<td align="center">31 (3,8)</td>
										<td align="center">5 (16,1)</td>
										<td>
										</td>
										<td align="center">83,9 (65,5–93)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">175 (21,5)</td>
										<td align="center">39 (22,3)</td>
										<td>
										</td>
										<td align="center">77,7 (70,8–83,2)</td>
										<td>
										</td>
										<td align="center">1,42 (0,56–3,61)</td>
										<td align="center">1,23 (0,49–3,16)</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">297 (36,5)</td>
										<td align="center">158 (53,2)</td>
										<td>
										</td>
										<td align="center">46,8 (41,0–52,4)</td>
										<td>
										</td>
										<td align="center">4,13 (1,69–10,06)</td>
										<td align="center">4,74 (1,92–11,66)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">310 (38,1)</td>
										<td align="center">89 (28,7)</td>
										<td>
										</td>
										<td align="center">71,3 (65,9–76)</td>
										<td>
										</td>
										<td align="center">1,94 (0,79–4,78)</td>
										<td align="center">1,95 (0,78–4,83)</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,008</td>
										<td>
										</td>
										<td align="center">0,005</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">136 (16,7)</td>
										<td align="center">48 (35,3)</td>
										<td>
										</td>
										<td align="center">64,7 (56,1–72,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">176 (21,7)</td>
										<td align="center">55 (31,3)</td>
										<td>
										</td>
										<td align="center">68,8 (61,3–75,0)</td>
										<td>
										</td>
										<td align="center">0,85 (0,58–1,25)</td>
										<td align="center">0,50 (0,33–0,75)</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">165 (20,3)</td>
										<td align="center">73 (44,2)</td>
										<td>
										</td>
										<td align="center">55,8 (47,9–63,0)</td>
										<td>
										</td>
										<td align="center">1,37 (0,95–1,97)</td>
										<td align="center">0,79 (0,53–1,18)</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">148 (18,2)</td>
										<td align="center">62 (41,9)</td>
										<td>
										</td>
										<td align="center">58,1 (49,7–65,6)</td>
										<td>
										</td>
										<td align="center">1,20 (0,82–1,75)</td>
										<td align="center">0,55 (0,36–0,84)</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">188 (23,1)</td>
										<td align="center">53 (28,2)</td>
										<td>
										</td>
										<td align="center">71,8 (64,8–77,7)</td>
										<td>
										</td>
										<td align="center">0,75 (0,51–1,11)</td>
										<td align="center">0,38 (0,25–0,59)</td>
									</tr>
									<tr>
										<td colspan="5"><bold>Câncer de fígado (C22)</bold><sup><bold>f</bold></sup></td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,727</td>
										<td>
										</td>
										<td align="center">0,407</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">29 (28,2)</td>
										<td align="center">24 (82,8)</td>
										<td>
										</td>
										<td align="center">17,2 (6,3–32,7)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">74 (71,8)</td>
										<td align="center">59 (79,7)</td>
										<td>
										</td>
										<td align="center">20,3 (12,0–30,0)</td>
										<td>
										</td>
										<td align="center">0,82 (0,51–1,32)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,022</td>
										<td>
										</td>
										<td align="center">0,182</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">18 (17,5)</td>
										<td align="center">10 (55,6)</td>
										<td>
										</td>
										<td align="center">44,4 (21,6–65,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">25 (24,3)</td>
										<td align="center">23 (92,0)</td>
										<td>
										</td>
										<td align="center">8,0 (1,4–22,5)</td>
										<td>
										</td>
										<td align="center">2,04 (0,97–4,31)</td>
										<td align="center">1,84 (0,86–3,94)</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">23 (22,3)</td>
										<td align="center">19 (82,6)</td>
										<td>
										</td>
										<td align="center">17,4 (5,4–35,0)</td>
										<td>
										</td>
										<td align="center">1,79 (0,83–3,86)</td>
										<td align="center">1,77 (0,82–3,82)</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">37 (35,9)</td>
										<td align="center">31 (83,8)</td>
										<td>
										</td>
										<td align="center">16,2 (6,6–29,6)</td>
										<td>
										</td>
										<td align="center">2,14 (1,05–4,38)</td>
										<td align="center">2,19 (1,06–4,53)</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,579</td>
										<td>
										</td>
										<td align="center">0,678</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">53 (51,4)</td>
										<td align="center">41 (77,4)</td>
										<td>
										</td>
										<td align="center">22,6 (12,5–34,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">36 (35,0)</td>
										<td align="center">31 (86,1)</td>
										<td>
										</td>
										<td align="center">13,9 (5,1–27,1)</td>
										<td>
										</td>
										<td align="center">1,23 (0,77–1,96)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">14 (13,6)</td>
										<td align="center">11 (78,6)</td>
										<td>
										</td>
										<td align="center">21,4 (5,2–44,8)</td>
										<td>
										</td>
										<td align="center">1,07 (0,55–2,09)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,606</td>
										<td>
										</td>
										<td align="center">0,010</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">94 (91,3)</td>
										<td align="center">75 (79,8)</td>
										<td>
										</td>
										<td align="center">20,2 (12,8–28,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">4 (3,8)</td>
										<td align="center">4 (100,0)</td>
										<td>
										</td>
										<td align="center">–</td>
										<td>
										</td>
										<td align="center">4,33 (1,53–12,26)</td>
										<td align="center">4,11 (1,40–12,07)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">5 (4,9)</td>
										<td align="center">4 (80,0)</td>
										<td>
										</td>
										<td align="center">20 (0,8–58,2)</td>
										<td>
										</td>
										<td align="center">1,07 (0,39–2,94)</td>
										<td align="center">0,85 (0,30–2,44)</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,529</td>
										<td>
										</td>
										<td align="center">0,507</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">54 (52,4)</td>
										<td align="center">44 (81,5)</td>
										<td>
										</td>
										<td align="center">18,5 (9,5–29,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">36 (35,0)</td>
										<td align="center">30 (83,3)</td>
										<td>
										</td>
										<td align="center">16,7 (6,8–30,4)</td>
										<td>
										</td>
										<td align="center">1,15 (0,72–1,83)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">13 (12,6)</td>
										<td align="center">9 (69,2)</td>
										<td>
										</td>
										<td align="center">30,8 (9,5–55,4)</td>
										<td>
										</td>
										<td align="center">0,74 (0,36–1,52)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,284</td>
										<td>
										</td>
										<td align="center">0,746</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">11 (10,7)</td>
										<td align="center">7 (63,6)</td>
										<td>
										</td>
										<td align="center">36,4 (11,2–62,7)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">40 (38,8)</td>
										<td align="center">34 (85,0)</td>
										<td>
										</td>
										<td align="center">15,0 (6,1–27,6)</td>
										<td>
										</td>
										<td align="center">1,33 (0,59–3,00)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">52 (50,5)</td>
										<td align="center">42 (80,8)</td>
										<td>
										</td>
										<td align="center">19,2 (9,9–30,9)</td>
										<td>
										</td>
										<td align="center">1,36 (0,61–3,03)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,212</td>
										<td>
										</td>
										<td align="center">0,203</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">25 (24,2)</td>
										<td align="center">18 (72,0)</td>
										<td>
										</td>
										<td align="center">28,0 (12,4–46)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">19 (18,4)</td>
										<td align="center">14 (73,7)</td>
										<td>
										</td>
										<td align="center">26,3 (9,6–46,8)</td>
										<td>
										</td>
										<td align="center">1,01 (0,50–2,03)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">22 (21,4)</td>
										<td align="center">21 (95,5)</td>
										<td>
										</td>
										<td align="center">4,6 (0,3–18,9)</td>
										<td>
										</td>
										<td align="center">1,84 (0,98–3,47)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">15 (14,6)</td>
										<td align="center">11 (73,3)</td>
										<td>
										</td>
										<td align="center">26,7 (8,3–49,6)</td>
										<td>
										</td>
										<td align="center">1,05 (0,50–2,23)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">22 (21,4)</td>
										<td align="center">19 (86,4)</td>
										<td>
										</td>
										<td align="center">13,6 (3,4–30,9)</td>
										<td>
										</td>
										<td align="center">1,57 (0,82–3,00)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td colspan="5"><bold>Câncer de pâncreas (C25)</bold><sup><bold>f</bold></sup></td>
										<td>
										</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,642</td>
										<td>
										</td>
										<td align="center">0,293</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">62 (55,4)</td>
										<td align="center">54 (87,1)</td>
										<td>
										</td>
										<td align="center">12,9 (6,0–22,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">50 (44,6)</td>
										<td align="center">42 (85,0)</td>
										<td>
										</td>
										<td align="center">16,0 (7,5–27,4)</td>
										<td>
										</td>
										<td align="center">0,81 (0,54–1,21)</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,340</td>
										<td>
										</td>
										<td align="center">0,072</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">10 (8,9)</td>
										<td align="center">7 (70,0)</td>
										<td>
										</td>
										<td align="center">30,0 (7,1–57,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">24 (21,4)</td>
										<td align="center">20 (83,3)</td>
										<td>
										</td>
										<td align="center">16,7 (5,2–33,7)</td>
										<td>
										</td>
										<td align="center">1,30 (0,55–3,08)</td>
										<td align="center">1,19 (0,49–2,87)</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">24 (21,4)</td>
										<td align="center">20 (83,3)</td>
										<td>
										</td>
										<td align="center">16,7 (5,2–33,7)</td>
										<td>
										</td>
										<td align="center">1,21 (0,51–2,85)</td>
										<td align="center">1,19 (0,50–2,82)</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">54 (48,2)</td>
										<td align="center">49 (90,7)</td>
										<td>
										</td>
										<td align="center">9,3 (3,4–18,7)</td>
										<td>
										</td>
										<td align="center">2,05 (0,93–4,54)</td>
										<td align="center">1,91 (0,85–4,29)</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,057</td>
										<td>
										</td>
										<td align="center">0,467</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">50 (44,6)</td>
										<td align="center">46 (92,0)</td>
										<td>
										</td>
										<td align="center">8,0 (2,6–17,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">54 (48,2)</td>
										<td align="center">42 (77,8)</td>
										<td>
										</td>
										<td align="center">22,2 (12,3–34)</td>
										<td>
										</td>
										<td align="center">0,79 (0,52–1,20)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">8 (7,2)</td>
										<td align="center">8 (100,0)</td>
										<td>
										</td>
										<td align="center">–</td>
										<td>
										</td>
										<td align="center">0,73 (0,34–1,54)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,236</td>
										<td>
										</td>
										<td align="center">0,638</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">97 (86,6)</td>
										<td align="center">81 (83,5)</td>
										<td>
										</td>
										<td align="center">16,5 (9,9–24,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">10 (8,9)</td>
										<td align="center">10 (100,0)</td>
										<td>
										</td>
										<td align="center">–</td>
										<td>
										</td>
										<td align="center">1,35 (0,70–2,62)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">5 (4,5)</td>
										<td align="center">5 (100,0)</td>
										<td>
										</td>
										<td align="center">–</td>
										<td>
										</td>
										<td align="center">0,89 (0,36–2,21)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,987</td>
										<td>
										</td>
										<td align="center">0,623</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">65 (58,0)</td>
										<td align="center">56 (86,2)</td>
										<td>
										</td>
										<td align="center">13,9 (6,8–23,3)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">40 (35,7)</td>
										<td align="center">34 (85,0)</td>
										<td>
										</td>
										<td align="center">15,0 (6,1–27,6)</td>
										<td>
										</td>
										<td align="center">1,23 (0,80–1,88)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">7 (6,3)</td>
										<td align="center">6 (85,7)</td>
										<td>
										</td>
										<td align="center">14,3 (0,7–46,5)</td>
										<td>
										</td>
										<td align="center">0,97 (0,42–2,24)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,638</td>
										<td>
										</td>
										<td align="center">0,172</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">8 (7,1)</td>
										<td align="center">7 (87,5)</td>
										<td>
										</td>
										<td align="center">12,5 (0,7–42,3)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">73 (65,2)</td>
										<td align="center">64 (87,7)</td>
										<td>
										</td>
										<td align="center">12,3 (6,1–21,0)</td>
										<td>
										</td>
										<td align="center">1,75 (0,80–3,82)</td>
										<td align="center">1,48 (0,67–3,45)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">31 (27,7)</td>
										<td align="center">25 (80,7)</td>
										<td>
										</td>
										<td align="center">19,4 (7,9–34,6)</td>
										<td>
										</td>
										<td align="center">1,24 (0,54–2,87)</td>
										<td align="center">0,87 (0,45–2,59)</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,764</td>
										<td>
										</td>
										<td align="center">0,885</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">14 (12,5)</td>
										<td align="center">12 (85,7)</td>
										<td>
										</td>
										<td align="center">14,3 (2,3–36,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">21 (18,8)</td>
										<td align="center">19 (90,5)</td>
										<td>
										</td>
										<td align="center">9,5 (1,6–26,1)</td>
										<td>
										</td>
										<td align="center">1,15 (0,56–2,37)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">28 (25,0)</td>
										<td align="center">25 (89,3)</td>
										<td>
										</td>
										<td align="center">10,7 (2,7–25,1)</td>
										<td>
										</td>
										<td align="center">1,09 (0,55–2,17)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">28 (25,0)</td>
										<td align="center">22 (78,6)</td>
										<td>
										</td>
										<td align="center">21,4 (8,7–37,8)</td>
										<td>
										</td>
										<td align="center">0,85 (0,42–1,72)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">21 (18,8)</td>
										<td align="center">18 (85,7)</td>
										<td>
										</td>
										<td align="center">14,3 (3,6–32,1)</td>
										<td>
										</td>
										<td align="center">1,06 (0,51–2,21)</td>
										<td align="center">-</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN9002">
									<p>S(t): probabilidade de sobrevivência em função do tempo; IC95%: intervalo de confiança de 95%; HR: razão de riscos proporcionais.</p>
								</fn>
								<fn id="TFN10002">
									<p><sup>a</sup> Valor de p do teste qui-quadrado.</p>
								</fn>
								<fn id="TFN11002">
									<p><sup>b</sup> Valor de p do teste Log-rank.</p>
								</fn>
								<fn id="TFN12002">
									<p><sup>c</sup> HR ajustada por sexo, raça, situação conjugal, extensão da doença e ano do diagnóstico.</p>
								</fn>
								<fn id="TFN13002">
									<p><sup>d</sup> HR ajustada por sexo, faixa etária e extensão da doença.</p>
								</fn>
								<fn id="TFN14002">
									<p><sup>e</sup> HR ajustada por faixa etária, raça, situação conjugal, extensão da doença e ano do diagnóstico.</p>
								</fn>
								<fn id="TFN15002">
									<p><sup>f</sup> HR ajustada por faixa etária e extensão da doença.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Estômago (C16)</title>
					<p>O câncer de estômago foi o terceiro mais frequente, com 333 casos (11,8% do total). Desses, 60,1% foram a óbito, e a probabilidade de sobrevivência foi de 39,9% (IC95% 34,7–45,2) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). As piores probabilidades de sobrevivência estiveram associadas a ter 60 anos ou mais e diagnóstico metastático. As variáveis sexo, faixa etária e extensão da doença foram incluídas na análise ajustada. O risco de óbito foi aumentado de forma independente entre os com 60 anos ou mais e naqueles com diagnóstico metastático ou registrados como sem informação da extensão da doença (<xref ref-type="table" rid="t3002">Tabela 3</xref>).</p>
				</sec>
				<sec>
					<title>Colón e reto (C18-21)</title>
					<p>O câncer de cólon e reto foi o mais frequente, com 813 registros (28,7% do total), dos quais 35,8% foram a óbito. A probabilidade de sobrevivência em cinco anos foi de 64,2% (IC95% 60,8–67,4) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). As piores taxas de sobrevivência foram entre as pessoas com 70 anos ou mais, com nove anos ou mais de escolaridade, da raça/cor branca e com diagnóstico metastático. Na análise ajustada, ter acima de 60 anos, oito anos ou menos de escolaridade, não ter companheiro e ter diagnóstico metastático aumentaram de forma independente o risco de óbito (<xref ref-type="table" rid="t3002">Tabela 3</xref>).</p>
				</sec>
				<sec>
					<title>Fígado (C22)</title>
					<p>O câncer de fígado teve 103 registros (3,6% do total), dos quais 80,6% foram a óbito. Esse câncer foi mais frequente em homens, pessoas brancas e com companheiro. A probabilidade de sobrevivência em cinco anos foi de 19,4% (IC95% 12,5–27,6), a segunda mais baixa (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). Essa foi associada à faixa etária e à raça. Na análise ajustada, ter 70 anos ou mais aumentou em 2,19 o risco de óbito, enquanto estar na categoria outra cor/raça, aumentou em 4 vezes (<xref ref-type="table" rid="t3002">Tabela 3</xref>).</p>
				</sec>
				<sec>
					<title>Pâncreas (C25)</title>
					<p>O câncer de pâncreas teve 112 casos registrados (4,0% do total) e no acompanhamento, 85,7% foram a óbito. Apresentou a pior probabilidade de sobrevivência em cinco anos, com 14,3% (IC95% 8,6–21,4) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). As probabilidades de sobrevivência foram baixas em todas as categorias de variáveis analisadas. Foram associadas à sobrevivência a faixa etária e a extensão da doença. Essas variáveis foram incluídas na análise ajustada, mas nenhuma aumentou de forma independente o risco de óbito (<xref ref-type="table" rid="t3002">Tabela 3</xref>).</p>
				</sec>
				<sec>
					<title>Laringe (C32)</title>
					<p>O câncer de laringe foi registrado em 88 pessoas (3,1% do total). No acompanhamento, 40,9% foram a óbito, e a probabilidade de sobrevivência em cinco anos foi de 59,1% (IC95% 48,1–68,5) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). Houve maior número de registros em homens, de 50 a 59 anos, com nove anos ou mais de escolaridade e com companheiro. Nenhuma variável foi associada à sobrevivência (<xref ref-type="table" rid="t2002">Tabela 2</xref>).</p>
				</sec>
				<sec>
					<title>Traqueia, Brônquios e Pulmão (C33-C34)</title>
					<p>O câncer de traqueia, brônquios e pulmão foi o terceiro mais frequente, com 527 casos (18,6% do total). No acompanhamento, 77,2% foram a óbito e a probabilidade de sobrevivência em cinco anos foi a terceira pior, 22,8% (IC95% 19,3–26,4) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). O diagnóstico foi mais frequente em homens, com mais de 60 anos, raça branca, com companheiro e extensão metastática. As variáveis sexo, faixa etária, escolaridade e extensão da doença foram adicionadas na análise ajustada. Os fatores de risco independentes para o óbito foram ter oito anos ou menos escolaridade (aumento de 18%) e o estadiamento metastático (incremento de 2,14) (<xref ref-type="table" rid="t2002">Tabela 2</xref>).</p>
				</sec>
				<sec>
					<title>Rim (C64-C66)</title>
					<p>O câncer de rim teve 177 registros (6,3% do total). Foram a óbito, em cinco anos, 24,3% da amostra, e a probabilidade de sobrevivência no mesmo período foi de 75,7% (IC95% 68,7–81,4) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). Foi mais frequente em homens, de raça branca e com companheiro. As piores taxas de sobrevivência foram registradas entre aqueles com 70 anos ou mais, de outras raças/cor, sem companheiro e com diagnóstico metastático. Na análise ajustada para faixa etária, escolaridade, raça, situação conjugal e extensão da doença, foram fatores de risco independentes para o óbito: ter idade de 70 anos ou mais (HR 3,77; IC95% 1,01–14,06) e ser da raça branca (HR 3,69; IC95% 1,20–11,29) (<xref ref-type="table" rid="t4002">Tabela 4</xref>).</p>
					<p>
						<table-wrap id="t4002">
							<label>Tabela 4</label>
							<caption>
								<title>Descrição, sobrevivência e riscos proporcionais de óbito dos casos registrados de cânceres de rim (C64-C66), bexiga (C67) e leucemia mieloide aguda (C92.0), Florianópolis, 2008–2017.</title>
							</caption>
							<table frame="hsides" rules="groups">
								<colgroup>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left" rowspan="3">Variáveis</th>
										<th rowspan="3">n (%)</th>
										<th>Óbitos</th>
										<th rowspan="3">p<sup>a</sup></th>
										<th rowspan="3">S(t) (IC95%)</th>
										<th rowspan="3">p<sup>b</sup></th>
										<th rowspan="3">HR bruta (IC95%)</th>
										<th rowspan="3">HR ajustada (IC95%)</th>
									</tr>
									<tr>
										<th>
											<hr/>
										</th>
									</tr>
									<tr>
										<th>n (%)</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td colspan="8"><bold>Câncer de Rim (C64-C66)</bold><sup><bold>c</bold></sup></td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,421</td>
										<td>
										</td>
										<td align="center">0,441</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">71 (40,1)</td>
										<td align="center">15 (21,1)</td>
										<td>
										</td>
										<td align="center">78,9 (67,4–86,7)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">106 (59,9)</td>
										<td align="center">28 (26,4)</td>
										<td>
										</td>
										<td align="center">73,6 (64,1–80,9)</td>
										<td>
										</td>
										<td align="center">1,28 (0,68–2,39)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,011</td>
										<td>
										</td>
										<td align="center">0,010</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">31 (17,5)</td>
										<td align="center">3 (9,7)</td>
										<td>
										</td>
										<td align="center">90,3 (72,9–96,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">51 (28,8)</td>
										<td align="center">9 (17,7)</td>
										<td>
										</td>
										<td align="center">82,4 (68,8–90,4)</td>
										<td>
										</td>
										<td align="center">1,89 (0,51–6,99)</td>
										<td align="center">1,54 (0,40–5,96)</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">62 (35,0)</td>
										<td align="center">17 (27,4)</td>
										<td>
										</td>
										<td align="center">72,6 (59,7–82,0)</td>
										<td>
										</td>
										<td align="center">3,12 (0,92–10,66)</td>
										<td align="center">2,57 (0,73–9,12)</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">33 (18,6)</td>
										<td align="center">14 (42,4)</td>
										<td>
										</td>
										<td align="center">57,6 (39,1–72,3)</td>
										<td>
										</td>
										<td align="center">5,33 (1,53–18,55)</td>
										<td align="center">3,77 (1,01–14,06)</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,129</td>
										<td>
										</td>
										<td align="center">0,158</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">91 (51,4)</td>
										<td align="center">24 (26,4)</td>
										<td>
										</td>
										<td align="center">73,6 (63,3–81,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">51 (28,8)</td>
										<td align="center">15 (29,4)</td>
										<td>
										</td>
										<td align="center">70,6 (56,0–81,1)</td>
										<td>
										</td>
										<td align="center">1,19 (0,62–2,26)</td>
										<td align="center">1,06 (0,54–2,07)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">35 (19,8)</td>
										<td align="center">4 (11,4)</td>
										<td>
										</td>
										<td align="center">88,6 (72,4–95,6)</td>
										<td>
										</td>
										<td align="center">0,42 (0,15–1,21)</td>
										<td align="center">0,94 (0,20–4,48)</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,023</td>
										<td>
										</td>
										<td align="center">0,020</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">152 (85,8)</td>
										<td align="center">38 (25,0)</td>
										<td>
										</td>
										<td align="center">75,0 (67,3–81,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">7 (4,0)</td>
										<td align="center">4 (57,1)</td>
										<td>
										</td>
										<td align="center">42,9 (9,8–73,4)</td>
										<td>
										</td>
										<td align="center">2,77 (0,99–7,78)</td>
										<td align="center">3,69 (1,20–11,29)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">18 (10,2)</td>
										<td align="center">1 (5,6)</td>
										<td>
										</td>
										<td align="center">94,4 (66,6–99,2)</td>
										<td>
										</td>
										<td align="center">0,20 (0,03–1,49)</td>
										<td align="center">0,40 (0,04–3,60)</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,061</td>
										<td>
										</td>
										<td align="center">0,073</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">92 (52,0)</td>
										<td align="center">23 (25,0)</td>
										<td>
										</td>
										<td align="center">75,0 (64,8–82,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">44 (24,9)</td>
										<td align="center">15 (34,1)</td>
										<td>
										</td>
										<td align="center">65,9 (50,0–77,9)</td>
										<td>
										</td>
										<td align="center">1,45 (0,76–2,78)</td>
										<td align="center">1,57 (0,80–3,12)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">41 (23,8)</td>
										<td align="center">5 (12,2)</td>
										<td>
										</td>
										<td align="center">87,8 (73,2–94,7)</td>
										<td>
										</td>
										<td align="center">0,47 (0,18–1,23)</td>
										<td align="center">0,96 (0,24–3,87)</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">33 (18,6)</td>
										<td align="center">6 (18,2)</td>
										<td>
										</td>
										<td align="center">81,8 (63,9–91,4)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">45 (25,4)</td>
										<td align="center">22 (48,9)</td>
										<td>
										</td>
										<td align="center">51,1 (35,8–64,5)</td>
										<td>
										</td>
										<td align="center">3,36 (1,36–8,29)</td>
										<td align="center">1,99 (0,75–5,29)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">99 (55,9)</td>
										<td align="center">15 (15,2)</td>
										<td>
										</td>
										<td align="center">84,9 (76,1–90,6)</td>
										<td>
										</td>
										<td align="center">0,81 (0,31–2,07)</td>
										<td align="center">0,57 (0,20–1,56)</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,956</td>
										<td>
										</td>
										<td align="center">0,969</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">37 (20,9)</td>
										<td align="center">8 (21,6)</td>
										<td>
										</td>
										<td align="center">78,4 (61,4–88,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">34 (19,2)</td>
										<td align="center">9 (26,5)</td>
										<td>
										</td>
										<td align="center">73,5 (55,3–85,3)</td>
										<td>
										</td>
										<td align="center">1,31 (0,50–3,39)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">49 (27,7)</td>
										<td align="center">13 (26,5)</td>
										<td>
										</td>
										<td align="center">73,5 (58,7–83,6)</td>
										<td>
										</td>
										<td align="center">1,22 (0,51–2,95)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">34 (19,2)</td>
										<td align="center">7 (20,6)</td>
										<td>
										</td>
										<td align="center">79,4 (61,6–89,6)</td>
										<td>
										</td>
										<td align="center">0,99 (0,36–2,73)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">23 (13,0)</td>
										<td align="center">6 (26,1)</td>
										<td>
										</td>
										<td align="center">73,9 (50,9–87,3)</td>
										<td>
										</td>
										<td align="center">1,24 (0,43–3,56)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td colspan="8"><bold>Câncer de Bexiga (C67)</bold><sup><bold>d</bold></sup></td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,938</td>
										<td>
										</td>
										<td align="center">0,987</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">73 (25,9)</td>
										<td align="center">22 (30,1)</td>
										<td>
										</td>
										<td align="center">69,9 (57,9–79,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">209 (74,1)</td>
										<td align="center">64 (30,6)</td>
										<td>
										</td>
										<td align="center">69,4 (62,6–75,1)</td>
										<td>
										</td>
										<td align="center">1,00 (0,62–1,63)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,002</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>49 anos ou menos</td>
										<td align="center">25 (8,9)</td>
										<td align="center">2 (8,0)</td>
										<td>
										</td>
										<td align="center">92,0 (71,6–97,9)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>50 a 59 anos</td>
										<td align="center">55 (19,5)</td>
										<td align="center">12 (21,8)</td>
										<td>
										</td>
										<td align="center">78,2 (64,8–87,0)</td>
										<td>
										</td>
										<td align="center">2,85 (0,64–12,75)</td>
										<td align="center">3,00 (0,66–13,52)</td>
									</tr>
									<tr>
										<td>60 a 69 anos</td>
										<td align="center">71 (25,2)</td>
										<td align="center">17 (23,9)</td>
										<td>
										</td>
										<td align="center">76,1 (64,3–84,4)</td>
										<td>
										</td>
										<td align="center">3,21 (0,74–13,90)</td>
										<td align="center">3,25 (0,74–14,19)</td>
									</tr>
									<tr>
										<td>70 anos ou mais</td>
										<td align="center">131 (46,5)</td>
										<td align="center">55 (42,0)</td>
										<td>
										</td>
										<td align="center">58,0 (49,1–65,9)</td>
										<td>
										</td>
										<td align="center">6,22 (1,52–25,51)</td>
										<td align="center">6,19 (1,49–25,82)</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,131</td>
										<td>
										</td>
										<td align="center">0,134</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">115 (40,8)</td>
										<td align="center">35 (30,4)</td>
										<td>
										</td>
										<td align="center">69,6 (60,3–77,1)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">109 (38,7)</td>
										<td align="center">39 (35,8)</td>
										<td>
										</td>
										<td align="center">64,2 (54,5–72,4)</td>
										<td>
										</td>
										<td align="center">1,24 (0,79–1,96)</td>
										<td align="center">1,09 (0,68–1,73)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">58 (20,6)</td>
										<td align="center">12 (20,7)</td>
										<td>
										</td>
										<td align="center">79,3 (66,5–87,7)</td>
										<td>
										</td>
										<td align="center">0,65 (0,34–1,26)</td>
										<td align="center">0,89 (0,36–2,19)</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,129</td>
										<td>
										</td>
										<td align="center">0,164</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">237 (84,0)</td>
										<td align="center">78 (32,9)</td>
										<td>
										</td>
										<td align="center">67,1 (60,7–72,7)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">12 (4,3)</td>
										<td align="center">2 (16,7)</td>
										<td>
										</td>
										<td align="center">83,3 (48,2–95,6)</td>
										<td>
										</td>
										<td align="center">0,47 (0,11–1,9)</td>
										<td align="center">0,65 (0,16–2,68)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">33 (11,7)</td>
										<td align="center">6 (18,2)</td>
										<td>
										</td>
										<td align="center">81,8 (63,9–91,4)</td>
										<td>
										</td>
										<td align="center">0,51 (0,22–1,18)</td>
										<td align="center">0,85 (0,27–2,68)</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,368</td>
										<td>
										</td>
										<td align="center">0,256</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">151 (53,6)</td>
										<td align="center">45 (29,8)</td>
										<td>
										</td>
										<td align="center">70,2 (62,2–76,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">78 (27,7)</td>
										<td align="center">28 (35,9)</td>
										<td>
										</td>
										<td align="center">64,1 (52,4–73,6)</td>
										<td>
										</td>
										<td align="center">1,36 (0,85–2,18)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">53 (18,8)</td>
										<td align="center">13 (24,5)</td>
										<td>
										</td>
										<td align="center">75,5 (61,5–85,0)</td>
										<td>
										</td>
										<td align="center">0,83 (0,45–1,54)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Extensão da doença</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td align="center">&lt; 0,001</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>In situ</td>
										<td align="center">17 (6,0)</td>
										<td align="center">5 (29,4)</td>
										<td>
										</td>
										<td align="center">70,6 (43,2–86,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">1,00</td>
									</tr>
									<tr>
										<td>Localizado</td>
										<td align="center">95 (33,7)</td>
										<td align="center">19 (20,0)</td>
										<td>
										</td>
										<td align="center">80,0 (70,5–86,7)</td>
										<td>
										</td>
										<td align="center">0,66 (0,25–1,78)</td>
										<td align="center">0,59 (0,22–1,58)</td>
									</tr>
									<tr>
										<td>Metastático</td>
										<td align="center">36 (12,8)</td>
										<td align="center">22 (61,1)</td>
										<td>
										</td>
										<td align="center">38,9 (23,3–54,2)</td>
										<td>
										</td>
										<td align="center">2,79 (1,06–7,37)</td>
										<td align="center">2,38 (0,89–6,33)</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">134 (47,5)</td>
										<td align="center">40 (29,9)</td>
										<td>
										</td>
										<td align="center">70,2 (61,6–77,1)</td>
										<td>
										</td>
										<td align="center">1,05 (0,41–2,66)</td>
										<td align="center">1,00 (0,39–2,56)</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,567</td>
										<td>
										</td>
										<td align="center">0,605</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">67 (23,8)</td>
										<td align="center">16 (23,9)</td>
										<td>
										</td>
										<td align="center">76,1 (64,0–84,6)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">58 (20,6)</td>
										<td align="center">20 (34,5)</td>
										<td>
										</td>
										<td align="center">65,5 (51,8–76,2)</td>
										<td>
										</td>
										<td align="center">1,53 (0,79–2,96)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">54 (19,2)</td>
										<td align="center">18 (33,3)</td>
										<td>
										</td>
										<td align="center">66,7 (52,4–77,5)</td>
										<td>
										</td>
										<td align="center">1,44 (0,74–2,83)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">54 (19,2)</td>
										<td align="center">19 (35,2)</td>
										<td>
										</td>
										<td align="center">64,8 (50,6–75,9)</td>
										<td>
										</td>
										<td align="center">1,57 (0,81–3,05)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">49 (17,4)</td>
										<td align="center">13 (26,5)</td>
										<td>
										</td>
										<td align="center">73,5 (58,7–83,6)</td>
										<td>
										</td>
										<td align="center">1,13 (0,54–2,34)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td colspan="8"><bold>Leucemia mieloide aguda (C92.0)</bold></td>
									</tr>
									<tr>
										<td>Sexo</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,934</td>
										<td>
										</td>
										<td align="center">0,819</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Feminino</td>
										<td align="center">15 (53,6)</td>
										<td align="center">9 (60,0)</td>
										<td>
										</td>
										<td align="center">40,0 (16,5–62,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Masculino</td>
										<td align="center">13 (46,4)</td>
										<td align="center">8 (61,5)</td>
										<td>
										</td>
										<td align="center">38,5 (14,1–62,8)</td>
										<td>
										</td>
										<td align="center">1,12 (0,43–2,90)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Faixa etária</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,247</td>
										<td>
										</td>
										<td align="center">0,205</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>65 anos ou menos</td>
										<td align="center">15 (55,6)</td>
										<td align="center">8 (53,3)</td>
										<td>
										</td>
										<td align="center">46,7 (21,2–68,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>66 anos ou mais</td>
										<td align="center">12 (44,4)</td>
										<td align="center">9 (75,0)</td>
										<td>
										</td>
										<td align="center">25,0 (6,0–50,5)</td>
										<td>
										</td>
										<td align="center">1,84 (0,71–4,81)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Escolaridade</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,010</td>
										<td>
										</td>
										<td align="center">0,015</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>9 anos ou mais</td>
										<td align="center">16 (57,1)</td>
										<td align="center">13 (81,3)</td>
										<td>
										</td>
										<td align="center">18,8 (4,6–40,3)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>8 anos ou menos</td>
										<td align="center">7 (25,0)</td>
										<td align="center">1 (14,3)</td>
										<td>
										</td>
										<td align="center">85,7 (33,4–97,9)</td>
										<td>
										</td>
										<td align="center">0,09 (0,01–0,72)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">5 (17,9)</td>
										<td align="center">3 (60,0)</td>
										<td>
										</td>
										<td align="center">40,0 (5,2–75,3)</td>
										<td>
										</td>
										<td align="center">0,45 (0,12–1,61)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Raça</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,444</td>
										<td>
										</td>
										<td align="center">0,432</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Branca</td>
										<td align="center">24 (85,7)</td>
										<td align="center">14 (62,5)</td>
										<td>
										</td>
										<td align="center">37,5 (19,0–56,0)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Outras</td>
										<td align="center">1 (3,6)</td>
										<td align="center">1 (100,0)</td>
										<td>
										</td>
										<td align="center">-</td>
										<td>
										</td>
										<td align="center">1,96 (0,25–15,37)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">3 (10,7)</td>
										<td align="center">1 (33,3)</td>
										<td>
										</td>
										<td align="center">66,7 (5,4–94,5)</td>
										<td>
										</td>
										<td align="center">0,35 (0,05–2,64)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Situação conjugal</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,819</td>
										<td>
										</td>
										<td align="center">0,827</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>Com companheiro</td>
										<td align="center">12 (42,9)</td>
										<td align="center">8 (66,7)</td>
										<td>
										</td>
										<td align="center">33,3 (10,3–58,8)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem companheiro</td>
										<td align="center">12 (42,9)</td>
										<td align="center">7 (58,3)</td>
										<td>
										</td>
										<td align="center">41,7 (15,3–66,5)</td>
										<td>
										</td>
										<td align="center">0,82 (0,30–2,27)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Sem informação</td>
										<td align="center">4 (14,3)</td>
										<td align="center">2 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (5,8–84,5)</td>
										<td>
										</td>
										<td align="center">0,63 (0,13–3,01)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>Ano do diagnóstico</td>
										<td>
										</td>
										<td>
										</td>
										<td align="center">0,584</td>
										<td>
										</td>
										<td align="center">0,714</td>
										<td>
										</td>
										<td>
										</td>
									</tr>
									<tr>
										<td>2008</td>
										<td align="center">4 (14,3)</td>
										<td align="center">2 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (5,8–84,5)</td>
										<td>
										</td>
										<td align="center">1,00</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2009</td>
										<td align="center">5 (17,9)</td>
										<td align="center">4 (80,0)</td>
										<td>
										</td>
										<td align="center">20,0 (0,8–58,2)</td>
										<td>
										</td>
										<td align="center">1,62 (0,30–8,90)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2010</td>
										<td align="center">6 (21,4)</td>
										<td align="center">3 (50,0)</td>
										<td>
										</td>
										<td align="center">50,0 (11,1–80,4)</td>
										<td>
										</td>
										<td align="center">0,72 (0,12–4,34)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2011</td>
										<td align="center">8 (28,6)</td>
										<td align="center">6 (75,0)</td>
										<td>
										</td>
										<td align="center">25,0 (3,7–55,8)</td>
										<td>
										</td>
										<td align="center">1,40 (0,28–6,96)</td>
										<td align="center">-</td>
									</tr>
									<tr>
										<td>2012</td>
										<td align="center">5 (17,9)</td>
										<td align="center">2 (40,0)</td>
										<td>
										</td>
										<td align="center">60,0 (12,6–88,2)</td>
										<td>
										</td>
										<td align="center">0,65 (0,09–4,62)</td>
										<td align="center">-</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN16002">
									<p>S(t): probabilidade de sobrevivência em função do tempo; IC95%: intervalo de confiança de 95%; HR: razão de riscos proporcionais.</p>
								</fn>
								<fn id="TFN17002">
									<p><sup>a</sup> Valor de p do teste c<sup>2</sup> (qui-quadrado).</p>
								</fn>
								<fn id="TFN18002">
									<p><sup>b</sup> Valor de p do teste Log-rank.</p>
								</fn>
								<fn id="TFN19002">
									<p><sup>c</sup> HR ajustada por faixa etária, escolaridade, raça, situação conjugal e extensão da doença.</p>
								</fn>
								<fn id="TFN20002">
									<p><sup>d</sup> HR ajustada por faixa etária, escolaridade, raça e extensão da doença.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Bexiga (C67)</title>
					<p>O câncer de bexiga teve 282 casos registrados (10,0% do total). Em cinco anos, 30,5% foram a óbito e a probabilidade de sobrevivência foi de 69,5% (IC95% 63,8–74,5) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). Foi mais frequente em homens, com 70 anos ou mais, com nove anos ou mais de escolaridade, da raça branca, com companheiro e diagnóstico localizado. As variáveis associadas à sobrevivência foram faixa etária e extensão da doença. Na análise ajustada, foram incluídas as variáveis faixa etária, escolaridade, raça e extensão da doença. Apenas ter 70 anos ou mais foi fator independente para pior prognóstico, com aumento de seis vezes no risco de óbito (<xref ref-type="table" rid="t4002">Tabela 4</xref>).</p>
				</sec>
				<sec>
					<title>Leucemia mieloide aguda (C92.0)</title>
					<p>A LMA foi registrada em 28 casos e, desses, 60,7% foram a óbito. Em cinco anos, a probabilidade de sobrevivência foi de 39,3% (IC95% 21,7–56,5) (<xref ref-type="table" rid="t1002">Tabela 1</xref> e <xref ref-type="fig" rid="f01002">Figura 1</xref>). A distribuição dos casos foi similar entre sexo e idade, mais frequente naqueles com nove anos ou mais de escolaridade e de raça branca. Nenhuma das características foi associada à sobrevivência.</p>
				</sec>
			</sec>
			<sec sec-type="discussion">
				<title>DISCUSSÃO</title>
				<p>Os achados da presente pesquisa demonstram que a sobrevivência e os fatores prognósticos variam de acordo com cada tipo de câncer relacionado ao tabaco no município de Florianópolis (SC). A maior probabilidade de sobrevivência foi encontrada no câncer de rim (75,7%), enquanto as menores, no câncer de pâncreas (14,3%), fígado (19,4%) e traqueia, brônquios e pulmão (22,8%). Os valores obtidos podem ser justificados por Santa Catarina apresentar longevidade 3,2 anos acima da média nacional e ter como perfil epidemiológico da população idosa a tripla carga de doenças, com forte predomínio das condições crônicas<sup><xref ref-type="bibr" rid="B13">13</xref></sup>. O Brasil está entre os países com maior redução na prevalência de tabagismo na população no período de 1990 a 2015, devido à adoção de políticas públicas<sup><xref ref-type="bibr" rid="B3">3</xref></sup>. Cabe destacar que há maior prevalência de adultos fumantes com 18 anos ou mais (14,7%) na região Sul, o que contribui como fator de risco para o aumento dessas doenças, e muitos dos fatores de risco para o óbito são relacionados ao tabagismo, como ser mais velho e ter menor escolaridade.</p>
				<p>As neoplasias com maiores frequências encontradas neste estudo foram câncer de colo e reto, estômago e traqueia, brônquios e pulmão, o que se assemelha ao padrão encontrado nas regiões Sul e Sudeste que os coloca entre os cinco tipos mais incidentes. Os estudos que analisam a sobrevivência e os fatores prognósticos desses grupos de neoplasias são escassos. Visto que apresentam comportamentos diferentes, cada um dos tipos de câncer será discutido separadamente.</p>
				<sec>
					<title>Câncer de lábio e cavidade oral</title>
					<p>Os achados deste estudo apresentam probabilidade de sobrevida de 57,9% e 65% para homens e mulheres, respectivamente. Outra pesquisa realizada no Rio Grande do Norte, que avaliou apenas dados sobre câncer de lábio, identificou que a sobrevida em cinco anos foi de 88,9% para homens e 87,3% para mulheres<sup><xref ref-type="bibr" rid="B14">14</xref></sup>. Pessoas com diagnóstico de cânceres de lábio, boca e faringe (CID-10 C00-C14) tiveram sobrevivência de 33,3% ao final de cinco anos de acompanhamento em Santa Catarina e o estadiamento ao diagnóstico foi o maior fator de risco para o óbito<sup><xref ref-type="bibr" rid="B15">15</xref></sup>. Entretanto, os casos de lábio e cavidade oral foram classificados no mesmo grupo. Nos dois estudos, a maioria dos casos foi diagnosticada no sexo masculino e em idade avançada, corroborando estes resultados. No estágio inicial, o câncer de lábio e cavidade oral costuma ser assintomático, o que leva ao diagnóstico tardio e com metástase<sup><xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B16">16</xref></sup>, piorando a sobrevivência e a qualidade de vida.</p>
				</sec>
				<sec>
					<title>Câncer de orofaringe</title>
					<p>Pesquisas têm demostrado maior acometimento desse tipo de câncer no sexo masculino, na faixa etária entre 50–60 anos, e baixas taxas de sobrevivência, o que vem ao encontro dos achados deste estudo<sup><xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref></sup>.</p>
					<p>Estudo realizado no Sul do Brasil com o intuito de observar a sobrevivência após câncer de orofaringe e boca identificou piores índices de sobrevida em indivíduos com tumores de orofaringe, associando tal dado à presença de metástase cervical e à maior disseminação tumoral, além da localização em regiões de difícil visualização e diagnóstico, o que contribui negativamente para as taxas de sobrevida<sup><xref ref-type="bibr" rid="B18">18</xref></sup>.</p>
					<p>A literatura também indica que o abuso de álcool e a presença de doença em estágio avançado atuam como principais fatores de risco para piores resultados de sobrevida<sup><xref ref-type="bibr" rid="B17">17</xref></sup>.</p>
				</sec>
				<sec>
					<title>Câncer de esôfago</title>
					<p>Uma revisão sistemática realizada em 2015 mostrou que a sobrevida por câncer de esôfago, em cinco anos, varia entre 10% e 15%, considerada baixa. Ainda, que é uma doença rara antes dos 30 anos de idade<sup><xref ref-type="bibr" rid="B19">19</xref></sup>. No presente estudo, a maior frequência foi na faixa etária entre 50 e 59 anos. Também foi realizado um levantamento com dados de diagnóstico entre os anos de 1997 e 2006 na Alemanha e nos Estados Unidos (EUA), no qual a sobrevida em cinco anos foi de 18% na Alemanha e de 17% nos EUA<sup><xref ref-type="bibr" rid="B20">20</xref></sup>, mais baixa do que a encontrada no presente estudo. A baixa probabilidade de sobrevivência ao câncer de esôfago é reflexo do diagnóstico tardio, que na maioria das vezes se deve à ausência de sinais clínicos no estágio inicial<sup><xref ref-type="bibr" rid="B21">21</xref></sup>, apesar de nossos resultados não apresentarem fatores de pior prognóstico.</p>
				</sec>
				<sec>
					<title>Câncer de estômago</title>
					<p>A taxa de sobrevivência em cinco anos para câncer de estômago é em torno de 31%, dado encontrado em estudos realizados nos Estados Unidos e na Alemanha, o que condiz com os achados deste estudo<sup><xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref></sup>. Em Florianópolis, também foram encontradas taxas de sobrevida abaixo de 50% para ambos os sexos (45,1% para as mulheres e 36,1% para os homens)<sup><xref ref-type="bibr" rid="B23">23</xref></sup>.</p>
					<p>Apesar dos avanços no diagnóstico e tratamento, a doença mantém-se com alta letalidade, o quinto câncer mais frequentemente diagnosticado e o terceiro mais letal. As taxas médias de sobrevivência refletem o fato de que a maioria das pessoas é diagnosticada com presença de metástases. Trata-se de uma doença com heterogeneidade histológica e etiológica<sup><xref ref-type="bibr" rid="B22">22</xref></sup>; portanto, a prevenção primária através do controle de fatores de risco bem estabelecidos (como fumo, consumo excessivo de álcool, ingesta de alimentos com alto teor de sal) é essencial para a redução das taxas de incidência, e alertas sobre os sinais e sintomas são essenciais para o diagnóstico precoce.</p>
				</sec>
				<sec>
					<title>Câncer de colón e reto</title>
					<p>Os achados do presente estudo vão ao encontro de pesquisas que identificaram taxa de sobrevida global, em cinco anos, para pessoas com câncer colorretal, entre 63 a 65% e pior prognóstico na faixa etária acima de 70 anos<sup><xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref></sup>.</p>
					<p>As taxas de sobrevida podem variar de acordo com o estágio e a localização primária da doença. Nas neoplasias metastáticas ou estágio IV, a taxa de sobrevida relativa é baixa, o que também foi identificado neste estudo. Logo, os tumores em cenário metastático tornam o tratamento mais complexo e tendem a ter pior perspectiva<sup><xref ref-type="bibr" rid="B25">25</xref></sup>. Além disso, destaca-se que a maior sobrevivência pode estar relacionada ao início precoce do tratamento, independentemente de outras características<sup><xref ref-type="bibr" rid="B24">24</xref></sup>.</p>
				</sec>
				<sec>
					<title>Câncer de fígado</title>
					<p>Apesar de algumas melhorias nas taxas de sobrevida do câncer de fígado nas décadas mais recentes, o prognóstico geral para tal doença permanece desfavorável. Estudo realizado nos Estado Unidos, em 2017, revela taxa de sobrevida em cinco anos de 21% no geral, variando de 4% para doença em estágio distante a 37% para doença localizada<sup><xref ref-type="bibr" rid="B26">26</xref></sup>, o que se aproxima do dado encontrado neste estudo.</p>
					<p>A literatura denota maiores taxas quanto à sobrevida desses indivíduos, o que pode estar relacionado a melhor controle dos fatores de risco, detecção e tratamento precoces, remetendo à qualidade da assistência em saúde prestada<sup><xref ref-type="bibr" rid="B24">24</xref></sup>.</p>
				</sec>
				<sec>
					<title>Câncer de pâncreas</title>
					<p>O câncer de pâncreas apresenta uma alta letalidade e apesar de não estar entre os dez tipos mais comuns, representa a oitava principal causa de morte. Em grande parte de seus casos, o diagnóstico é realizado em fase tardia, o que dificulta a possibilidade de tratamento curativo. A taxa de sobrevida conhecida é por volta de 5% em cinco anos<sup><xref ref-type="bibr" rid="B28">28</xref></sup>. No presente estudo, a taxa de sobrevida foi levemente superior, de 12,9% para mulheres e 16,0% para homens, o que ainda reflete uma baixa sobrevida.</p>
					<p>Quanto aos fatores de risco independente para o óbito, apenas a idade avançada foi significativa para esses achados, o que encontra sustentação na literatura em relação ao predomínio de indivíduos acometidos na sexta década de vida<sup><xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref></sup>.</p>
				</sec>
				<sec>
					<title>Câncer de brônquios, traqueia e pulmão</title>
					<p>Neste estudo, o câncer de brônquios, traqueia e pulmão foi o segundo mais diagnosticado. No entanto, no mundo, este é o tipo mais incidente, com 2,1 milhões de casos, acometendo mais os homens e geralmente detectado em casos mais avançados<sup><xref ref-type="bibr" rid="B4">4</xref></sup>.</p>
					<p>Pesquisa realizada em Florianópolis apresentou resultados similares aos aqui encontrados, com taxas de sobrevivência de 22,5%<sup><xref ref-type="bibr" rid="B23">23</xref></sup>. Tais taxas são superiores às relatadas em levantamento realizado na Espanha, que em cinco anos, obteve 14%<sup><xref ref-type="bibr" rid="B30">30</xref></sup>.</p>
					<p>O risco de ocorrência do câncer de pulmão e consequente morte pela doença está relacionado a maior intensidade de exposição ao tabagismo, além de fatores como a exposição ocupacional a agentes químicos ou físicos<sup><xref ref-type="bibr" rid="B30">30</xref></sup>.</p>
				</sec>
				<sec>
					<title>Câncer de bexiga</title>
					<p>O câncer de bexiga é o mais frequente no trato urinário e acomete com mais frequência homens, resultados similares aos deste estudo<sup><xref ref-type="bibr" rid="B4">4</xref></sup>. A sobrevida global em cinco anos identificada neste estudo está entre os 60% a 80% descritos na literatura<sup><xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B31">31</xref></sup>.</p>
					<p>Entre os casos recém-diagnosticados, aproximadamente 30% têm se apresentado com a doença localmente avançada ou metastática. No entanto, o maior acesso da população a métodos de diagnóstico por imagem tem ampliado os diagnósticos precoces, cujas taxas refletem resultados muito mais favoráveis<sup><xref ref-type="bibr" rid="B31">31</xref></sup>.</p>
				</sec>
				<sec>
					<title>Leucemia mieloide aguda</title>
					<p>A LMA é um dos quatro tipos mais frequentes de leucemia e o que mais acomete adultos<sup><xref ref-type="bibr" rid="B4">4</xref></sup>. Os achados deste estudo são semelhantes aos encontrados em pesquisa realizada nos Estados Unidos, que demonstrou que indivíduos com diagnóstico de LMA e 75 anos ou mais tiveram taxas de sobrevida mais baixas em comparação com outras faixas etárias<sup><xref ref-type="bibr" rid="B32">32</xref></sup>.</p>
					<p>Outro estudo realizado nos EUA denota que idosos com LMA têm mais comorbidades e maiores taxas de complicações quando comparados a controles sem câncer. Assim, a presença de comorbidades, disfunção orgânica anterior e uma percepção de inaptidão à quimioterapia intensiva interferem nas taxas de sobrevida desta população<sup><xref ref-type="bibr" rid="B33">33</xref></sup>.</p>
				</sec>
			</sec>
			<sec sec-type="conclusions">
				<title>CONSIDERAÇÕES FINAIS</title>
				<p>Este estudo apresentou a taxa de sobrevivência e fatores prognósticos para 13 tipos de câncer que são relacionados ao tabaco. Os fatores de pior prognóstico e as taxas de sobrevivência diferem entre os tipos. O estadiamento foi o fator de risco de pior prognóstico mais frequente, demonstrando a importância de campanhas para alertar sobre prevenção primária e diagnóstico precoce. O tabagismo permanece como um dos principais fatores de risco para diversas DCNTs, entre elas o câncer, e com isso impacta diretamente na carga de doenças, com custos sociais, econômicos e perda da qualidade de vida.</p>
				<p>O estudo apresenta limitações relacionadas à utilização de dados secundários, o que resulta em ausência de informações que poderiam complementá-lo, como dados sobre o perfil socioeconômico e status do tabagismo. Da mesma forma, a ocorrência de dados incompletos devido à falta da informação ou erro de digitação no SIM dificulta a análise dos dados e pode interferir nos resultados da pesquisa. Destaca-se também a falta de informação sobre o hábito tabágico durante a vida, já que esta poderia reforçar para a população a importância do tabagismo enquanto fator de risco para o desenvolvimento e evolução da doença.</p>
				<p>Entre os pontos positivos, destaca-se os índices de qualidade do RCBP, o percentual de verificação histológica – 92,6% –, o percentual de casos identificados somente pela declaração de óbito – 2,68% – e o percentual de casos diagnosticados com localização primária desconhecida (C80.9) – 0,83% – durante o período de 2008 a 2012. Além disso, o SIM de Santa Catarina tem alta completude.</p>
				<p>Florianópolis segue o comportamento do Sul do país, como já identificado em outros estudos, tal como o panorama internacional para alguns tipos de câncer. A Política Nacional para a Prevenção e Controle do Câncer baseia-se em dados de estudos nacionais e internacionais para o direcionamento de suas ações. Nesse sentido, este estudo pode contribuir para a adequação das políticas e ações às realidades locais, visto que existe uma diversidade sociocultural, econômica e populacional muito grande no país. Tais realidades impactam diretamente nos dados encontrados nas diferentes regiões brasileiras. Para o controle do câncer, é essencial conhecer as características locais, que dialogam com as características sociais e de acesso à saúde do território. Compreender o comportamento da doença através da análise de sobrevida é uma das formas de embasar a realização dos trabalhos de prevenção, promoção e conscientização.</p>
				<p>Os achados deste estudo ainda reforçam a necessidade de investimento público na política de controle do tabagismo, a fim de ampliar e garantir o acesso da população às políticas a nível local, visto que todas as neoplasias aqui abordadas têm relação com o uso do tabaco e integram os planos de enfrentamento à DCNT. Apesar das leis que respaldam os casos de suspeita ou diagnóstico de neoplasia, da lei antitabaco do município de Florianópolis e da Política de Controle do Tabagismo, é necessário extrapolar os dados encontrados para os profissionais de saúde e gestores, visando o fortalecimento e consolidação das medidas de prevenção, detecção precoce, rastreamento e tratamento adequado para o câncer.</p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="financial-disclosure" id="fn2002">
					<p><bold>Financiamento:</bold> Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina, no Programa de Pesquisa para o SUS: Gestão Compartilhada em Saúde (PPSUS - Termo de Outorga n° 2016RT2206).</p>
				</fn>
			</fn-group>
		</back>
	</sub-article>
</article>